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ZUSAMMENFASSUNG 
Die Direktionalität chemischer Synapsen sowie die Zelltyp-, Zelldomänen- und Neurotransmitter-
spezifischen Innervierungsmuster neuronaler Netze im zentralen Nervensystem (ZNS) implizieren, 
dass Mechanismen existieren, die synaptische Spezifität gewährleisten. Die Erkenntnis, dass 
synaptische Proteine eine grosse molekulare Vielfalt aufweisen, hat zur Hypothese geführt, dass die 
Kombination synaptischer Proteine einen molekularen Code darstellt, der die Identität von Synapsen 
bestimmt. Diese Hypothese wurde in dieser Arbeit am Beispiel des GABAergen Neurotransmitter-
Systems geprüft. Zwei synaptische Proteine, mit selektiv GABAerger und postsynaptischer 
Lokalisierung, wurden auf ihren Beitrag zur Spezifizierung GABAerger Synapsen in Bezug auf ihre 
präsynaptische Innervierung untersucht. Mittels Gen-Ablationsexperimenten in Mäusen wurde die 
Rolle des Dystrophin-Glykoprotein Komplexes (DGC) in der Bildung und im Unterhalt von Synapsen 
einer spezifischen Untergruppe GABAerger Interneuronen, der Cholecystokinin (CCK)-positiven 
Korbzellen, aufgedeckt. Der DGC hat folglich eine Funktion in der Spezifizierung von Synapsen 
innerhalb eines Neurotransmitter-Systems. Im Gegensatz dazu haben Ablations- und 
Überexpressionsexperimente des Dystrophin-Interaktionspartners synArfGEF in Primärneuronen 
gezeigt, dass dieses GABAerge postsynaptische Protein die Koordinierung von prä- und 
postsynaptischen GABAergen Strukturen kontrolliert. Somit trägt synArfGEF zur Spezifizierung von 
Synapsen zwischen Neurotransmitter-Systemen bei. 
Durch die konditionelle Deletion des Dag1 Gens, das für Dystroglycan (DG) kodiert, in 
Pyramidalzellen mittels der NEX-Cre-Linie, wurde die Ablation des neuronalen DGC erreicht. Dies 
hat die Untersuchung der Funktion des neuronalen DGC erlaubt, ohne begleitende Defizite in 
neuronaler Migration, die von der Beeinträchtigung der Funktion des DGC in Gliazellen ausgehen 
würde. Die immunhistochemische Analyse postsynaptischer GABAerger Proteine in Gewebe des 
Hippocampus und Neocortex von konditionellen knock-out (cKO)-Mäusen konnte nur geringe 
Abweichungen zu Kontrollmäusen nachweisen, weshalb eine obligatorische Rolle des DGC für die 
synaptische Aggregierung von Proteinen der postsynaptischen Dichte (PSD) ausgeschlossen werden 
konnte. Dieses Ergebnis steht schwerwiegenden Veränderungen der Immunoreaktivität 
präsynaptischer Markerproteinen gegenüber. DG-Ablation führte zum Verlust von 
immunhistochemischen Markern von Axonterminalen der CCK-positiven Korbzellen, aber nicht der 
Parvalbumin (PV)-positiven Korbzellen. Des Weiteren waren unspezifische Marker GABAerger 
Axonterminale nicht beeinträchtigt durch die Ablation von DG. Weil der spezifische Verlust der 
Epitope von CCK-positiven Axonterminalen nicht nur im Erwachsenenalter sondern auch in 21 Tage 
alten Mäusen beobachtet wurde, ist eine Funktion des DGC in der Bildung von Axonterminalen der 
CCK-positiven Korbzellen wahrscheinlich. Die Zufuhr von Cre mittels viralem Vektor in die Cornu 
ammonis 1 (CA1)-Region von Mäusen mit gefloxtem Dag1 Gen ermöglichte die Ablation von DG im 
Erwachsenenalter. Der Verlust von DG lange nach dem entwicklungsbedingten ersten Schub der 
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Synaptogenese resultierte unerwarteterweise in einer Reduktion eines Axonterminal-Markers, der 
spezifisch ist für CCK-positive Korbzellen, was eine Funktion von DG in trans-synaptischer 
Signalübertragung nahelegt. Die physiologischen Konsequenzen des Verlustes der Axonterminale 
CCK-positiver Korbzellen wurden anhand von Patch-Clamp Messungen von spontanen 
inhibitorischen postsynaptischen Strömen (sIPSC) in DG-defizienten Pyramidalzellen untersucht. Eine 
Reduktion der sIPSC-Amplitude und -Frequenz deutete auf funktionelle Defizite in CCK-positiven 
Axonterminalen hin, was durch das Unvermögen von Carbachol, eine sIPSC-Frequenzerhöhung 
auszulösen, bestätigt wurde. Da DG an Neurexin bindet, abhängig von dessen alternativen Splice 
Inserts, wurde abschliessend die Erfordernis der Neurexinbindung für die Bildung der CCK-positiven 
Axonterminale anhand der Neurexin-bindungsunfähigen DG T190M Mutante geprüft. Die CCK-
positiven Axonterminale waren nicht beeinträchtigt in DG T190M knock-in (KI) Mäusen, was 
nahelegt, dass ein neuartiger präsynaptischer DG Bindungspartner für die trans-synaptische 
Signalübertragung an CCK-positiven Axonterminalen verantwortlich ist. Insgesamt weisen diese 
Ergebnisse eine entscheidende Funktion des DGC in der Übertragung synaptischer Spezifität 
innerhalb des GABAergen Neurotransmitter-Systems nach und dienen als Ausgangspunkt für 
ätiologische Untersuchungen von Dystroglycanopathien mit geistiger Behinderung. 
In einer Reihe von Zellkultur- und in vitro-Experimenten wurde die Rolle des GTP-Austauschfaktors 
(GEF) synArfGEF für die synaptische Spezifität analysiert. Obwohl synArfGEF ein Dystrophin-
interagierendes Motiv enthält konnte eine Bindung an Gephyrin nachgewiesen werden, was auf eine 
allgemeinere Funktion im GABAergen System hindeutete. Deshalb wurde die Rolle von synArfGEF 
in der Koordinierung synaptischer Strukturen anhand von prä- und postsynaptischen Markern in 
Kulturen von hippocampalen Ratten-Primärneuronen untersucht. Ablation von synArfGEF mithilfe 
des Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9-Systems führte zu 
einer Erhöhung des Anteils an Gephyrin-Clustern, die mit glutamatergen Axonterminalen fehlgepaart 
waren. Die spezifische Funktion von synArfGEF in fehlgepaarten GABAergen postsynaptischen 
Strukturen wurde bestätigt durch die Beobachtung dass die Gephyrin Cluster-Dichte insgesamt nicht 
durch die Ablation von synArfGEF beeinflusst wurde. Für eine genauere Betrachtung der 
Mechanismen, die dieser Regulierung zugrunde liegen, wurden synArfGEF-Konstrukte in Domänen 
mit bekannter Funktion mutiert und in primären hippocampalen Neuronen überexprimiert. Die 
Überexprimierung eines Konstrukts, das eine mutierte, für die GEF-Funktion wichtige, Sec7-Domäne 
enthielt, führte zu einer Erhöhung des Anteils an fehlgepaarten GABAergen PSD-Proteinen. Der 
Befund dass diese Mutante keinen Einfluss auf die Koordination des glutamatergen PSD-Proteins 
PSD-95 mit präsynaptischen Strukturen hatte, bestätigte, dass die Funktion von synArfGEF auf 
GABAerge PSD-Proteine beschränkt ist. Weil die Überexpression von Mutanten des potentiellen 
synArfGEF-Substrats Adenosyl-Ribosylierungs-Faktor 6 (Arf6) den Phänotyp der Sec7-Mutante 
widerspiegelte, könnte die Regulierung von fehlgepaarten GABAergen postsynaptischen Proteinen 
durch Arf6-Aktivierung vermittelt sein. Zudem deuteten die Bindung von Apocalmodulin an das IQ-
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Motiv in synArfGEF, N-Methyl-D-Aspartat (NMDA)-verursachte Aggregierungsänderungen von 
dendritischem synArfGEF und die dendritische Lokalisierung von synArfGEF mRNA auf eine 
Abhängigkeit der Funktion von synArfGEF von neuronaler Aktivität hin. Diese Ergebnisse 
beschreiben insgesamt eine wichtige Funktion der katalytischen Aktivität von synArfGEF in der 
selektiven Regulierung von GABAergen postsynaptischen Proteinen, die mit glutamatergen 
präsynaptischen Strukturen fehlgepaart sind. 
Zusammenfassend hat die Analyse zweier GABAerger PSD-Proteine mit selektiver Lokalisierung im 
ZNS gezeigt, dass postsynaptische Proteine an der Übertragung synaptischer Spezifität innerhalb von 
und zwischen Neurotransmitter-Systemen beteiligt sind. Die Ergebnisse dieser Arbeit legen eine 
funktionelle Beziehung zwischen der präsynaptischen Diversität und der postsynaptischen 
molekularen Vielfalt dar und tragen damit zur Hypothese eines molekularen Codes der synaptischen 
Spezifizierung bei.  
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ABSTRACT 
The directionality of chemical synapses as well as the cell type-, subcellular domain- and 
neurotransmitter-specific innervation patterns of neuronal networks in the central nervous system 
(CNS) imply that mechanisms exist which ensure synapse specificity. The finding of a large molecular 
diversity of synaptic proteins gave rise to the hypothesis that the combination of synaptic proteins 
forms a molecular code, instructing the identity of synapses. This hypothesis was tested in this thesis 
at the example of the GABAergic neurotransmitter system. Two synaptic proteins, with selective 
GABAergic postsynaptic localization, were examined for their contribution to specification of 
GABAergic synapses in relation to their presynaptic innervation partners. Gene ablation experiments 
in mice revealed a role for the dystrophin-glycoprotein complex (DGC) in formation and maintenance 
of synapses from a specific subgroup of GABAergic interneurons, the cholecystokinin (CCK)-positive 
basket cells. Therefore, the DGC serves a function in synapse specification within the GABAergic 
neurotransmitter system. In contrast, ablation and overexpression experiments in primary neuron 
cultures, focusing on the dystrophin-interacting protein synArfGEF, demonstrated that this 
GABAergic postsynaptic protein controls pre- and postsynaptic alignment of GABAergic structures, 
thus regulating synaptic specificity between neurotransmitter systems. 
Disruption of the neuronal DGC in mice was achieved by conditional deletion of Dag1, encoding 
dystroglycan (DG), in pyramidal cells using the NEX-Cre driver line. This allowed the study of the 
role of the DGC specifically in neurons, without interfering with glial DGC functions in neuronal 
migration. Immunohistochemical analysis of postsynaptic GABAergic proteins in DG conditional 
knock-out (cKO) hippocampal and neocortical tissue only identified minor alterations, excluding an 
obligatory role for the DGC in clustering of GABAergic postsynaptic density (PSD) proteins. This 
finding was contrasted by severe changes in immunoreactivity of presynaptic marker proteins. DG 
ablation led to the loss of immunohistochemical markers of axon terminals from CCK-positive but not 
from parvalbumin (PV)-positive basket cells. Furthermore, markers of GABAergic axon terminals not 
specific to a subgroup of GABAergic interneurons were not affected by DG ablation. The specific loss 
of CCK-positive terminal epitopes was observed in DG-deficient mice at postnatal day 21 as well as in 
adulthood, suggesting that formation of synapses of CCK-positive basket cells on pyramidal cells 
requires DG. Delivery of Cre to the cornu ammonis 1 (CA1) region of mice containing the floxed 
Dag1 gene using a viral vector allowed ablation of DG during adulthood. Unexpectedly, loss of DG 
long after developmental synaptogenesis resulted in a reduction of a CCK-positive basket cell terminal 
marker, pointing towards a function of DG in continuous trans-synaptic signaling. The physiological 
consequences of CCK-positive basket cell terminal loss were assessed by patch-clamp recordings of 
spontaneous inhibitory postsynaptic currents (sIPSC) from DG-deficient pyramidal cells. The notion 
that loss of CCK-positive terminal markers was paralleled by functional deficits was suggested by a 
reduction of sIPSC amplitude and frequency and corroborated by the inefficiency of carbachol to 
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increase sIPSC frequency in DG cKO mice. Finally, since neurexin binds to DG in an alternative 
splice insert-dependent manner, knock-in (KI) mice containing the neurexin binding-deficient DG 
T190M were examined. CCK-positive terminals were not compromised in DG T190M KI mice, 
indicating that a novel presynaptic DG binding partner might be responsible for trans-synaptic 
signaling at CCK-positive basket cell terminals. Together, these findings demonstrate the crucial role 
of the DGC in conferring synaptic specificity within the GABAergic neurotransmitter system and 
provide a framework to explore the etiology of intellectual disability in dystroglycanopathy patients. 
In a set of cell culture and in vitro experiments, the function of the guanine nucleotide exchange factor 
(GEF) synArfGEF in synapse specification was studied. Although synArfGEF contains a dystrophin-
interacting motif, gephyrin was found to bind to synArfGEF, hinting at a more general function for the 
GABAergic system. Therefore, a role of synArfGEF in synaptic alignment was assessed by analysis of 
pre- and postsynaptic markers in rat primary hippocampal cultures. Clustered regularly interspaced 
short palindromic repeats (CRISPR) / Cas9-mediated ablation of synArfGEF uncovered that the 
fraction of gephyrin clusters mismatched to glutamatergic presynaptic axon terminals was increased in 
the absence of synArfGEF. Importantly, total gephyrin cluster density was not affected by synArfGEF 
ablation, demonstrating the specificity of synArfGEF function to mismatched GABAergic PSDs. To 
explore the mechanisms of this regulation, synArfGEF constructs were mutated in domains with 
known functions and overexpressed in primary hippocampal neurons. Overexpression of a construct 
containing a mutated Sec7 domain, essential for GEF function, led to an elevated proportion of 
mismatched GABAergic PSDs. The inability of this mutation to influence the presynaptic apposition 
of the glutamatergic PSD protein PSD-95 confirmed that synArfGEF function is restricted to 
GABAergic postsynaptic proteins. Because overexpression of mutations of the putative synArfGEF 
target ADP ribosylation factor 6 (Arf6) mirrored the Sec7 mutant phenotype, regulation of 
mismatched GABAergic PSDs might be mediated by Arf6 activation. In addition, the binding of 
apocalmodulin to the IQ motif in synArfGEF, changes in dendritic clustering of synArfGEF upon N-
methyl-D-aspartate (NMDA) application and dendritically localized synArfGEF mRNA provided 
evidence of neuronal activity-dependence of synArfGEF function. Overall, these findings implicate 
the catalytic function of the GABAergic postsynaptic protein synArfGEF in the selective regulation of 
GABAergic PSDs mismatched to glutamatergic presynaptic terminals. 
In conclusion, analysis of two GABAergic PSD proteins with selective distribution in the CNS 
revealed that postsynaptic proteins are involved in synapse specification within and between 
neurotransmitter systems. The findings of this thesis imply a functional relationship between the 
presynaptic diversity of innervation and the postsynaptic molecular heterogeneity, thereby providing 
evidence for a molecular code of synapse specification. 
General introduction 
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GENERAL INTRODUCTION 
Synapses in the central nervous system 
The nervous system enables animals to sense the environment and to appropriately react to it. For such 
interactions with the environment to be favored by natural selection, the fidelity and speed of 
information processing are of decisive importance. Noxious stimuli, for instance, have to be identified 
as harmful and avoidance behavior initiated rapidly. Some environments thus favor the development 
of a direct and fast connection between sensory and motor systems. However, adaptation to changing 
environments requires plasticity of the nervous system. This need drove the development of complex 
central nervous systems (CNS), containing central synaptic connections. 
The requirement for fidelity and speed are seemingly best met by a syncytium, where sensory input 
and motor output are linked without being interrupted by intercellular connections. The existence of 
such a syncytium was posited by Camillo Golgi among others and became known as the reticular 
theory (Bock, 2013). However, visualization of individual neurons by Santiago Ramon y Cajal using 
the Golgi method later fortified the notion that the brain consists of interconnected individual cells (a 
notion that became the “neuron doctrine”). This first implied that synapses are abundant in the brain 
and that they are capable of mediating fast and precise communication between neurons. Indeed, an 
average neuron in the mouse neocortex forms several thousand synapses (Schuz and Palm, 1989). 
The vast majority of CNS synapses are chemical synapses. Electrochemical gradients traveling along 
the plasma membrane have to be converted to chemical signals by the presynaptic terminal in order to 
transmit the signal to the postsynaptic cell. Pre- and postsynaptic structures are physically separated by 
the synaptic cleft, a narrow extracellular space filled with adhesion and signaling molecules. Under 
physiological conditions, a pool of neurotransmitter-containing synaptic vesicles is docked at the 
plasma membrane, allowing rapid release of neurotransmitters into the synaptic cleft. The process of 
neurotransmitter release is initiated by increasing intracellular calcium concentrations in response to 
an action potential, directly influencing the vesicle exocytosis machinery. Once released, 
neurotransmitters bind to specialized, mostly postsynaptic, receptors. The effect of this binding can be 
exerted on the postsynaptic cell directly, if the neurotransmitter receptor is an ion channel, by a change 
in ion permeability (ionotropic receptors). On the other hand, neurotransmitter receptors can act 
indirectly via activation of intracellular signaling pathways (e.g. metabotropic receptors). Finally, 
several mechanisms are employed to end neurotransmission, of which reuptake of the neurotransmitter 
into the presynaptic neuron or into surrounding glial cells is the most common. 
Neurotransmission through chemical synapses thus relies on the coordinated action of a complex 
molecular machinery. Although this complexity leaves chemical synapses susceptible to dysfunctions, 
it provides several advantages over continuous intercellular connections. First, the nature of 
neurotransmitter release and receptor binding provides a clear directionality of neurotransmission 
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(even in reciprocal dendrodendritic synapses (Shepherd, 2009)). Secondly, the variety of 
neurotransmitter-receptor systems which can be employed offers a way to tune the kinetics with which 
postsynaptic membrane potential is impacted. Finally, the pre- and postsynaptic structures involved in 
chemical neurotransmission are amenable to molecular modifications, allowing neuronal activity-
dependent and other plasticity mechanisms to change synaptic strength and properties. 
Besides the directional neurotransmission of chemical synapses, which functions in an all-or-none 
fashion, the brain is capable of electrical neurotransmission between cells over gap junctions (Pereda, 
2014). In these electrical synapses, transmembrane ion channels of the connexin family form a direct 
connection between neurons. Small molecules and ions (for example Ca2+ or cyclic AMP) are capable 
of diffusing through connexin channels, effectively building a partial syncytium between neurons 
connected by gap junctions. Still, neurotransmission at electrical synapses is not purely passive, since 
connexin channels can take open or closed conformations and are subject to molecular modifications. 
A change in membrane potential in one cell thus does not imply that a cell connected by gap junctions 
necessarily undergoes the same potential changes. However, if electrical synapses allow electrical 
conductance, such neurotransmission is bidirectional. Evidence has accumulated that electrical 
synapses, similar to chemical synapses, are dynamic. The connexin hemichannels are subject to endo- 
and exocytosis and their properties are under the control of neuromodulators. Furthermore, neuronal 
activity (at chemical synapses) can also induce plasticity at electrical synapses (Haas et al., 2016). 
Electrical synapses are likely to play a crucial role in coordinated network activity. For instance, 
parvalbumin (PV)-positive GABAergic interneurons in hippocampus and neocortex are interconnected 
via gap junctions (Katsumaru et al., 1988; Fukuda and Kosaka, 2000; Fukuda et al., 2006). Since the 
activity of PV-positive interneurons is coupled to, and in some brain regions crucial for, network 
oscillations, electrical synapses might coordinate firing properties between PV-positive interneurons in 
this process. 
Challenging the absolute validity of the neuron doctrine, clonally related pyramidal cells in the 
neocortex transiently form electrical synapses between them (Yu et al., 2012). Formation of electrical 
synapses is necessary for later preferential chemical synapse formation between related cells. The 
importance for electrical neurotransmission for chemical synapse formation is also demonstrated by 
reduced chemical neurotransmission in mice lacking connexin 36 (Maher et al., 2009). Transient 
electrical coupling of clonally related pyramidal cells therefore determines the assembly of neocortical 
neuronal circuits. Electrical and chemical synapses are also interconnected in mature neurons. In 
“mixed synapses”, electrical and chemical synaptic structures are in close proximity, influencing each 
other’s properties. The strength of electrical synapses was shown to be modulated by activation of N-
methyl-D-aspartate (NMDA) receptors in mixed glutamatergic / electrical synapses (Yang et al., 1990; 
Kothmann et al., 2012). Electrical and chemical synapses are thus interdependent during development 
and for plasticity in adulthood. 
General introduction 
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The abundance of glial cells in the brain highlights that the local environment of CNS synapses has to 
be considered in order to appreciate their complexity (Azevedo et al., 2009). Central synapses are 
exposed to the extracellular matrix (ECM) and perisynaptic astrocyte processes. These structures 
heavily impact the kinetics of neurotransmitter action. Astrocytes express a large variety of 
neurotransmitter transporters, which remove neurotransmitter molecules from the synaptic cleft. More 
indirectly, astrocytes influence neurotransmission by providing essential metabolites to neurons. 
Furthermore, the involvement of astrocytes and microglia in synapse elimination shows how 
intimately these cells are connected to synaptic plasticity and points towards a prominent role of glial 
cells in the pathological loss of synapses (Chung et al., 2013; Hong et al., 2016). 
Neurotransmitter systems and their receptors 
Even before the ultrastructural confirmation of physically separated contacts at chemical synapses, the 
molecular identity of some substances mediating neurotransmission in the peripheral nervous system 
(PNS) was elucidated. The relative ease of manipulation of peripheral nerves allowed the 
identification of epinephrine and acetylcholine as neurotransmitters, although the molecular 
mechanisms of their actions were still obscure (Elliott, 1905; Loewi, 1924). In the CNS, the search for 
neurotransmitters was advanced by experiments involving direct application of substances to the CNS 
and then probing the consequences for neurotransmission. In this manner, glutamate was identified as 
the main excitatory neurotransmitter in the brain. At present, several dozens of neurotransmitters are 
known, the exact number depending on the definition of neurotransmitters (Purves, 2012). 
Since modulation of neurotransmission upon application of a substance is not conclusive evidence that 
a substance acts as a neurotransmitter, several criteria to classify a substance as a neurotransmitter 
were compiled (Cowan and Kandel, 2001). No binding definition has been agreed on, but the 
following criteria are generally accepted as the minimal requirements for classification as a 
neurotransmitter: 
1. The substance is present in the presynaptic terminal and is released upon neuronal activity 
2. The substance binds to postsynaptic receptors, affecting electrical and / or physiological 
properties of the postsynaptic cell 
3. There exists a mechanism to degrade the substance or to remove the substance from the 
synaptic cleft, ending its action on the postsynaptic cell 
Neurotransmitters are chemically heterogeneous and cover a wide range of molecular weights. For 
instance, amino acids, peptides, monoamines, adenosine triphosphate, nitric oxide and even protons 
are capable of acting as neurotransmitters (Du et al., 2014). Generally, a distinction between small-
molecule neurotransmitters and peptide neurotransmitters (neuropeptides) is made. Neuropeptides 
have a slow, neuromodulatory effect on the postsynaptic cell and are released from large dense-core 
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synaptic vesicles (as opposed to small clear-core vesicles employed by most small-molecule 
neurotransmitters). Fast neurotransmission in the CNS is mediated by small-molecule 
neurotransmitters. Among them, most chemical synapses rely on neurotransmitters from the amino 
acid or the biogenic amine family. Catecholamines (dopamine, norepinephrine and epinephrine) are 
biogenic amine neurotransmitters which share tyrosine as the substrate for their biosynthesis. The two 
other biogenic amine neurotransmitters, serotonin (5-hydroxytryptamine) and histamine, depend on 
tryptophan and histidine for synthesis, respectively. The action of biogenic amine neurotransmitters on 
postsynaptic neurons is determined by specific, mostly metabotropic, receptors and can be excitatory 
as well as inhibitory. 
Acetylcholine, although neither belonging to the group of amino acids or biogenic amines, is a small-
molecule neurotransmitter essential for function of the PNS as well as the CNS. Named after the 
respective agonists, acetylcholine receptors are divided into two groups. The nicotinic acetylcholine 
receptors (nAChR) are ion channels permeable to Na+ and K+, therefore depolarizing the postsynaptic 
cell. Because nAChRs are responsible for the depolarization and therefore the contraction of muscle 
cells, they are among the best studied neurotransmitter receptors. However, nAChR-mediated 
neurotransmission also serves crucial roles in the autonomous nervous system and in the CNS. In 
contrast to nAChRs, muscarinic acetylcholine receptors (mAChR) are metabotropic receptors. 
Depending on the intracellular signaling cascade which is activated, acetylcholine binding to mAChRs 
can have excitatory or inhibitory effects on the postsynaptic cell. Besides their function in 
parasympathetic neurotransmission, mAChRs are also expressed in the CNS. 
Four amino acids are known to act as neurotransmitters: Glutamate, aspartate, γ-aminobutyric acid 
(GABA) and glycine. In the mature mammalian brain, glutamate and GABA mediate the bulk of 
excitatory and inhibitory neurotransmission, respectively. As a nonessential amino acid, glutamate is 
metabolized from α-ketoglutarate, a product of the citric acid cycle. In addition, glutamine can be 
converted to glutamate, a reaction catalyzed by glutaminase. Although glutamate is abundant 
intracellularly, glutamate concentrations are kept low in the synaptic cleft through continual removal 
of glutamate by high-affinity excitatory amino acid transporters. It is estimated that glutamate 
concentrations in the synaptic cleft fluctuate from micro- to low millimolar concentrations during 
vesicular release (Clements et al., 1992). Glutamic acid decarboxylase (GAD) catalyzes the 
conversion of glutamate to GABA. Thus, the main excitatory and inhibitory neurotransmitters are only 
separated by a single catalytic step. Accordingly, GAD is localized almost exclusively at GABAergic 
axon terminals. Packing of glutamate and GABA into synaptic vesicles requires specific transporter 
proteins located on synaptic vesicles. Vesicular GABA transporter (VGAT) mediates active transport 
of GABA whereas glutamate accumulation in vesicles depends on vesicular glutamate transporters 
(VGluT). 
Glutamate exerts its actions on postsynaptic cells by acting as a ligand for specific ionotropic and 
metabotropic receptors. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors 
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are the most abundant glutamate receptors in the CNS and together with kainate receptors are 
responsible for most fast excitatory neurotransmission. Ionotropic glutamatergic neurotransmission is 
also mediated by NMDA receptors, albeit with slower kinetics. Activation of NMDA receptors plays a 
crucial role in plasticity of glutamatergic synapses (Luscher and Malenka, 2012). The G-protein 
coupled metabotropic glutamate transporters (mGluR) are also involved in plasticity of the 
postsynaptic response to glutamate, in particular in long-term depression (LTD). In addition, a subset 
of mGluRs is localized presynaptically and modulates transmitter release. As in glutamatergic 
transmission, GABA acts as a ligand for both ionotropic and metabotropic receptors, which were 
named GABAA and GABAB receptors, respectively. Apart from the molecular mode of action, 
GABAA and GABAB receptors differ largely in kinetics of the postsynaptic potentials that they elicit. 
While activation of GABAB receptors produces slow and long-lasting inhibition, GABAA receptors 
mediate the vast majority of fast inhibitory neurotransmission in the adult mammalian brain 
(Hammond, 2008). 
Molecular heterogeneity of the GABAergic postsynaptic density 
GABAA receptors 
GABAA receptors (GABAAR) are pentameric GABA-gated anion channels. All of the individual 
subunits are members of the Cys-loop ligand-gated ion channel superfamily and as such are closely 
related to nAChRs, glycine receptors (GlyR) and ionotropic serotonin receptors. Based on sequence 
homology and pharmacological characterization, a total of 19 genes encoding GABAAR subunits were 
identified in mammals (Figure 1; (Olsen and Sieghart, 2008)). 
Figure 1. Dendrogram of the 19 human 
GABAAR subunit genes. 
The length of horizontal branches represents the 
fractional divergence of any two GABAAR 
subunit amino acid sequences. To illustrate the 
close homology to nAChRs, the δ subunit of 
nAChRs was included. The scale bar represents 
20% sequence divergence (Simon et al., 2004). 
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All subunits display a common secondary structure with an N-terminal extracellular tail including the 
eponymous Cys-loop, four transmembrane domains and an extracellular C-terminus (Figure 2). Also 
characteristic of GABAARs, a large intracellular loop between transmembrane domain 3 and 4 is 
present in all subunits. Theoretically, thousands of GABAAR combinations are possible by 
permutation of the 19 subunits in a pentameric receptor. However, the number of functional GABAAR 
compositions is much lower, as suggested by experiments in heterologous cells overexpressing 
different subunit combinations. These experiments, together with biochemical and morphological 
studies, have revealed that the most abundant receptor composition in the forebrain consists of two α, 
two β and one γ subunit. In most synaptic GABAARs in the forebrain the β2 and γ2 subunits are 
combined with the α1 subunit, but receptors containing α2 are also widespread, especially in the 
hippocampal formation (Fritschy and Panzanelli, 2014). Besides that, sufficient evidence has 
accumulated for the existence of several other subunit combinations, notably receptors containing α3-6 
with β and γ subunits and receptors containing a δ subunit instead of the γ subunit. Major distinctions 
between GABAAR combinations include kinetics, pharmacological properties and expression patterns. 
In addition, individual subunits have a major influence on subcellular localization of the receptor. β / γ 
-combinations together with the α5 subunit results in widespread extrasynaptic distribution whereas α1 
and α2-containing receptors are clustered at GABAergic synapses (Serwanski et al., 2006; Kasugai et 
al., 2010). Similarly, α4 and the closely related α6 subunit can associate with either a single δ or γ2 
subunit and are mostly present extrasynaptically. The existence of heterogeneous α or β subunit 
combinations in a single receptor was demonstrated (Li and De Blas, 1997; Benke et al., 2004; Balic et 
al., 2009). Furthermore, receptors containing ε, θ and π subunits were reported but these subunits 
show a limited distribution in the brain. ρ subunits (formerly GABAC receptors) are pharmacologically 
distinct from all other subunits and are thought to build homopentamers. Although association with 
other subunits cannot be excluded, their distinct pharmacological properties make an assembly with α 
or β subunits unlikely. Thus, among the 19 different subunit genes, the α to δ subunits make up most 
of the GABAAR repertoire available to mediate GABA-induced fast inhibition in the brain. 
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Figure 2. Domain structure and heteropentamerization of GABAAR subunits. 
GABAAR subunits possess a characteristic domain structure containing four transmembrane domains, a large 
intracellular loop between transmembrane domains 3 and 4, and a large N-terminal region containing the Cys-
loop (left). Functional receptors are pentameric, most commonly formed by two α, two β and one γ subunit 
(right). GABA binds at the interface of α and β subunits whereas benzodiazepines bind at the interface of α and γ 
subunits. BZ, benzodiazepines; TM, transmembrane domain (Jacob et al., 2008). 
Heteropentameric GABAARs possess two GABA binding sites, both at the interface between the α and 
β subunit. Binding of GABA induces a conformational change in the receptor, leading to the opening 
of the central pore. GABAARs are selective anion channels with the highest permeability for Cl- ions. 
Besides Cl-, GABAARs are known to be permeable to HCO3- ions, but the physiological importance of 
this conduction is unclear. The consequences of channel opening are primarily determined by the 
intra- and extracellular concentrations of Cl-. Specific Cl- co-transporters that mediate Cl- influx 
(NKCC1) and efflux (KCC2) play a central role in controlling these concentrations. Since there is a 
developmental delay in KCC2 expression, intracellular Cl- concentrations are high early in 
development. GABAAR activation during embryogenesis and around birth therefore leads to strong 
depolarization of the postsynaptic cell, exceeding the action potential threshold. Only in the adult 
CNS, when KCC2 expression surpasses NKCC1 expression, can an increase in Cl- permeability cause 
hyperpolarization and therefore inhibition of the postsynaptic cell (Fiumelli and Woodin, 2007). 
GABAAR channel opening can also have an inhibitory effect by depolarization, if the Cl- equilibrium 
potential is below the action potential threshold (“shunting inhibition”). Furthermore, because of local 
differences in subcellular KCC2 distribution, the impact of GABAAR activation is likely to be 
different in distinct subcellular compartments. 
GABAARs are the target of many drugs of pharmaceutical importance. Benzodiazepines, for instance, 
bind GABAARs at the interface of α and γ subunits (Figure 2; (Rudolph and Knoflach, 2011)). 
Through allosteric modulation of the receptor, benzodiazepines increase the efficiency of GABA in 
activating GABAARs. The maximal response generated by GABA is not elevated by benzodiazepines, 
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reducing the danger of overdose substantially. Because of the anti-convulsive, anxiolytic, sedative and 
myorelaxant properties of benzodiazepines, their interaction with GABAAR subunits was studied 
extensively. In the study of the contribution of different GABAARs to the clinical effects, the 
development of individual GABAAR subunit knock-out (KO) and knock-in (KI) mice was 
instrumental. The change of a single histidine residue in any α subunit is sufficient to abolish the 
effects of diazepam. Application of diazepam in KI mice containing histidine to arginine point 
mutations revealed a prominent role for α1 subunit-containing receptors for sedation (Rudolph et al., 
1999; McKernan et al., 2000). Conversely, α2-containing receptors were shown to be necessary for the 
anxiolytic effects of diazepam (Low et al., 2000). KI mice harboring the homologous mutation in α3 
or α5 subunits were also generated and revealed specific roles in myorelaxation (Crestani et al., 2001; 
Crestani et al., 2002). In addition, benzodiazepines can act as analgesics and anti-hyperalgesics, and 
experiments with triple KI mice demonstrated that these effects are mostly mediated by the α2 subunit 
(Ralvenius et al., 2015). These specific involvements in diazepam action exemplify the crucial 
importance of GABAAR heterogeneity for neuropharmacological studies but also for the physiological 
role of GABAergic neurotransmission. 
In addition to subunit diversity, trafficking and post-translational modification (PTM) of GABAARs 
add another layer of complexity by providing a dynamic regulation of GABAergic neurotransmission. 
The assembly of receptor subunits in the endoplasmic reticulum (ER) determines subunit composition 
of native receptors at the plasma membrane (Luscher et al., 2011). α / β / γ combinations have an 
obligatory directional arrangement regarding the positioning of the α to the γ subunit. Receptors 
exhibiting a different arrangement are degraded in the ER-associated protein degradation pathway. 
Expression of subunit combinations in heterologous cells demonstrated that, in contrast to α and β 
subunits, the γ subunit is not essential for the formation of functional receptors. However, assembly 
with the γ subunit is favored and necessary for synaptic targeting of GABAARs. Many of the subunit-
specific modifications, which convey their distinct properties, target the large intracellular loop 
between transmembrane domains 3 and 4. The Golgi-specific DHHC zinc finger protein (GODZ) 
interacts specifically with γ2 intracellular loop and catalyzes palmitoylation of the γ2 subunit. This 
palmitoylation is essential for synaptic targeting of the receptor, as demonstrated by the loss of 
synaptic GABAARs when GODZ is downregulated (Fang et al., 2006). As other transmembrane 
proteins, GABAARs travel through the Golgi apparatus and are then present in secretory vesicles 
which are exocytosed. Integration into the plasma membrane is also controlled by interaction at the 
intracellular loop, by multiple proteins. GABAAR-associated protein (GABARAP) was the first 
GABAAR-interacting protein identified. Culture experiments provided evidence that GABARAP is 
involved in exocytosis of GABAARs in response to potentiation of glutamatergic synapses (Marsden et 
al., 2007). However, the role of GABARAP and specificity in constitutive GABAAR trafficking is 
unclear, since GABARAP KO mice show normally clustered γ2 immunolabeling (O'Sullivan et al., 
2005). The fact that GABARAP is not solely responsible for regulating GABAAR trafficking is 
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underlined by the finding of multiple GABARAP-interacting proteins which are involved in GABAAR 
exocytosis. These include the phospholipase C-related catalytically inactive proteins 1 and 2 
(PRIP1/2). PRIP1/2 double KO mice exhibit a reduction in surface GABAAR abundance and in 
GABARAP interaction with GABAARs, indicating that PRIP and GABARAP form a complex to 
regulate receptor trafficking (Mizokami et al., 2007). GABAARs in perisynaptic regions undergo 
endocytosis, a process which is also subject to activity-dependent regulation. Receptor endocytosis is 
clathrin-dependent and involves binding of the adaptor protein 2 (AP2) to β and γ subunits. AP2 
binding is modulated by phosphorylation of serine residues in  β1-3 subunits. Phosphorylation status 
of these residues, in turn, is controlled by protein kinase C (PKC), protein kinase A (PKA) and the 
protein phosphatases PP1α and PP2A. Interestingly, PRIP1/2 interact with these phosphatases and 
modulate their activity. Regulation of PP1α/PP2A through PRIP1/2 can thus lead to dephosphorylation 
of serine residues in  β1-3, thereby facilitating their internalization. A substantial part of endosomes 
containing GABAARs is exocytosed and therefore contributes to receptor recycling. However, 
GABAARs can be degraded if the containing endosomes enter the lysosomal pathway. Receptor 
trafficking is both a constitutive process and a mechanism used to adjust synaptic strength through 
homeostatic plasticity. Excessive internalization of GABAARs in response to flurazepam treatment 
was reported in cultured hippocampal neurons and is thought to represent one of the mechanisms 
underlying tolerance to benzodiazepines (Jacob et al., 2012). 
Gephyrin 
For proper GABAergic transmission, GABAARs have to be concentrated opposite GABAergic axon 
terminals. Mechanisms to adapt this clustering on a short time-scale allow short-term plasticity of the 
strength of GABAergic transmission. The scaffolding protein gephyrin clusters GABAARs at synaptic 
sites and provides a platform for fast regulation of the GABAergic postsynaptic density (PSD). 
The capability of self-assembly is a feature of gephyrin that allows the formation of a lattice below 
synaptic GABAARs (Tyagarajan and Fritschy, 2014). GABAARs are trapped at synaptic sites by this 
lattice, making the gephyrin scaffold an important determinant of synaptic strength. Although most 
studies have focused on the clustered form of gephyrin (in association with receptors), gephyrin is 
present also in the cytosol (Specht et al., 2013). It is the dynamics of the equilibrium between the 
soluble and clustered form of gephyrin which determines the extent to which gephyrin acts as a 
scaffold for GABAARs. 
Gephyrin was first isolated in conjunction with GlyRs from rat spinal cord (Pfeiffer et al., 1982). 
Binding of gephyrin to GlyRs occurs with nanomolar affinity, explaining the enrichment for gephyrin 
with purification of GlyRs (Schrader et al., 2004). Localization of gephyrin and receptors in the CNS 
by immunohistochemistry revealed that gephyrin is not only colocalized with glycine receptors but 
also with GABAARs (Sassoe-Pognetto et al., 1995; Sassoe-Pognetto et al., 2000). As expected from 
sequence homology of GlyRs and GABAARs, gephyrin binds to GABAARs, albeit with lower affinity 
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(Maric et al., 2011). In addition, gephyrin interacts with tubulin, and thus connects the receptors to the 
cytoskeleton (Kirsch et al., 1991). Binding to β2 and β3 subunits was described, but the functional 
involvement of these interactions for gephyrin clustering is unclear (Kowalczyk et al., 2013). A direct 
binding to α2 subunit was mapped to the large intracellular loop between transmembrane domains 3 
and 4 (Saiepour et al., 2010). The drastic reduction of gephyrin clusters in brains of GABAAR α2 
subunit KO mice, despite compensatory upregulation of other subunits and intact clustering of other 
synaptic proteins, indicates and outstanding importance of α2 interaction for gephyrin synaptic 
clustering (Panzanelli et al., 2011). 
Gephyrin consists of three domains: The N-terminal G domain, the C-terminal E domain and an 
intermediate C domain. The names of the G and E domains were derived from homology to the 
bacterial enzymes MogA and MoeA, respectively. These enzymes are essential for biosynthesis of 
molybdenum cofactor and gephyrin has retained this function. It is therefore not surprising that 
gephyrin expression in mammals is widespread throughout the body. Despite its crucial metabolic 
function, gephyrin has acquired novel features through the fusion of individual proteins during its 
evolutionary history. The quaternary structure of gephyrin homomultimers is still not fully elucidated. 
However, gephyrin G domain was shown to form trimers whereas the E domain assembles 
preferentially as dimers (Schwarz et al., 2001; Sola et al., 2001; Sola et al., 2004). Based on these 
interactions gephyrin was proposed to form a hexagonal lattice but the three-dimensional arrangement 
of gephyrin clusters is likely more complex and dynamic, involving interactions of the C-domain 
(Herweg and Schwarz, 2012). Gephyrin exists as multiple splice variants, some of which affect the 
capability of multimerization (Saiyed et al., 2007; Fritschy et al., 2008). In addition, gephyrin 
undergoes a large variety of PTMs. Many of these modifications control the propensity of gephyrin to 
self-assemble and thereby indirectly regulate GABAAR synaptic clustering and GABAergic 
transmission. 
Most PTM target residues within gephyrin are located in the C domain. A large variety of PTMs were 
identified thus far: Gephyrin can be phosphorylated, acetylated, nitrosylated, ubiquitinated and 
SUMOylated (Tyagarajan and Fritschy, 2014). Although the exact conformational changes induced by 
PTMs are not understood in most cases, the consequences of PTM on gephyrin clustering are well 
described. For the serine residues 268, 270, 303 and 305 (all part of the C domain), the 
phosphorylating kinases as well as the downstream effectors and the impact on GABAergic 
neurotransmission were elucidated (Figure 3). The dephosphorylation-mimicking S268A mutant forms 
larger and more numerous clusters than wildtype gephyrin in primary hippocampal neurons 
(Tyagarajan et al., 2013). A corresponding increase in miniature inhibitory postsynaptic current 
(mIPSC) amplitude and frequency was observed in S268A-expressing neurons. Extracellular signal-
regulated kinase 1 (ERK1) can phosphorylate gephyrin S268 and application of an ERK inhibitor 
recapitulated the morphological changes seen in S268A-expressing cells. Since the increase in 
gephyrin cluster size upon ERK inhibitor treatment was dependent on S268, ERK1 phosphorylation at 
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this site is likely to play a physiological role for modulating gephyrin cluster size. ERK1 activity, in 
turn, is regulated by neuronal activity, implicating this pathway in activity-dependent plasticity of 
GABAergic synapses. Interestingly, site-directed mutagenesis of the neighboring S270 revealed that 
phosphorylation state of this residue also plays a role in controlling gephyrin clustering (Tyagarajan et 
al., 2011). Compared to wildtype, S270A-mutated gephyrin overexpressed in primary hippocampal 
neurons shows primarily an elevated cluster density. This phenotype is obtained also by inhibition of 
glycogen synthase kinase 3β (GSK3β) in neurons overexpressing wildtype gephyrin. In gephyrin 
S270A-overexpressing neurons, however, application of GSK3β inhibitor does not affect cluster 
density. GSK3β, but not ERK1, can phosphorylate S270, and thus the phosphorylation state of the two 
nearby serine residues is controlled by two different pathways. Phosphorylation of S270 makes 
gephyrin prone to proteolytic cleavage by calpain. Yet, gephyrin is likely to be phosphorylated at S268 
and S270 under basal conditions, and the phosphorylation state at both residues interacts to determine 
gephyrin cluster properties (Tyagarajan et al., 2013). The gephyrin monoclonal antibody 7a (mAb7a), 
which is most commonly used for immunofluorescent localization of gephyrin, requires 
phosphorylation at S270 for recognition of the epitope (Kuhse et al., 2012). This observation supports 
the notion that a large portion of clustered gephyrin is phosphorylated at this site and raises the 
concern of underrepresentation of non-phosphorylated gephyrin in immunofluorescence studies. 
Gephyrin residues S303 and S305 build another pair of serine phosphorylation sites which are under 
the control of an activity-dependent kinase (Flores et al., 2015). The homeostatic upregulation of 
inhibitory synapses in response to increased neuronal activity was shown to require Ca2+/calmodulin-
dependent protein kinase II (CaMKII), which phosphorylates S305. Serine to alanine mutation of both 
sites abolished the increase of gephyrin clustering normally seen after artificially stimulating neurons. 
These studies illustrate how the strength of GABAergic neurotransmission is regulated in response to 
neuronal activity by modifying single residues within the gephyrin C domain. 
A multitude of gephyrin-interacting proteins have been identified. Intriguingly, most interactions were 
located to the C domain, the most heavily phosphorylated region in gephyrin (Tyagarajan and 
Fritschy, 2014). It is therefore likely that regulatory pathways converging on gephyrin not only 
modulate gephyrin conformation and self-assembly, but also influence its interactions with binding 
partners. 
Other GABAergic postsynaptic density proteins 
In the study of submembrane clustering mechanisms of gephyrin, collybistin has emerged as an 
essential protein promoting gephyrin clustering. When expressed in human embryonic kidney 293 
(HEK293) cells, collybistin lacking its N-terminal Src homology 3 (SH3) domain induces gephyrin 
clustering near the plasma membrane (Kins et al., 2000; Harvey et al., 2004). In contrast, collybistin 
isoforms containing the SH3 domain localize together with gephyrin in large intracellular aggregates. 
The SH3 domain, assumed to exert an autoinhibitory effect on collybistin function, was shown to bind 
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to the intracellular region of neuroligin 2 (NL2) (Poulopoulos et al., 2009). Collybistin, NL2 and 
gephyrin co-expression in HEK293 cells leads to submembrane gephyrin clustering even with the SH3 
domain present in collybistin. It was therefore proposed that collybistin binding to NL2 is an essential 
step in formation of the GABAergic PSD. Collybistin KO mice display a strong reduction of gephyrin 
as well as GABAAR clustering in major forebrain regions, confirming the essential role in gephyrin 
synaptic assembly (Papadopoulos et al., 2007; Papadopoulos et al., 2008). Because of the existence of 
several splice isoforms in the rat, either containing or lacking the SH3 domain and exhibiting variable 
C-termini, it is conceivable that collybistin differentially contributes to gephyrin clustering in different 
brain areas or subcellular compartments. Co-expression of collybistin isoforms with gephyrin in 
cultured neurons suggested that different isoforms promote gephyrin clustering to a similar degree 
(Korber et al., 2012). However, site-directed mutagenesis of the C-terminal region revealed that 
collybistin splice isoforms differ in ubiquitination sites, leading to distinct protein stabilities (De 
Groot-Ebeling, 2014). Furthermore, collybistin isoforms have different developmental expression 
patterns. Thus, it seems likely that collybistin isoforms take different functional roles and thereby 
provide another layer of complexity in regulation of the GABAergic PSD. 
Figure 3. Schematic overview of the GABAergic PSD. 
Protein interactions with the DGC, which is selectively localized in perisomatic regions in pyramidal cells, are 
depicted (left). The putative trans-synaptic interaction of α-DG with neurexin is illustrated. SynArfGEF is shown 
to interact with dystrophin and with S-SCAM, which in turn binds to NL2 and to β-DG. Various signaling 
pathways were found to act on gephyrin PTM, thereby regulating the strength of GABAergic neurotransmission 
(right). Gephyrin phosphorylation by the kinases GSK3β and ERK1/2 and the interconnection with calpain-
mediated gephyrin degradation is shown. DLC1, dynein light chain 1; NLGN, neuroligin; nNOS, neuronal nitric 
oxide synthase; PI3K, phosphatidylinositol 3-kinase (Tyagarajan and Fritschy, 2014). 
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Among NLs, NL2 selectively interacts with the SH3-containing form of collybistin (Poulopoulos et 
al., 2009). This fits with the observation that NL2 is located preferentially at GABAergic synapses 
(Graf et al., 2004; Chih et al., 2005). NLs are the first postsynaptic molecules for which 
neurotransmitter-specific synaptogenic properties were described. Whereas NL1 and NL3 
preferentially promote glutamatergic presynaptic differentiation, NL2 overexpression in heterologous 
cells induces glutamatergic and GABAergic differentiation in approximately equal amounts. These 
differences were later attributed to isoform-specific splice inserts in the extracellular esterase-
homology domains (Chih et al., 2006). Splice insert “B”, which is present in NL1 but not NL2, 
promotes differentiation of glutamatergic presynaptic terminals, even when artificially inserted in 
NL2. NLs form trans-synaptic complexes with presynaptic neurexins. Alternative splicing of the three 
mammalian neurexin genes generates an enormous diversity of neurexin isoforms (Baudouin and 
Scheiffele, 2010). Since the interaction of NLs with neurexins relies heavily on splice inserts, trans-
synaptic signaling of NL-neurexin complexes is thought to underlie much of the specificity of synapse 
formation. Besides NL2, NL3 is localized at GABAergic synapses (Budreck and Scheiffele, 2007). 
NLs undergo both homo- and heterodimerization but the existence of NL2 / NL3 heterodimers was not 
yet conclusively demonstrated (Bemben et al., 2015). The inability of NL3 to interact with SH3-
containing collybistin raises the question whether NL3 can fully compensate for the function of NL2. 
Finally, colocalization of NL4 with gephyrin and interaction with collybistin was shown (Hoon et al., 
2011). NL4 has a limited distribution in the central nervous system with prominent expression in the 
brainstem and spinal cord, in contrast to the abundance of NL2 in the forebrain. The interaction of 
NLs with gephyrin and the selective interactions with collybistin, together with specific presynaptic 
interactions, suggest that NLs are important for validation of GABAergic synapses. 
Although many proteins contribute to the molecular heterogeneity of the GABAergic PSD, few 
proteins are known that display a spatially restricted distribution in a subset of GABAergic synapses. 
Dystrophin and dystroglycan (DG), which together form the dystrophin-glycoprotein complex (DGC), 
are such sparsely localized GABAergic PSD proteins. In CNS neurons, the DGC is present mostly at 
perisomatic GABAergic synapses in pyramidal cells and in cerebellar Purkinje cells (Lidov et al., 
1990; Knuesel et al., 1999). By interaction with synaptic scaffolding molecule (S-SCAM) and 
synArfGEF, the DGC seems to form an extended complex (Figure 3; (Sumita et al., 2007; Fukaya et 
al., 2011)). The physiological role of these biochemical interactions is unclear at present. Interestingly, 
an interaction of S-SCAM with NL2 was mapped to the NL2-gephyrin interaction region, raising the 
possibility that S-SCAM can interfere with gephyrin clustering at NL2-containing synapses (Sumita et 
al., 2007). Furthermore, similar to NL3, S-SCAM is also present at glutamatergic synapses, where its 
PDZ domains might bind to scaffolding molecules such as postsynaptic density protein 95 (PSD-95). 
The repertoire of GABAergic PSD proteins was extended recently with two NL2-interacting proteins. 
Immunoglobulin superfamily member 9b (IgSF9b) binds to NL2 indirectly over S-SCAM, perhaps in 
analogy with putative indirect interactions with the DGC (Woo et al., 2013). Overexpression of 
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IgSF9b is not sufficient to drive GABAergic synapse formation, but through clustering of NL2 IgSF9b 
promotes the aggregation of the GABAergic PSD. Interestingly, IgSF9b shows a selective localization 
to GABAergic synapses in interneurons. Given the pyramidal cell-specific distribution of the DGC, S-
SCAM might connect different proteins to NL2, depending on neuronal cell type. In contrast to 
IgSF9b, MAM domain-containing GPI anchor protein (MDGA) binds directly to the extracellular part 
of NL2 (Lee et al., 2013; Pettem et al., 2013). MDGA binding to NL2 inhibits the synaptic 
development-inducing properties of NL2, presumably by interfering with neurexin binding. 
Synapse formation and differentiation 
Formation of chemical synapses is a developmental process to first establish neuronal circuits but 
persists in adulthood as an important mechanism for learning and memory. The vast majority of 
synapses in the CNS are formed between subcellular domains which are specialized as either pre- or 
postsynaptic structures. Cell polarity in neurons is established before synapse formation, so that 
neurites are differentiated into dendrites or axons when intercellular contacts are first made. 
The first step in synaptogenesis, cell adhesion, is common for all synapses, independent of which 
neurotransmitter system is employed (Missler et al., 2012). Cadherins and protocadherins are protein 
families which mediate homophilic cell adhesion during synaptogenesis. Although synaptic adhesion 
molecules are not necessarily inducing differentiation of pre- and postsynaptic structures, transmitter 
system-specificity might be primed already before contact is made, because factors secreted by 
neurons can have specific synaptogenic properties. For instance, neuronal activity-regulated pentraxin 
(Narp) is a presynaptically secreted factor which promotes the clustering of AMPA receptors but has 
no effect on GABAergic PSD proteins (O'Brien et al., 1999; O'Brien et al., 2002). Other factors such 
as Wnt proteins or fibroblast growth factors are secreted by target neurons and regulate axon 
morphology and differentiation (Krylova et al., 2002; Umemori et al., 2004). Thus, although initial 
cell adhesion might be mediated by the same protein families in synapses using different 
neurotransmitters, differentiation into specific pre- and postsynaptic structures begins already before 
contact formation. This is further illustrated by the finding that GABAergic synapse formation, in 
contrast to glutamatergic synapses, does not rely on dendritic protrusions (Wierenga et al., 2008). Still, 
at least in overexpression experiments, cell adhesion proteins can promote one type of synapse 
specifically. NLs, for instance, can change the ratio of excitatory to inhibitory synapses that contact 
the overexpressing neuron (Chih et al., 2006). The neurotransmitter specificity is mediated by 
selective trans-synaptic signaling, involving specific presynaptic neurexin isoforms. NLs are not 
required for synapse formation, as illustrated by the normal synapse number in NL triple KO mice 
(Varoqueaux et al., 2006). Therefore, although the pre- and postsynaptic side are primed to form a 
synapse of a specific neurotransmitter system, synapse validation by trans-synaptic complexes such as 
the NL-neurexin complex further drives differentiation. 
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The molecular diversity of trans-synaptic signaling complexes is thought to be instrumental in 
achieving the vastly heterogeneous composition of CNS synapses. Secreted morphogenic factors are 
essential for axon guidance and therefore for connectivity, especially with long-range projection 
neurons. However, given the diffuse nature of morphogenic signals, it is clear that in addition, trans-
synaptic signaling must contribute to cell type-specific differentiation of synapses. A central role for 
the NL-neurexin complex in this process is suggested by the existence of thousands of neurexin 
alternative splice isoforms. Theoretically, this diversity in presynaptic binding partners could instruct 
differentiation of the PSD beyond the determination of the neurotransmitter used by the synapse. 
Instead, NL-neurexin interaction is hypothesized to represent a molecular “code” which defines the 
precise composition of synapses. With the help of Sam68-like mammalian protein 2 (SLM2) KO mice, 
evidence of such a code was recently found (Traunmuller et al., 2016). SLMs are splicing factors 
involved in regulation of alternative splicing of synaptic proteins, including neurexins. SLM2 KO 
mice showed a specific increase of the GluA1 subunit of AMPA receptors, minor alterations in 
excitatory neurotransmission and deficits in long-term potentiation (LTP). Heterozygotic deletion of 
neurexin 1 exon 21 was sufficient to rescue these changes, suggesting that alternative splicing of this 
exon by SLM2 is crucial for instructing specific synaptic properties. 
The exact sequence in which proteins are recruited during synapse formation is not fully elucidated. 
Also, the minimally required set of proteins required for building functional synapses is still under 
debate. Insights into these questions was gained by overexpressing potentially synaptogenic proteins 
in heterologous cells. Besides NLs, synaptic cell adhesion molecule 1 (synCAM1) was found to 
promote synaptic structures when overexpressed in HEK cells (Biederer et al., 2002). The co-
expression of GluA2 was sufficient to induce glutamatergic transmission onto HEK cells. Similarly, 
GABAergic currents can be detected in HEK cells which constitutively overexpress GABAARs (Fuchs 
et al., 2013). GABAAR contribute to trans-synaptic interactions directly over their N-terminal domains 
(Brown et al., 2016b). The relevance of these interactions in vivo is unclear, since co-expression of 
NL2 increased GABAergic transmission markedly (Fuchs et al., 2013). 
The observation that neuronal activity is not necessary for developmental synapse formation supports 
the notion that trans-synaptic interactions are mainly driving synapse formation (Verhage et al., 2000). 
However, neurotransmission is required for the maintenance of synapses and membrane potential 
changes play a crucial role in neuronal differentiation and in maturation of synapses. The depolarizing 
action of GABAergic neurotransmission early after developmental synapse formation is critical for the 
functional development of silent glutamatergic synapses. By depolarizing the membrane, the Mg2+ 
block, which prevents the opening of NMDA receptors, is released (Ben-Ari et al., 2007). During 
adulthood, neuronal activity is an important factor in the elimination and formation of synapses 
(Caroni et al., 2014). For instance, growth of new spines is promoted by theta burst stimulation and 
hindered by low-frequency stimulation (Nagerl et al., 2004). Also, rearrangements of inhibitory 
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synapses assessed by gephyrin puncta dynamics in vivo, are induced when neuronal activity is blunted 
by monocular deprivation (Chen et al., 2012; van Versendaal et al., 2012). 
Development and diversity of GABAergic interneurons 
From a morphological, physiological and molecular perspective, GABAergic interneurons display a 
vast diversity in comparison to glutamatergic principal neurons. Different aspects of this heterogeneity 
partly coincide, giving rise to functionally distinct GABAergic cell types (Fishell and Rudy, 2011). 
Recently it has become clear that glutamatergic principal neurons are rivaling interneurons in regard to 
cell type diversity (Lodato et al., 2015). The obvious differences in appearance of GABAergic 
interneurons thus might have led to an overestimation of their functional diversity. However, 
GABAergic interneuron subtypes were implicated in many specific functions and have temporally 
unique firing properties. Understanding GABAergic interneuron diversity is thus important for 
understanding how their interaction with principal neurons impacts behavior (Klausberger and 
Somogyi, 2008). 
GABAergic interneurons in the cerebrum are generated in the ganglionic eminences and the preoptic 
area, distantly from their target regions. The main bout of interneuron proliferation around E13 
coincides with the generation of most pyramidal cells in the pallium (Le Magueresse and Monyer, 
2013). Interneurons however, because they originate outside of the pallium, undergo tangential 
migration for several days before reaching the target destination. Differentiation of interneurons is on 
the one hand determined by the region in which they originate, equipping cells with a specific 
transcriptional program before migration. On the other hand, the effect of transcription factors on cell 
fate varies with time of development, so that transcription factors are essential for different cell types 
in different time windows. In addition, interneurons are exposed to a multitude of morphogenic factors 
during migration, which refines their differentiation along the way. All neocortical and hippocampal 
GABAergic interneurons originate in either the medial ganglionic eminence (MGE), the caudal 
ganglionic eminence (CGE) or the preoptic area (POA). Nkx2-1 is a transcription factor which is 
restricted to the MGE and POA and is essential for development of interneurons originating from 
these areas. Couptf2, in contrast, is specifically expressed in the CGE and essential for migration of 
CGE-derived interneurons (Kanatani et al., 2008).  For differentiation of somatostatin (SST)-positive 
interneurons Nkx2-1 is required at E10.5 but not at E12.5 (Butt et al., 2008). Vasoactive intestinal 
polypeptide (VIP)-positive interneurons, in contrast, depend on Nkx2-1 expression at both time points, 
illustrating the importance of both temporal and spatial expression patterns for development of 
interneuron subtypes. 
The tangential migration of GABAergic interneurons out of the subpallium into the pallium is guided 
by attractive and repulsive cues. For instance neuregulin-1 is a diffusible protein which acts in the 
pallium as a chemoattractant for interneurons (Flames et al., 2004). Regions which have to be avoided 
are thought to express chemorepulsive proteins. Class 3 semaphorins were identified as the molecules 
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responsible for mediating chemorepulsion of the striatum for interneurons targeted to the cortical 
regions (Marin et al., 2001). Although the response of interneurons to guidance cues depends on their 
expression profiles, the mechanisms of migration seem similar in all interneuron classes. Tangentially 
migrating GABAergic neurons share a common morphology with a prominent leading process, which 
is essential for sensing cues in the environment (Martini et al., 2009). Finally, ambient GABA and 
glutamate play an important role in migration of GABAergic neurons by activating GABAA and 
AMPA receptors which are diffusely located at the plasma membrane (Cuzon et al., 2006; Manent et 
al., 2006). The migration-inducing effect of GABA on GABAergic interneurons depends on 
depolarization of cells and therefore on the onset of KCC2 expression (Bortone and Polleux, 2009). In 
the developing cerebral cortex, interneurons migrate through the marginal zone, the subplate and the 
subventricular zone. Because they avoid the cortical plate, a tangential-to-radial switch is necessary to 
populate the newly formed neocortex with GABAergic neurons. Whether an intrinsic genetic program 
or external cues are responsible for the switch in direction is currently unclear. 
GABAergic interneurons in the adult neocortex and hippocampus were classified according to 
morphological, transcriptional and electrophysiological criteria. Because of partial overlaps in 
expression profiles and smooth transitions between morphological classes it is difficult to clearly 
delineate all interneuron subtypes. Nevertheless, in the hippocampus at least 21 interneuron subgroups 
were clearly defined (Figure 4; (Klausberger and Somogyi, 2008)). Efforts to classify interneurons did 
not yet lead to a comprehensive list of GABAergic neuron subtypes. Common and objective criteria 
were therefore proposed to systematically classify interneurons in the cerebral cortex (Ascoli et al., 
2008). Although GABAergic interneuron subtypes are not yet fully characterized, the use of molecular 
markers proved to be practical to bin interneurons into large classes. The expression of either PV, SST 
or 5-hydroxytryptamine 3a receptor (5-HT3aR) fully covers the range of GABAergic interneurons in 
the neocortex (Rudy et al., 2011). This classification partially correlates with developmental origin of 
cells, as PV-positive cells originate mostly in the MGE and 5-HT3aR-positive cells originate mostly in 
the CGE, for instance. 
Importantly, glutamatergic principal neurons are targeted by GABAergic interneurons at distinct 
subcellular domains by different cell classes. In contrast to glutamatergic innervation which is 
restricted to dendritic spines, GABAergic axon terminals target the soma, dendrites and the axon 
initial segment of pyramidal cells. GABAergic interneurons innervating the soma and perisomatic 
region of pyramidal cells are called basket cells. All basket cells can be distinguished by the 
expression of either PV or cholecystokinin (CCK). However, axon initial segment-innervating 
chandelier cells are also PV-positive. Thus, although expression profiles reveal clues about neuronal 
function, morphology and electrophysiological properties have to be taken into account to describe the 
functional role of interneurons in network activity. During oscillatory activity in the hippocampus, 
interneuron classes were found to follow distinct patterns of activity (Klausberger and Somogyi, 
2008). CCK-positive basket cells display maximal activity shortly before the peak of theta oscillations 
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in the hippocampus with respect to local field potential (LFP) activity. Bistratified cells, on the other 
hand, fire most at the trough of theta oscillations. Although PV-positive basket cells are similar in 
morphology and target region as CCK-positive basket cells, they show peak activity only after the 
peak of theta oscillations and also display distinct behavior from CCK-positive basket cells during 
other network activity. Molecular marker expression is thus indicative of neuronal function, albeit 
other criteria always have to be taken into account. 
Figure 4. GABAergic interneuron diversity in the hippocampus CA1 region. 
At least 21 distinct classes of interneurons were identified thus far. Orange cells represent interneuron classes 
which mainly innervate pyramidal cells (blue). The main synaptic terminations are shown in yellow. CA1, cornu 
ammonis 1; CCK, cholecystokinin; O-LM, oriens-lacunosum moleculare; PV, parvalbumin; VGLUT, vesicular 
glutamate transporter; VIP, vasoactive intestinal polypeptide (Klausberger and Somogyi, 2008). 
PV- and CCK-positive cells build two non-overlapping groups of basket cells and together comprise 
all cells of this interneuron class. Besides spiking properties during network activity, the two groups 
also differ in expression profiles, membrane properties and the physiology of input and output 
synapses (Bartos and Elgueta, 2012). Firing patterns in response to current injection are 
accommodating for CCK-positive basket cells and non-accommodating for PV-positive cells. The 
majority of PV-positive cells also displays a higher firing frequency upon current injection. Synaptic 
terminals formed by the two groups of basket cells are equipped with a different set of receptors and 
other synaptic proteins. Cannabinoid receptor 1 (CB1) is exclusively located at CCK-positive 
terminals whereas the μ-opioid receptor (MOR) is mostly present at PV-positive terminals. Both CB1 
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and MOR activation can lead to suppression of GABA release from terminals. However, receptor 
agonists are released under different circumstances, implicating CB1- and MOR-containing terminals 
in different processes. Endocannabinoids are synthesized in response to strong glutamatergic 
transmission and are released to activate presynaptic CB1 receptors. This retrograde signaling 
underlies the process of depolarization-induced suppression of inhibition (DSI), which was first 
described electrophysiologically at a subset of inhibitory synapses. Along with CB1, vesicular 
glutamate transporter 3 (VGluT3) is also exclusive to CCK-positive basket cells among GABAergic 
interneurons. The presence of VGluT3 in VGAT-containing synaptic vesicles of CCK-positive basket 
cells indicates that glutamate is coreleased from these synapses together with GABA (Stensrud et al., 
2013; Stensrud et al., 2015). Some CCK-positive basket cells express VIP instead of VGluT3, 
illustrating that subtypes of interneuron classes can be defined by the combination of molecular 
marker expression. 
The dystrophin-glycoprotein complex 
In the light of GABAergic molecular diversity, the DGC is of special interest for three reasons. First, 
this complex is restricted to a subset of GABAergic synapses, most prominently on pyramidal cells in 
the forebrain and in cerebellar Purkinje cells. Secondly, multiple proteins were shown to associate 
with the DGC. These interactions may impart a role of a molecular hub to the DCG, on which several 
signaling pathways could converge. Finally, through its interactions with presynaptic binding partners, 
the DGC might be involved in trans-synaptic signaling. The selective distribution of the DGC suggests 
that such trans-synaptic signaling might be specific to certain interneurons classes. 
Dystrophin 
The core of the DGC is formed by the proteins dystrophin and DG, of which β-DG builds the 
transmembrane and α-DG the extracellular part of the complex (Figure 3). Dystrophin is a large 
cytosolic protein and builds the connection of the DGC to intracellular binding partners. Its domain 
structure reveals clues about the function of dystrophin in the DGC. On the N-terminal end an actin-
binding domain is located whereas the C-terminal end contains domains which interact with DG and 
the associated proteins syntrophin and dystrobrevin (Anderson et al., 2012). The N-terminal actin-
binding domain is separated from the C-terminus by the rod domain, named after the tubular structure 
that is formed by its spectrin-like repeats. Interestingly, the crucial interaction of dystrophin with β-
DG is mediated in part by WW domains in dystrophin, the same domains which are necessary for 
binding the signaling protein synArfGEF (Fukaya et al., 2011). S-SCAM, in turn, interacts with β-DG 
and NL2 over its WW domains (Sumita et al., 2007). The observation that the same modular domain 
structure serves to build the DGC and associated interactions points towards a common regulation of 
this extended protein complex. 
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Because the dystrophin gene (DMD) contains several internal promoters, shorter protein isoforms exist 
which lack the actin-binding domain. The DMD gene is, due to extensive intronic regions, one of the 
largest genes in the human genome, spanning around 2.4 megabases (Koenig et al., 1987; Love et al., 
1990). The large size of the DMD gene makes dystrophin susceptible to mutations. This underlies the 
relatively high incidence of muscular dystrophies, one of the clinical manifestations of dystrophin 
mutations. 
Dystroglycan 
Several glycoproteins were isolated in conjunction with dystrophin (Campbell and Kahl, 1989; Ervasti 
et al., 1990). Among these, a 43 kilodalton (kDa) protein was found to be directly linked to dystrophin 
and was later renamed β-DG (Ervasti and Campbell, 1991). On the basis of biochemical interactions 
of glycoproteins, it was concluded that the large glycoprotein α-DG is located on the extracellular side 
of the DGC. Other glycoproteins associated with dystrophin turned out to bind to DG but not directly 
to dystrophin (Ozawa et al., 2005). These proteins were named sarcoglycans, in line with their 
prominent expression in muscle. 
α- and β-DG are encoded by a single gene (Dag1) and generated by proteolytic cleavage of a precursor 
protein (Ibraghimov-Beskrovnaya et al., 1992). The two mature proteins remain non-covalently 
attached and the function of proteolytic cleavage is still unclear. However, mutation of the cleavage 
site in DG leads to glycosylation defects and muscular dystrophy (Jayasinha et al., 2003). α-DG is 
more extensively glycosylated than β-DG, making up more than half of its molecular weight (Barresi 
and Campbell, 2006). By far most glycosylation sites in α-DG lie in the mucin-like domain and 
undergo O-mannosylation. The sequence of catalytic steps involved in α-DG is not fully elucidated but 
can be broadly divided into two processes. First, there is the attachment of mannose, which is in turn 
linked to other glycans and phosphorylated. This modification depends in part on protein-O-mannosyl-
transferase 1 and 2 (POMT1/2). Secondly, further glycans are attached to the phosphate group in the 
process of post-phosphoryl-glycosylation. Several enzymes are putatively involved in this 
modification but only the role of like-acetylglucosaminyltransferase (LARGE) is established so far 
(Waite et al., 2012). 
Glycosylation of α-DG is essential for interaction with extracellular binding partners. Both proteins 
secreted into the ECM and located presynaptically were found to interact with α-DG. The presence of 
a laminin G-domain is common to most α-DG-binding proteins such as laminin, agrin and neurexin. 
Interaction with laminin and agrin is important for structural integrity of the sarcolemma and 
clustering of receptors at the neuromuscular junction (NMJ), respectively. The finding that neurexin 
binds α-DG in a splice isoform-specific manner fueled speculations about a trans-synaptic function of 
DG in the brain (Sugita et al., 2001). 
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Distribution of the dystrophin-glycoprotein complex in the brain 
Because of the prominent involvement of the DGC in muscular dystrophies and the strong expression 
in muscle, the function of the DGC in this tissue is well studied. However, DGC components are 
widely expressed throughout the body, albeit in different subcompositions (Chamberlain et al., 1988; 
Chelly et al., 1988; Hoffman et al., 1988). In the brain, the strongest expression of dystrophin and DG 
is found in astrocytes, where the DGC is located at the end-feet surrounding blood vessels (Tian et al., 
1996). The neuronal DGC displays a punctate distribution, which is due to the clustering of the 
complex in GABAergic PSDs (Miike et al., 1989; Lidov et al., 1990; Lidov et al., 1993; Knuesel et al., 
1999). Neuronal DGC expression is widespread in the CNS, ranging from the spinal cord to the brain 
stem and cortical areas (Gorecki et al., 1992; Zaccaria et al., 2001; Wright et al., 2012). By far the 
most prominent immunolabeling, however, was described in forebrain pyramidal cells and in 
cerebellar Purkinje cells. On these cells, DGC components can be detected in characteristic large 
clusters that are restricted to the perisomatic subcellular compartment. The reason for this limited 
distribution is unknown thus far, but the compartment-specific innervation of some interneuron classes 
in the cerebral cortex suggests a function of the DGC specifically in basket cell synapses. 
Functions of the dystrophin-glycoprotein complex in the central nervous system 
Depending on cell type and developmental stage, DG serves various functions in the CNS. 
Constitutive ablation of DG is lethal early in embryonic development (Williamson et al., 1997). 
Therefore, conditional KO (cKO) strategies were employed to study the function of the DGC in the 
brain. Crossing DG floxed mice with mice expressing glial fibrillary acidic protein (GFAP)-driven Cre 
recombinase efficiently led to the ablation of DG in astrocytes (Moore et al., 2002). This resulted in 
gross structural brain abnormalities, including defects in the layering of the cerebral cortex and 
macrocephaly. The absence of the DGC from the glia limitans likely underlies these structural deficits. 
The DGC, however, is also expressed in radial glial cells (RGC), and Nestin-Cre / DG null mice 
display a similar layering phenotype (Satz et al., 2010). Neuronal migration in the cerebral cortex is 
thus likely controlled by DG expressed in astrocytes and in RGCs. In addition, mice expressing a 
mutated DG glycosyl transferase exhibit abnormal layering of the cerebral cortex, stressing the 
importance of DG glycosylation for this function. In another subcellular compartment of astrocytes, 
the end-feet surrounding blood vessels, the DGC serves an unrelated function. In this context, the 
DGC is involved in clustering aquaporin-4 channels (Waite et al., 2012). 
Because intellectual disability is a common finding in patients with Duchenne’s muscular dystrophy 
(DMD), mice lacking the largest form of dystrophin (mdx mice) were examined extensively for 
neurological abnormalities. The finding that clustering of GABAAR subunits, but not of gephyrin, is 
reduced in mdx mice, indicated that the DGC is involved in clustering GABAergic PSD proteins 
(Knuesel et al., 1999; Vaillend et al., 2010). However, DG is not necessary for synaptic clustering of 
GABAAR subunits in primary hippocampal neurons (Levi et al., 2002). Also, the observation that 
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DGC components are always apposed to GABAergic presynaptic terminals in primary cultures 
suggests a trans-synaptic, rather than a purely postsynaptic function of the DGC (Brunig et al., 2002). 
Multiple other alterations in brain morphology and physiology of mdx mice were reported (Cohen et 
al., 2015). Yet, because mdx mice carry a constitutive mutation which also affects muscle and other 
tissue, it is not clear whether these changes are due to indirect compensatory effects or whether they 
represent the physiological function of dystrophin in the brain. 
Brain involvement in muscular dystrophies 
Already in the earliest descriptions of DMD, intellectual disability (ID) was noted as a hallmark of the 
disease (Duchenne de Boulogne, 1861). The degree of neurological involvement in muscular 
dystrophies ranges from severe brain malformations in congenital muscular dystrophies (CMD) to 
very mild ID in dystrophinopathies. It is well established that the mean intelligence quotient of DMD 
patients lies around one standard deviation below average (Cotton et al., 2001; Cotton et al., 2005). 
The severity of ID correlates with the position of the mutation in the DMD gene, presumably because 
more downstream mutations cause more dystrophin isoforms to be lost (Taylor et al., 2010). In 
contrast to CMDs, dystrophinopathies are not associated with lissencephaly or other severe brain 
abnormalities, hinting towards a crucial role of synaptic dystrophin for cognitive function. Moreover, 
severe ID is common in rare forms of limb girdle muscular dystrophy without structural brain 
abnormalities, further supporting the notion that the neuronal DGC is essential for normal cognition 
(Dincer et al., 2003; Hara et al., 2011). 
SynArfGEF 
SynArfGEF was first described as a protein-coding complementary DNA isolated from human brain 
(Kikuno et al., 1999). The initial finding that this gene is expressed most abundantly in brain was 
confirmed by Northern and Western blot analyses as well as by immunohistochemical stainings (Inaba 
et al., 2004). Furthermore, biochemical and immunolocalization experiments suggested that 
synArfGEF is enriched in the glutamatergic PSD, giving rise to the “syn” prefix. Based on sequence 
homology, the presence of a Sec7 domain in synArfGEF was identified early on, suggesting a function 
as a guanine nucleotide exchange factor (GEF) (Osada et al., 2001). Indeed, synArfGEF (brefeldin A-
resistant Arf-GEF 3 [BRAG3]; IQ motif and Sec7 domain 3 [IQSEC3]) belongs to the group of Sec7 
domain-containing ADP ribosylation factor (Arf) nucleotide exchangers (Cox et al., 2004). Later, it 
was described as a dystrophin-interacting protein present in the GABAergic PSD (Fukaya et al., 2011; 
Sakagami et al., 2013). In the light of the gephyrin clustering-inducing properties of collybistin, 
another GEF protein in the GABAergic PSD, speculations about the involvement of synArfGEF in 
GABAergic PSD regulation arose. 
Conflicting results were reported about Arf selectivity of synArfGEF catalytic function. The human 
isoform was shown to activate Arf1 whereas the rat isoform seems to act specifically as an Arf6 GEF 
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(Hattori et al., 2007; Fukaya et al., 2011). Arf6 exhibits a wide-spread distribution in the CNS and 
serves various functions, most notably as a modulator of neuronal morphology (Jaworski, 2007). It is a 
membrane-bound small GTPase, and, in contrast to Arf1-5, cycles between the plasma membrane and 
endocytic compartments. The synaptic localization of synArfGEF is therefore in line with activation of 
Arf6 rather than Arf1. Cell morphology is controlled by Arf6 through two mechanisms. Arf6 
activation affects actin dynamics by increasing Ras-related C3 botulinum toxin substrate 1 (Rac1) 
activity. On the other hand, Arf6 activation can induce both clathrin-dependent and -independent 
endocytosis. The use of Arf6 constitutively active (CA) and dominant negative (DN) mutants in 
overexpression experiments in cultured neurons elucidated the crucial role of this GTPase in 
regulation of neuronal morphology. Axonal and dendritic branching as well as the abundance of 
dendritic spines are impacted by Arf6 activity (Hernandez-Deviez et al., 2002; Hernandez-Deviez et 
al., 2004; Miyazaki et al., 2005). Under physiological conditions, however, Arf6 activity is controlled 
by a multitude of GEFs and GTPase activating proteins (GAP), so that Arf6 function is determined by 
the nanodomain distribution of these regulatory proteins (Jaworski, 2007). 
The synArfGEF homologs IQSEC1 and IQSEC2 are both present at glutamatergic PSDs and regulate 
internalization of GluA2 and GluA1-containing AMPA receptors, respectively (Scholz et al., 2010; 
Myers et al., 2012). In the case of GluA1 internalization, unbinding of calmodulin from IQSEC2 
precedes the activation of Arf6 by IQSEC2. The IQ motif binds to calmodulin preferably in low Ca2+ 
concentrations (apocalmodulin), so that an influx of Ca2+ might trigger the release of calmodulin from 
IQSEC2. Like its close homologs, synArfGEF also contains an IQ motif N-terminally to the Sec7 
domain. Functions of synArfGEF in the GABAergic PSD are therefore likely to be modulated by 
neuronal activity. In line with this hypothesis, synArfGEF transcription is induced by increased 
neuronal activity or enriched environment through the transcription factor neuronal PAS domain 
protein 4 (NPAS4) (Bloodgood et al., 2013). Strikingly, NPAS4 regulates GABAergic synapses in a 
layer-specific manner in the hippocampus, correlating with the association of synArfGEF with the 
mostly perisomatically localized DGC.  
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AIMS OF THE THESIS 
Since the identification of GABA as a neurotransmitter, advances in molecular genetics, 
pharmacology, electrophysiology and optical imaging have revealed an enormous molecular diversity 
of GABAergic postsynaptic proteins. This molecular complexity is mirrored by the morphological and 
physiological heterogeneity of GABAergic interneurons. On the other hand, the molecular 
mechanisms of cell- and compartment-selectivity of GABAergic innervation are still unclear. This 
thesis aims to uncover a relationship between the molecular heterogeneity of GABAergic synaptic 
proteins and the specificity of GABAergic synapse formation, maintenance and elimination. Two 
levels will be considered in the investigation of the dependence of synapse specificity on PSD protein 
heterogeneity: The interplay of these factors within and between neurotransmitter systems. 
The presence of the DGC at synaptic sites in CNS neurons and its role in the development and 
function of GABAergic synapses are largely unexplored scientific issues. Due to its restricted 
localization in a subset of GABAergic synapses and its potential post- as well as trans-synaptic 
functions, the DGC represents an ideal candidate to explore whether GABAergic PSD composition 
and the specificity of GABAergic innervation are interconnected. The preferred perisomatic 
localization of this complex in forebrain pyramidal neurons implies that the DGC is essential 
specifically for GABAergic basket cell function, if a direct structure-to-function relationship exists. In 
the first study, this hypothesis is tested mainly by disrupting the complex in vivo, using conditional 
deletion of DG. A role in postsynaptic clustering of GABAergic PSD proteins was assigned to the 
DGC on the basis of studies that examined mice deficient in a single dystrophin isoform. However, 
unveiling potential trans-synaptic functions of the DGC requires disrupting the complex, and therefore 
any specific signaling, completely. Nevertheless, the conditional deletion approach also offers the 
possibility to examine whether GABAergic PSD components require the DGC for postsynaptic 
clustering, without the issue of residual DGC formed by other dystrophin isoforms. The dependence of 
GABAergic PSD proteins, in particular NL2, on the DGC for postsynaptic clustering is therefore 
tested in DG-deficient mice as well. Finally, elucidation of the neuronal networks which depend on 
DGC signaling might facilitate the development of novel strategies to alleviate some of the 
neurological symptoms many muscular dystrophy patients suffer from. 
In order to characterize the mechanisms that convey neurotransmitter-specificity of synapse formation 
and function, the second study focuses on the DGC-associated protein synArfGEF. This protein, due 
to its initial characterization in glutamatergic as well as GABAergic PSDs, its function as an activator 
of Arf GTPases and the potential activity-dependence of its function, lends itself to study postsynaptic 
regulatory processes that convey neurotransmitter-specificity. The purpose of this study is to 
characterize the biochemical interactions, the functions of individual synArfGEF domains and the 
neuronal activity-dependence of these functions. These aspects are examined primarily by using an 
ablation and an overexpression approach in primary neuronal cultures, combined with the targeted 
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mutagenesis of synArfGEF. With an emphasis on the processes that promote the alignment of pre- and 
postsynaptic structures, a function of synArfGEF in conferring glutamatergic or GABAergic synaptic 
specificity is considered. The occurrence of “mismatched” synapses in primary cultures offers the 
opportunity to study the sorting mechanisms that ensure targeting of PSD proteins to appropriate 
synapses. Neurotransmitter specificity of synArfGEF function is studied in this context, in order to 
uncover processes which are not amenable to study under physiological conditions in vivo.
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Abstract 
Distinct types of GABAergic interneurons target different subcellular domains of pyramidal cells, 
thereby shaping pyramidal cell activity patterns. Whether the presynaptic heterogeneity of GABAergic 
innervation is mirrored by specific postsynaptic factors is largely unexplored. Here we show that 
dystroglycan, a protein responsible for the majority of congenital muscular dystrophies when 
dysfunctional, has a function at postsynaptic sites restricted to a subset of GABAergic interneurons. 
Conditional deletion of Dag1, encoding dystroglycan, in pyramidal cells caused loss of CCK-positive 
basket cell terminals in hippocampus and neocortex. PV-positive basket cell terminals were unaffected 
in mutant mice, demonstrating interneuron subtype-specific function of dystroglycan. Loss of 
dystroglycan in pyramidal cells had little influence on clustering of other GABAergic postsynaptic 
proteins and of glutamatergic synaptic proteins. CCK-positive terminals were not established at P21 in 
the absence of dystroglycan and were markedly reduced when dystroglycan was ablated in adult mice, 
suggesting a role for dystroglycan in both formation and maintenance of CCK-positive terminals. The 
necessity of neuronal dystroglycan for functional innervation by CCK-positive basket cell axon 
terminals was confirmed by reduced frequency of inhibitory events in pyramidal cells of dystroglycan-
deficient mice and further corroborated by the inefficiency of carbachol to increase IPSC frequency in 
these cells. Finally, neurexin binding seems dispensable for dystroglycan function since knock-in mice 
expressing binding-deficient T190M dystroglycan displayed normal CCK-positive terminals. Taken 
together, we describe a novel function of dystroglycan in interneuron subtype-specific trans-synaptic 
signaling, revealing correlation of pre- and postsynaptic molecular diversity.  
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Introduction 
GABAergic interneurons, which provide the main source of inhibitory drive in the adult mammalian 
brain, form several distinct classes according to morphological, molecular and functional criteria 
(Fishell and Rudy, 2011). This specialization allows interneurons to adapt to different demands of 
postsynaptic targets and thereby control membrane excitability in a spatially and temporally precise 
manner (Klausberger and Somogyi, 2008). Most interneuron classes innervate only a specific 
subcellular domain of target cells, for example the axon initial segment, the cell soma or dendritic 
regions. Synaptic transmission from different interneuron subtypes has thus fundamentally different 
impact on the activity of postsynaptic cells. It might be advantageous to account for this diversity of 
GABAergic innervation with postsynaptic specializations matching the specific properties and 
plasticity mechanisms of synaptic terminals they are contacted from. Indeed, the GABAergic 
postsynaptic density (PSD) is characterized by a large molecular heterogeneity (Tyagarajan and 
Fritschy, 2014). However, little is known about such subtype-specific postsynaptic GABAergic 
adaptations. 
Basket cells are GABAergic interneurons that specifically target the perisomatic region of principal 
neurons. In cerebral cortex and hippocampus, expression of parvalbumin (PV) or cholecystokinin 
(CCK) identifies basket cells as belonging to one of two non-overlapping groups (Freund and Katona, 
2007). Although these two interneuron subtypes innervate the same subcellular domain, they are 
distinguished by various traits (Bartos and Elgueta, 2012). Only CCK-positive basket cells express 
presynaptic cannabinoid receptors, enabling retrograde signaling of endocannabinoids to suppress 
GABA release. Different firing patterns, expression profiles and developmental origins further set the 
two subtypes apart. Therefore, it is conceivable that the two types of basket cells use different 
mechanisms for synapse formation and require a different set of postsynaptic proteins to exert their 
vastly different functions. 
Dystroglycan (DG) is the central component of the dystrophin-glycoprotein complex (DGC). The 
extracellular α-DG and transmembrane β-DG, generated by proteolytic cleavage of a single gene 
product, bind the large cytoplasmic protein dystrophin, which in turn can interact with actin filaments. 
α-DG, through its glycosyl side chains, can bind to extracellular matrix components. The crucial role 
of the DGC in muscle tissue was revealed by mutations affecting DGC components that lead to 
muscular dystrophies (McNally and Pytel, 2007). The DGC, albeit differing slightly in its molecular 
composition, is also expressed in the central nervous system by glial cells and neurons (Waite et al., 
2012). Developmental brain malformations and intellectual disability, observed frequently in muscular 
dystrophies caused by DGC dysfunction, testify to the importance of this complex for brain function. 
The finding that the DGC is present in pyramidal cells as large, mostly perisomatic clusters 
postsynaptic to GABAergic terminals spurred interest in the synaptic function of the DGC (Lidov et 
al., 1990). Because reduced GABAAR immunoreactivity was found in a mouse model of Duchenne’s 
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muscular dystrophy (DMD), a function for the DGC in clustering of PSD components was posited 
(Knuesel et al., 1999; Vaillend et al., 2010). Despite the selective DGC subcellular distribution, 
biochemical interaction with presynaptic neurexins and the obligatory association of DG with 
GABAergic presynaptic terminals in neuronal cultures, the role of the DGC in trans-synaptic signaling 
was never systematically assessed (Sugita et al., 2001; Brunig et al., 2002). 
We hypothesized that the diversity of GABAergic PSD composition is functionally related to the 
heterogeneity of GABAergic innervation. Due to its restricted distribution and known role as a 
transmembrane complex, DG seemed ideally suited to address this issue. Ablation of DG specifically 
in pyramidal neurons allowed us to study the synaptic function of the DGC without confounding 
deficits in neuronal migration associated with loss of DG in other tissues. Using this approach, we 
demonstrate that the neuronal DGC plays an essential role in trans-synaptic signaling necessary for 
formation and maintenance of functional axon terminals from CCK-positive basket cells. Since the 
neuronal circuits depending on this signaling have been shown to be involved in major cognitive 
functions, our findings open new avenues in identifying the causes of intellectual disability in 
muscular dystrophies.  
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Materials and methods 
Animals 
All mice were bred on C57BL/6 background at the Laboratory Animal Service Center (Schlieren, 
Zurich, Switzerland) and kept in standard housing with food and water provided ad libitum. Mice 
harboring loxP sites in exon 2 of Dag1 were obtained from The Jackson Laboratory (Bar Harbor, ME). 
NEX-Cre transgenic mice were used to achieve selective ablation of neuronal DG (Goebbels et al., 
2006) and were provided by Dr. Sandra Goebbels (Max-Planck-Institute of Experimental Medicine, 
Goettingen, Germany). Dag1 T190M knock-in mice were provided by Dr. Kevin P. Campbell 
(Howard Hughes Medical Institute, Iowa City, IA). Dag1 floxed mice were genotyped by PCR 
analysis using primers 5’-GGAGAGGATCAATCATGG-3’ and 5’-CAACTGCTGCATCTCTAC-3’. 
Genotyping of NEX-Cre transgenic mice was performed as described (Goebbels et al., 2006). To 
obtain DG cKO and control mice, NEX-Cretg/+ / Dag1loxP/+ mice were bred to NEX-Cre+/+ / 
Dag1loxP/loxP mice. All experiments were approved by the veterinary office of the Canton of Zurich. 
Western blotting 
Adult DG cKO and control mice of both sexes were anaesthetized with pentobarbital (Nembutal; 50 
mg/kg intraperitoneally) and sacrificed by decapitation. Cheek muscle was dissected on ice and 
transferred to lysis buffer (50 mM Tris (pH 7.6), 150 mM NaCl, 1% Triton X-100, Complete Mini 
Protease Inhibitor Cocktail [Roche, Rotkreuz, Switzerland]). Tissue was Dounce homogenized, 
sonicated and incubated on ice for 1h. Lysates were centrifuged at 50’000 RPM for 1h at 4 °C and 
supernatants were stored at -80 °C. For anti-α-DG blots, glycosylated proteins were enriched by 
incubating lysates with wheat germ agglutinin (WGA) agarose beads (Vector Labs, Burlingame, CA) 
at 4 °C overnight (ON). Proteins were eluted with 300 mM N-Acetyl-glucosamine and stored at -20 
°C. Laemmli buffer was added to WGA-enriched and non-enriched lysates (for loading control) and 
samples were run on 8% tris-glycine polyacrylamide gels. Proteins were transferred to polyvinylidene 
fluoride (PVDF) membranes. Mouse anti-α-DG (11H6C4; Millipore; 1:1000) and rabbit anti-actin 
(Sigma; 1:5000) antibodies were incubated in tris-buffered saline with 0.05% Tween 20 (TBST) 
including 5% Western Blocking Solution (Roche) ON at 4 °C. Membranes were washed 5 times in 
TBST. Horseradish peroxidase-coupled donkey secondary antibodies (1:20’000) were incubated for 
1h at room temperature (RT) and membranes were washed again 5 times in TBST. SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Fisher Scientific, Waltham, MA) was applied and 
membranes were developed on X-ray film (Fujifilm, Tokyo, Japan). 
Tissue preparation for immunohistochemistry 
DG cKO and control mice of both sexes at the age of 8 to 12 weeks were anaesthetized by 
intraperitoneal pentobarbital injection (Nembutal; 50 mg/kg) and perfused transcardially with ice-cold 
oxygenated artificial cerebrospinal fluid (ACSF; pH 7.4) for 2 min, as described (Notter et al., 2014). 
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Brains were immediately dissected and fixed in 4% paraformaldehyde (PFA) for 100 min on ice. After 
rinsing in phosphate-buffered saline (PBS), brains were incubated in 30% sucrose (in PBS) at 4 °C 
ON. 50 μm thick coronal sections were cut from frozen blocks using a sliding microtome (HM400; 
Microm, Walldorf, Germany) and stored at -20 °C in antifreeze solution. Tissue preparation from P21 
mice followed the same protocol with the following modifications: Mice were perfused with 4% PFA 
(after brief perfusion with PBS to rinse blood) and brains were post-fixed for 3h. 
Target Host species Dilution Cat. no. Company / origin 
α-Dystroglycan (VIA4-1) Mouse 1:100 05-298 EMD Millipore 
α-Dystroglycan (11H6C4) Mouse 1:100 05-593 EMD Millipore 
β-Dystroglycan Mouse 1:100 ab49515 Abcam 
Bassoon Mouse 1:2000 VAM-PS003 StressGen 
Cannabinoid receptor 1 Rabbit 1:3000 258 003 Synaptic Systems 
Cholecystokinin 8 Mouse 1:1000 ab37274 Abcam 
Cre recombinase Rabbit 1:1000 PRB-106C Covance 
Dystrophin (C-terminal) Mouse 1:100 BT39-9050-05 Biotrend 
GABAAR α1 subunit Guinea pig 1:20‘000 - (Fritschy and Mohler, 1995) 
GABAAR α2 subunit Guinea pig 1:6000 - (Fritschy and Mohler, 1995) 
GABAAR γ2 subunit Guinea pig 1:10‘000 - (Fritschy and Mohler, 1995) 
GAD65/67 Rabbit 1:2000 GC 3008 Biomol 
Gephyrin Mouse 1:1000 147 021 Synaptic Systems 
NeuN Mouse 1:1000 MAB377 Chemicon 
Neuroligin 2 Rabbit 1:10‘000 - Gift from Dr. Peter Scheiffele 
Parvalbumin Rabbit 1:1000 24428 ImmunoStar 
PSD-95 Mouse 1:1000 MA1-045 ABR 
Synaptotagmin 2 Rabbit 1:1000 105 123 Synaptic Systems 
synArfGEF Guinea pig 1:3000 - Gift from Dr. Hiroyuki Sakagami 
(Fukaya et al., 2011) 
VGAT Rabbit 1:3000 131 003 Synaptic Systems 
VGluT1 Guinea pig 1:1000 135 304 Synaptic Systems 
VGluT3 Guinea pig 1:4000 AB5421 Merck Millipore 
Table 1. Antibodies used for immunohistochemical stainings. 
If not otherwise stated, antibody VIA4-1 was used to label α-dystroglycan. For secondary antibodies see 
materials and methods. 
Immunohistochemistry 
After rinsing once in PBS, sections were incubated in primary antibody solution (50 mM Tris, 150 
mM NaCl, 0.2% Triton X-100, 2% normal goat serum (NGS), pH 7.4) with antibodies listed in Table 
1. Primary antibodies were incubated at 4 °C ON, or for 3 days if DG or dystrophin was labelled. 
Sections were washed 3 times for 10 min in PBS and incubated in secondary antibody solution (50 
mM Tris, 150 mM NaCl, 0.05% Triton X-100, 2% NGS, pH 7.4) for 30 min at RT with secondary 
antibodies raised in goat. Antibodies conjugated to Alexa Fluor 488 and Alexa Fluor 647 (Invitrogen, 
La Jolla, CA) were diluted 1:1000 whereas antibodies conjugated to Cy3 (Jackson ImmunoResearch, 
West Grove, PA) were diluted 1:500. Sections were washed 3 times for 10 min in PBS and mounted 
on gelatin-coated slides using Fluorescence Mounting Medium (Dako, Carpinteria, CA). For 
immunoperoxidase stainings, biotinylated secondary antibodies were diluted 1:300. After washing 3 
times for 10 min in PBS, sections were incubated with avidin-peroxidase-complex solution (Vector 
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Labs) for 30 min at RT and washed again 3 times for 10 min in PBS. Sections were pre-incubated in 
diaminobenzidine (DAB) solution (50 mM Tris, 150 mM NaCl, 0.05% Triton X-100, 0.5 g/L DAB, 
pH 7.7) for 5 min under agitation and DAB solution containing 0.01% H2O2 was added to sections. 
The reaction was stopped by washing in ice-cold PBS several times. Sections were mounted on 
gelatinized slides and dried ON. After dehydration by immersion in increasingly concentrated ethanol 
solutions and clearing in xylene, slides were coverslipped with Eukitt (Merck, Darmstadt, Germany). 
Stereology 
Immunoreactive cells were counted and the size of the dorsal hippocampus estimated with the help of 
Mercator software (Explora Nova, La Rochelle, France). 4 equidistant coronal sections per mouse 
were used to count cells in all layers of the hippocampus proper. The volume was estimated using 
Mercator software and cell density was calculated. 
Image acquisition and statistical analysis 
Z-stack images (3 optical sections, 0.5 µm step size) were recorded of all specimens using confocal 
laser scanning microscopy (LSM 700, Carl Zeiss, Oberkochen, Germany). Images were taken using a 
40x objective with a numerical aperture of 1.4 and had a pixel size of 112 x 112 nm2. To reduce 
variability, 3-4 sections were imaged per mouse and cluster density values were averaged from these 
sections. All imaging parameters were kept constant between genotypes. For cluster analysis, 
maximum intensity projections were created from z-stacks and analyzed using ImageJ (NIH, 
Bethesda, MD). Representative example images were processed with Imaris (Bitplane, Belfast, UK). 
Statistical tests were performed using Prism software (GraphPad, La Jolla, CA). A minimum of 4 mice 
per group were used and statistical tests were performed using data points from individual mice for 
density values and using pooled cluster data from all mice per group for size (see Table 2). 
Stereotactic injections 
8 to 10 weeks old mice transgenic for loxP in exon 2 of Dag1 were anaesthetized with isoflurane 
(Attane; Piramal, Mumbai, India). After mice were head-fixed on a stereotactic frame (David Kopf 
Instruments, Tujunga, CA), a small longitudinal incision was made under continuous administration of 
isoflurane to reveal the skull. Bregma was identified and the skull was perforated unilaterally using a 
surgical drill at the following coordinates relative to Bregma: x = -1.9 mm, y = 1.6 mm. A glass 
pipette filled with virus solution was inserted into the brain to z = 1.5 mm. A total of 1 μL virus 
solution was injected using an automated injection pump in increments of 70 nL over 10 min. The 
pipette was removed and the incision sutured. Mice were injected intraperitoneally with 1 mg/kg 
buprenorphine (Temgesic; Essex Chemicals, Lucerne, Switzerland) and placed on a warm pad for 
recovery before returning to the home cage. 
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Virus 
AAV8-CaMKIIa-mCherry-Cre (dot blot titer 4.7x1012 VG/mL) was purchased from the University of 
North Carolina Vector Core (Chapel Hill, NC). 
Acute brain slice preparation 
5 to 6 weeks old DG cKO and control mice were briefly anaesthetized with isoflurane and decapitated. 
The brain was quickly removed and transferred to ice-cold solution containing 65 mM NaCl, 2.5 mM 
KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM glucose and 105 
mM sucrose saturated with 95% O2 and 5% CO2. 350 μm-thick transverse slices containing the 
hippocampus were cut from the tissue block with a vibratome (Microm HM 650V, Thermo Scientific, 
Waltham, MA) and kept in oxygenated ACSF (315 mOsm) containing 125 mM NaCl, 2.5 mM KCl, 
1.25 mM NaH2PO4, 25 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2 and 25 mM glucose at 34 °C for 25 
min and then at room temperature until use. 
Electrophysiology and data analysis 
For recording, individual slices were transferred to a recording chamber perfused with oxygenated 
ACSF solution (same as above) at a flow rate of 1 to 2 mL/min. Whole-cell recordings were made 
from hippocampal cornu ammonis 1 (CA1) pyramidal neurons. Cells were first selected using oblique 
IR illumination with a BX51 microscope (40x water-immersion objective; Olympus, Tokyo, Japan). 
Subsequently, neurons were anatomically identified using a fluorescent dye (Alexa 488, 10 µM) 
included in the intracellular solution. The dye was excited with wLS broad-band LED illumination 
(488 nm) and images were acquired with Retiga R1 camera using Ocular software (Qimaging, Surrey, 
Canada). The cells were patched with borosilicate glass pipettes (2-5 MΩ) containing: 135 mM KCl, 
10 mM HEPES, 10 mM sodium phosphocreatine, 4 mM Mg-ATP, 0.3 mM Na-GTP, pH 7.3 with 
KOH. Recordings were performed using Multiclamp 700B amplifier and data were acquired with a 
Digidata 1550A 16-bit board (all from Molecular Devices, Sunnyvale, CA). All experiments were 
performed at room temperature. Spontaneous inhibitory postsynaptic currents (sIPSC) were recorded 
from CA1 pyramidal cells clamped at a membrane voltage of -70 mV in the presence of 10 μM NBQX 
to block excitatory transmission. Recordings with unstable baseline or greater than -400 pA were 
rejected. Currents were filtered off-line using a Butterworth low-pass filter (2 kHz) and analyzed in 1 
or 2 min bins using the Mini-Analysis Program 6.0.7 (Synaptosoft, Decatur, GA). For pharmacology, 
baseline was analyzed 2 minutes before the application of carbachol (CCh, 10 μM). To study the effect 
of CCh, 1-2 min bins were analyzed at least 8 minutes following the arrival of CCh into the bath. 
Recordings with leak increasing more than 100 pA and access resistance changing more than 30% 
between the beginning and the end of the recording were discarded. At least 100 events were analyzed 
for any condition in any experiment. Events were identified as sIPSC by setting the event detection 
threshold at least 2-fold the baseline noise level and by checking that events had (i) rise times faster 
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than the decay time, (ii) rise times greater than 0.5 ms and (iii) decay times greater than 1.5 ms. Events 
not fitting the above parameters were rejected. Event amplitudes, inter-event intervals, rise and decay 
times were first averaged within each experiment and regrouped by condition. The frequencies were 
calculated from the inter-event intervals and the resulting means were averaged between experiments. 
Single cell properties (access resistance, membrane capacitance, etc.) were analyzed with Clampfit 
10.5 (Axon instruments, Union City, CA). Graphs were done using Igor 6.37 software (Wavemetrics, 
Tigard, OR) and Illustrator 15.1.0 (Adobe, San José, CA).  
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Results 
Use of NEX-Cre driver line for pyramidal cell-specific DG ablation 
To study the role of neuronal DGC in the brain without gross morphological alterations, it is necessary 
to target DG in neurons but spare glial DG. For this reason, mice harboring loxP sites in Dag1 were 
crossed to the NEX-Cre driver line, which exhibits an exclusively neuronal Cre recombinase 
expression pattern (Goebbels et al., 2006; Satz et al., 2010). In hippocampus and neocortex, NEX 
promoter-mediated Cre expression is restricted to pyramidal cells, the cell type displaying most 
prominent DG expression in the forebrain. DG conditional knockout mice (cKO; NEX-CreTg/+, 
Dag1loxP/loxP) showed reduced size compared to control mice (NEX-CreTg/+, Dag1loxP/+; Figure 1A). The 
smaller size was reflected in reduced body and brain weight (Figure 1B and C; 25.3 ± 1.0 g [mean ± 
SEM] versus 18.7 ± 1.0 g, t28=4.670, p<0.001 and 473.1 ± 5.4 mg versus 436.4 ± 6.5 mg, t28=4.381, 
p<0.001, unpaired t-tests). Although cKO mice were born in Mendelian proportions, in adulthood less 
than the expected 25% cKO were observed due to higher lethality of cKO mice (Figure 1D). To 
exclude a contribution of muscular dystrophy to this phenotype because of Cre leakage in muscle 
cells, α-DG levels were examined by Western blotting of WGA-enriched muscle proteins. cKO mice 
showed similar levels of muscle α-DG as control mice (Figure 1E). As reported before, DG cKO mice 
retained proper lamination of hippocampus (Figure 1F) and neocortex (Figure 1G) according to NeuN 
and DAPI labeling (Satz et al., 2010). Cre expression was restricted to pyramidal cells in hippocampus 
and neocortex and was not detected in dentate gyrus granule cells of adult mice (Figure 1F and G) 
(Goebbels et al., 2006). 
Efficiency and specificity of DG ablation was examined immunohistochemically in relevant brain 
regions. α-DG, β-DG and dystrophin can be detected immunohistochemically in large perisomatic 
clusters in CA1 pyramidal cells (Figure 2A) (Lidov et al., 1990; Knuesel et al., 1999). This 
characteristic immunolabeling was absent in DG cKO mice for DG and to the same extent for 
dystrophin, showing that dystrophin needs DG for synaptic clustering in vivo. In neocortex, 
perisomatic distribution of α-DG, β-DG and dystrophin was replaced by diffuse unspecific staining in 
neuropil in DG cKO mice (Figure 2B). Astrocyte endfeet are labeled prominently by antibodies to β-
DG and dystrophin and this labeling was preserved in DG cKO mice, as expected from neuron-
specific Cre expression (asterisks in Figure 2A and B). α-DG immunolabeling in dentate gyrus granule 
cells showed the same clustered distribution in both genotypes (Figure 2C). The transient NEX 
promoter activity in these cells during early postnatal development might not be sufficient to achieve 
recombination (Goebbels et al., 2006). Alternatively, loss of DG during early development might be of 
little consequence in adulthood because of DG expression by granule cells that were born later. To 
further demonstrate specificity of NEX-induced DG ablation, striatum was selected as a control 
region. As expected, the characteristic sparse α-DG labeling persisted in striatum of DG cKO mice 
(Figure 2D). 
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Figure 1. Characterization of NEX-Cre / Dag1 conditional KO mice. 
A, Representative examples of NEX-CreTg/+ / Dag1loxP/+ (control) and NEX-CreTg/+ / Dag1loxP/loxP (cKO) 
mice (4 months of age, siblings, both female). B, cKO mice exhibit reduced body weight compared to sibling 
control mice. C, Wet brain weight was lower in cKO mice than in controls. D, cKO mice exhibited a higher 
mortality rate than control mice, resulting in a frequency of cKO mice lower than the expected 25% at the age of 
10 weeks. E, Similar levels of α-DG isolated from cheek muscle were found for cKO and control mice. F, Cre 
expression was restricted to pyramidal cells in the hippocampus of cKO and control mice. In adult mice, dentate 
gyrus granule cells were not immunoreactive for Cre recombinase. NeuN and DAPI labeling show intact 
neuronal migration when NEX-Cre is used as driver line to ablate Dag1. G, In primary somatosensory cortex Cre 
expression was also restricted to pyramidal cells. No migratory deficits were found in the neocortex in cKO 
mice. ***p<0.001.  
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Epitope 
 
Conditions 
Unpaired t-test 
(density) 
 
Kolmogorov-Smirnov test (size) 
GABAAR α1 subunit DG cKO / adult / CA1 t6=0.920, p=0.393 n=33385, D=12.662, p<0.001 
GABAAR α2 subunit DG cKO / adult / CA1 t15=3.816, p=0.002 n=18495, D=3.484, p<0.001 
GABAAR γ2 subunit DG cKO / adult / CA1 t7=1.607, p=0.152 n=31807, D=3.692, p<0.001 
Gephyrin DG cKO / adult / CA1 t7=1.252, p=0.251 n=39289, D=0.720, p=0.677 
Neuroligin 2 DG cKO / adult / CA1 t6=0.979, p=0.366 n=32217, D=5.476, p<0.001 
synArfGEF DG cKO / adult / CA1 t6=1.093, p=0.316 n=22737, D=3.850, p<0.001 
VGAT DG cKO / adult / CA1 t15=0.646, p=0.528 n=20569, D=0.528, p=0.943 
 DG cKO / adult / neocortex t9=1.309, p=0.223 n=24713, D=1.107, p=0.172 
Parvalbumin DG cKO / adult / CA1 t7=0.198, p=0.849 n=24929, D=1.068, p=0.204 
 DG cKO / adult / neocortex t9=0.454, p=0.661 n=20534, D=4.845, p<0.001 
 DG cKO / P21 / CA1 t8=0.869, p=0.410 n=8010, D=1.037, p=0.233 
Cannabinoid DG cKO / adult / CA1 t6=16.869, p<0.001 n=4654, D=4.325, p<0.001 
receptor 1 DG cKO / adult / neocortex t11=7.117, p<0.001 n=8067, D=6.960, p<0.001 
 T190M / adult / CA1 t8=0.681, p=0.515 n=9152, D=0.881, p=0.420 
Synaptotagmin 2 DG cKO / adult / CA1 t9=1.456, p=0.179 n=3397, D=1.977, p=0.001 
Cholecystokinin 8 DG cKO / adult / CA1 t17=6.292, p<0.001 n=5111, D=4.133, p<0.001 
 DG cKO / adult / neocortex t6=4.475, p=0.004 n=1387, D=1.874, p=0.002 
PSD-95 DG cKO / adult / CA1 / SP t6=1.106, p=0.311 n=16281, D=1.554, p=0.016 
 DG cKO / adult / CA1 / SR t6=0.243, p=0.817 - 
Bassoon DG cKO / adult / CA1 / SP t10=0.767, p=0.461 n=32489, D=2.275, p<0.001 
 DG cKO / adult / CA1 / SR t10=0.871, p=0.404 - 
VGluT1 DG cKO / adult / CA1 t6=0.094, p=0.928 n=12776, D=0.492, p=0.969 
VGluT3 DG cKO / adult / CA1 t21=13.213, p<0.001 n=5975, D=8.273, p<0.001 
 DG cKO / adult / neocortex t9=0.456, p=0.659 n=6523, D=2.054, p<0.001 
 DG cKO / P21 / CA1 t8=13.437, p<0.001 n=1830, D=8.270, p<0.001 
 T190M / adult / CA1 t8=0.494, p=0.634 n=4763, D=0.702, p=0.708 
Table 2. Results of statistical tests performed for immunohistochemical stainings. 
Numbers in subscript in t-tests represent degrees of freedom. D represents test statistics for Kolmogorov-
Smirnov tests.  
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Epitope 
 
 
 
Conditions 
t-test (unpaired 
between genotypes, 
paired between  
hemispheres; density) 
 
Kruskal-
Wallis test 
(size) 
 
Dunn’s multiple 
comparison test 
(size) 
VGluT3 28dpi / loxP/+ t3=0.520, p=0.639 n=13610 y=283.498, p<0.05 
 28dpi / loxP/loxP t4=2.895, p=0.044 H=55.796 y=539.294, p<0.001 
 28dpi / contralateral t7=1.032, p=0.336 p<0.001 y=136.188, p>0.05 
 28dpi / ipsilateral t7=2.894, p=0.023  y=391.984, p<0.001 
 42dpi / loxP/+ t4=0.870, p=0.434 n=9915 y=93.906, p>0.05 
 42dpi / loxP/loxP t4=3.478, p=0.025 H=87.162 y=693.091, p<0.001 
 42dpi / contralateral t8=1.040, p=0.329 p<0.001 y=82.049, p>0.05 
 42dpi / ipsilateral t8=4.059, p=0.004  y=681.234, p<0.001 
 84dpi / loxP/+ t5=1.843, p=0.125 n=7378 y=16.550, p>0.05 
 84dpi / loxP/loxP t3=8.578, p=0.003 H=52.415 y=466.868, p<0.001 
 84dpi / contralateral t8=0.682, p=0.515 P<0.001 y=143.428, p>0.05 
 84dpi / ipsilateral t8=3.495, p=0.008  y=593.745, p<0.001 
Table 3. Results of statistical tests performed for immunohistochemical stainings of injected tissue. 
Numbers in subscript in t-tests represent degrees of freedom. H and y represent test statistics for Kruskal-Wallis 
tests and Dunn’s multiple comparison tests, respectively. 
 
Figure 2. NEX-Cre-mediated ablation of dystroglycan leads to specific loss of dystrophin-glycoprotein 
complex in pyramidal cells. 
A, Characteristic staining of α- and β-DG and dystrophin around CA1 pyramidal layer is lost in cKO mice. 
Labeling of β-DG and dystrophin in astrocyte end-feet is retained in cKO mice (asterisks). B, In primary 
somatosensory cortex layer 2/3, clustered labeling of DGC components around pyramidal cells is replaced by 
diffuse staining in the neuropil. Astrocyte end-feet labeling of β-DG and dystrophin is retained in cKO mice 
(asterisks). C, α-DG immunofluorescence in dentate gyrus is unaffected by NEX-Cre-mediated ablation of DG. 
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(Figure legend continued) D, α-DG expression in striatum is unaffected in cKO mice, confirming specificity of 
NEX-Cre expression to pyramidal cells. SR, stratum radiatum; SP, stratum pyramidale; ML, molecular layer; 
GCL, granule cell layer. 
Loss of neuronal DG results in minor alterations in GABAergic PSD protein clustering 
Dependence of GABAergic postsynaptic density (PSD) proteins on the DGC for synaptic clustering 
was suggested because of the subcellular localization of the DGC, its molecular interactions and 
because a reduction in GABAAR clustering was observed in mice lacking full-length dystrophin 
(Knuesel et al., 1999; Sumita et al., 2007; Waite et al., 2012). However, requirement of DG for 
clustering of GABAergic postsynaptic proteins was never systematically tested in vivo. We 
hypothesized that loss of neuronal DG affects neuroligin 2 (NL2) clustering, which might be important 
for clustering of GABAARs at perisomatic synapses through its interaction with gephyrin 
(Poulopoulos et al., 2009; Panzanelli et al., 2011). DG cKO and control mice were analyzed for 
changes in clustering of these markers in CA1 pyramidal layer. As previously reported (Knuesel et al., 
1999; Brunig et al., 2002; Levi et al., 2002), extensive colocalization of α-DG and dystrophin was 
observed with GABAergic markers, with a minority of DGC clusters showing no colocalization 
(Figure 3A and B; arrowheads and arrows, respectively). Visual examination of GABAergic markers 
revealed no obvious differences between genotypes (Figure 3A-C). However, quantification of cluster 
density and size showed a significant decrease of GABAAR α1 subunit size in cKO accompanied by 
an increase of GABAAR α2 subunit density (Figure 3D and F). No changes were observed in 
GABAAR γ2 subunit and gephyrin clustering (Figure 3E and H), indicating that total synaptic 
GABAAR content might be unchanged whereas α subunit composition is altered by loss of DG. 
Surprisingly, NL2 clustering was barely affected in cKO mice, showing no difference in density and 
only a slight but significant reduction in cluster size (Figure 3G). Neuronal DGC is also dispensable 
for normal colocalization of GABAAR γ2 subunit with gephyrin and of α1 subunit with NL2 (Figure 
3I). Furthermore, dystrophin was suggested to be important for anchoring synArfGEF at GABAergic 
PSDs (Fukaya et al., 2011). Although dystrophin clustering is lost in DG cKO mice, synArfGEF 
distribution remained almost unchanged in CA1 pyramidal layer of cKO mice (Figure 3J). 
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Figure 3. Loss of neuronal dystroglycan does not prohibit formation of GABAergic PSD but leads to 
minor changes in GABAAR subunit clustering. 
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(Figure legend continued) A-C, Triple immunofluorescence labeling of GABAergic postsynaptic markers in 
pyramidal layer of hippocampus CA1 area. The DGC is largely colocalized with α2 subunit and VGAT (A; 
arrowheads) but also with α1 subunit and NL2 (B; arrowheads). A minority of DGC clusters is not associated 
with GABAergic markers (A and B; arrows). D-H, Quantification of postsynaptic GABAergic markers in CA1 
pyramidal cell layer. Cluster density and size are shown for GABAAR α1 (D), α2 (F) and γ2 (H) subunits and for 
gephyrin (E) and NL2 (G). A decrease of α1 subunit cluster size was accompanied by an increased α2 subunit 
cluster density. I, Colocalization of postsynaptic GABAergic markers was analyzed in cKO and control mice. 
Data represent the number of colocalized clusters as percentage of first mentioned marker. No significant 
differences in colocalization were found between genotypes. J, Clustering of synArfGEF was analyzed in CA1 
pyramidal layer of DG cKO and control mice. Data points represent individual mice. **p<0.01, ***p<0.001 (see 
Table 2 for statistical tests). 
Neuronal DG ablation leads to selective loss of markers of CCK-positive basket cell 
terminals 
Many binding partners of α-DG have been identified, among them the presynaptic neurexins (Sugita et 
al., 2001). Taken together with the observation that DG is always apposed to GABAergic presynaptic 
terminals in primary neuronal culture, a trans-synaptic function for DG seemed probable (Brunig et 
al., 2002). We therefore probed DG cKO and control brains tissue with antibodies to presynaptic 
GABAergic markers. Perisomatic GABAergic terminals can be attributed to parvalbumin (PV)- or 
cholecystokinin (CCK)-positive interneurons, which are labeled by PV / synaptotagmin 2 (Syt2) and 
CCK8 / VGluT3 / cannabinoid receptor 1 (CB1), respectively. We found that markers for presynaptic 
terminals from CCK-positive interneurons were virtually absent in CA1 pyramidal layer of DG cKO 
mice (Figure 4A-D, G, I and K). Still, like in control mice, CCK-positive cell somata were 
occasionally observed in cKO CA1 pyramidal layer, and these were often covered with VGluT3-
positive boutons (arrowheads in Figure 4A). Syt2 and PV immunolabeling were still present in typical 
punctate distribution in the pyramidal layer of cKO mice (Figure 4A-D, H and J), demonstrating 
specific requirement of DG for formation of presynaptic terminals from CCK-positive interneurons. 
Preferential apposition of DG to CCK-positive interneuron terminals might be expected from this 
finding. However, apposition of DG to VGluT3 as well as to PV suggests no such distinction, at least 
at the resolution of conventional confocal laser scanning microscopy (arrowheads in C). Still, as 
percentage of presynaptic immunofluorescence apposed to DG, VGluT3 showed more complete 
overlap with DG, indicating PV apposition to DG might be caused by mere abundance of PV 
immunofluorescence in the pyramidal layer (data not shown). Loss of CCK-positive interneuron 
terminals extended from CA3 to CA1 (Figure 4E). Surprisingly, no corresponding reduction in VGAT 
puncta was observed (Figure 4F). To test if sprouting of PV-positive axons compensates for the loss of 
CCK-positive terminals, the portion of VGAT-positive terminals containing PV was assessed. No 
significant difference was found in the fraction of VGAT puncta colocalized with PV between 
genotypes (31.05 ± 2.05 % for control versus 33.24 ± 1.57 % for cKO, t8=0.847, p=0.422, unpaired t-
test), suggesting that PV-positive axon terminal sprouting does not account for the persisting VGAT 
immunolabeling. 
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Figure 4. Neuronal dystroglycan ablation leads to specific loss of terminals from CCK-positive basket cells 
on hippocampal pyramidal cells. 
A-D, Triple immunofluorescence labeling of presynaptic GABAergic markers in hippocampus CA1 area. A, In 
pyramidal layer, markers labeling CCK-positive basket cell terminals (CCK8, VGluT3) are missing around 
pyramidal cell bodies, but are still present on CCK-positive cell somata occasionally observed near the 
pyramidal layer (arrows). These VGluT3-positive boutons on CCK-positive somata were often immunopositive 
for synaptotagmin 2. In the pyramidal layer, immunostaining for synaptotagmin 2 remained in cKO mice. B1 
and B2 show separated channels of insets in A. C, PV immunolabeling in CA1 pyramidal layer of DG cKO mice 
is indistinguishable from control. In CA1 pyramidal layer of control mice, the majority of α-DG clusters is either 
apposed to VGluT3 (arrow 1) or PV (arrow 2), but some clusters are not apposed to either marker (arrow 3). A 
minority of α-DG clusters showed apposition to both VGluT3 and PV (arrow 4). D, Along with CCK8 and 
VGluT3, CB1 staining is strongly reduced in CA1 pyramidal layer of DG cKO mice. E, Loss of CB1 
immunofluorescence in DG cKO mice was observed from CA1 to CA3. F-K, Quantification of presynaptic 
GABAergic markers in CA1 pyramidal layer. No changes were found for VGAT (F) and PV-positive basket cell 
markers (H, J) between genotypes but cluster density and size of markers of CCK-positive basket cell terminals 
(G, I, K) were strongly reduced in DG cKO mice. Data points represent individual mice. ***p<0.001 (see Table 
2 for statistical tests). SR, stratum radiatum; SP, stratum pyramidale. 
Despite the drastic loss of CCK-positive terminals, somata exhibiting CCK immunofluorescence were 
observed in cKO hippocampi (Figure 4A). In order to characterize the distribution and abundance of 
CCK-positive interneurons, sections of cKO and control dorsal hippocampus were 
immunoperoxidase-stained and CCK-positive cell density quantified using stereology. CCK-positive 
cell somata in cKO mice were reduced to less than half the density observed in control mice (816.77 ± 
28.38 mm-3 versus 368.51 ± 4.88 mm-3, t8=15.566, p<0.001, unpaired t-test). Along with cell density, 
immunoperoxidase staining intensity of CCK-positive cells was diminished in CA1 to CA3 region in 
DG cKO mice. 
Because the DGC is prominently expressed by pyramidal cells in the neocortex, it seemed likely that 
CCK-positive interneuron terminals in neocortex are also compromised by loss of neuronal DG. 
Indeed, CCK8 and CB1 immunolabeling was strongly reduced in primary somatosensory cortex (S1) 
of DG cKO mice whereas PV staining was unchanged (apart from a minute difference in size; Figure 
5). VGluT3 puncta density was not decreased in neocortex of DG cKO mice, in agreement with 
histological studies showing VGluT3 is present mostly in serotonergic fibers in this brain area (Figure 
5B and G)(Schafer et al., 2002). As in hippocampus, reduction of CCK-positive terminals was not 
paralleled by a decrease of VGAT puncta (Figure 5A and E). Markers for CCK-positive terminals 
were reduced uniformly across all cortical layers and in all regions of the neocortex which were 
examined (Figure 5D). 
Satz et al. (2010) have reported blunted long-term potentiation in CA1 pyramidal cells of mice with 
NEX-Cre-mediated DG ablation. To exclude that loss of CCK-positive interneuron terminals 
represents compensatory changes to large glutamatergic alterations, glutamatergic markers were 
examined as a proxy for integrity of glutamatergic synapses (Figure 6). Clustering of the postsynaptic 
glutamatergic markers PSD-95 and bassoon did not differ significantly between genotypes (Figure 6A 
and B) and neither did VGluT1 immunolabeling (Figure 6C). Furthermore, the portion of PSD-95 
clusters apposed to VGluT1 was similar in both genotypes (Figure 6D). 
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Figure 5. Neuronal dystroglycan ablation leads to specific loss of terminals from CCK-positive basket cells 
on pyramidal cells in neocortex. 
A-C, Triple immunofluorescence labeling of GABAergic markers in layer 2/3 of primary somatosensory cortex 
(S1) of DG cKO and control mice. A, As in hippocampus, the majority of DG clusters is colocalized with pre- 
and postsynaptic GABAergic markers in neocortex. B, Neocortical PV and VGluT3 immunolabeling is not 
affected by loss of neuronal DG. C, CCK8 and CB1 immunofluorescence is strongly reduced in neocortex of DG 
cKO mice. Immunolabeling of synArfGEF showed clustered distribution and did not differ between genotypes. 
D, Overview of S1 of DG cKO and control mice. Typical punctate CB1 immunofluorescence was lost across all 
layers of the cortex in DG cKO mice. E-I, Quantification of presynaptic GABAergic markers in S1 layer 2/3. 
VGAT and PV, and in contrast to hippocampus, also VGluT3 were not reduced in density and size in mice 
lacking neuronal DG (E, F, G). However, CB1 and CCK8 showed a similar reduction as in hippocampus in DG 
cKO mice compared to control mice (H and I). Data points represent individual mice. **p<0.01, ***p<0.001 
(see Table 2 for statistical tests). 
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Figure 6. Neuronal dystroglycan is not necessary for clustering of glutamatergic synaptic proteins. 
A and B, To assess integrity of glutamatergic postsynaptic structures, antibodies to PSD-95 and bassoon were 
used and immunofluorescence quantified in stratum pyramidale and stratum radiatum. Cluster density and size 
was analyzed in stratum pyramidale and fluorescence intensity in stratum radiatum. All parameters analyzed did 
not differ between genotypes. C, VGluT1 was used as a marker of glutamatergic presynaptic terminals and 
puncta density and size in stratum pyramidale was quantified. No changes in VGluT1 puncta density and size 
were found between genotypes. D, PSD-95 apposition to VGluT1 was examined in stratum pyramidale and 
represented as percent PSD-95 clusters apposed to VGluT1 puncta. The apposition of PSD-95 to VGluT1 did not 
differ between genotypes. Data points represent individual mice. *p<0.05, ***p<0.001 (see Table 2 for statistical 
tests). 
Formation and maintenance of CCK-positive basket cell terminals require neuronal DG 
DG expressed by pyramidal cells might have a function in synapse formation or in guidance of a 
subset of axons, similar to its role in the spinal cord (Wright et al., 2012). Alternatively, a function in 
maintenance of synapses through continuous trans-synaptic signaling is conceivable. If neuronal DG is 
crucial for synapse formation of CCK-positive terminals, these boutons should be reduced to the same 
degree as in adults at a time point right after initial synaptogenesis. Following this reasoning, we 
examined CCK-positive terminals of 21-day-old DG cKO and control mice in CA1 pyramidal layer. 
Indeed, VGluT3 puncta were largely missing also at this stage of development whereas 
immunostaining of PV-positive terminals was not significantly different between genotypes (Figure 
7). 
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Figure 7. CCK-positive terminals are not established in the absence of neuronal dystroglycan. 
A, Triple immunofluorescence labeling of DG cKO and control CA1 pyramidal layer at postnatal day 21. B and 
C, Quantification of puncta density and size reveals loss of VGluT3 puncta in DG cKO tissue to the same degree 
as in adult mice (B) but unchanged PV immunolabeling (C). Data points represent individual mice. ***p<0.001 
(see Table 2 for statistical tests). 
Although this finding indicates that synapse formation of functional CCK-positive terminals depends 
on DG, it does not rule out a role for DG in maintaining already formed connections. In order to assess 
this putative function of DG in synapse maintenance, we ablated DG long after developmental synapse 
formation, by viral delivery of Cre to adult mice carrying one or both floxed Dag1 alleles. AAV8-
CaMKII-mCherry-Cre was stereotactically injected unilaterally into the CA1 region and mice 
sacrificed at 14, 28, 42 or 84 days post injection (dpi; Figure 8A and C). At 14 dpi, Cre as well as 
mCherry fluorescence were clearly visible (Figure 8B). Loss of β-DG staining at 28 dpi in 
homozygously floxed mice indicated efficient recombination of loxP sites (Figure 8D). In 
heterozygously floxed mice only a moderate reduction of β-DG labeling was observed, suggesting one 
wildtype allele is sufficient to sustain the bulk of DG expression. Because dystrophin immunostaining 
revealed a reduction that mirrored β-DG, and in addition showed lower background, dystrophin was 
used to assess DGC loss at subsequent time points (Figure 8E-G). Examination of VGluT3-positive 
terminals at 28 dpi in Cre-expressing regions of CA1 pyramidal layer revealed a moderate but 
significant reduction of VGluT3 puncta density and size in homozygously floxed mice compared to 
contralateral side as well as compared to the ipsilateral side of heterozygously floxed mice (Figure 
8H). VGluT3-positive terminals in heterozygous mice were not affected. Compromised VGluT3 
immunolabeling was also found at later time points in homozygous mice, and the effect became more 
prominent with increased time after injection (Figure 8I and J). Together, these results provide strong 
evidence for a role of DG both in synapse formation and in retrograde trans-synaptic signaling for 
maintenance of CCK-positive terminals. 
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Figure 8. Maintenance of CCK-positive basket terminals requires dystroglycan. 
A, Overview of experimental design. Virus was stereotactically injected unilaterally into CA1 region in adult 
mice heterozygous or homozygous for loxP sites flanking Dag1 gene. B, After 14 dpi, Cre recombinase 
immunolabeling as well as mCherry fluorescence was clearly visible in pyramidal cell somata. C, Example of 
injection site at 28 dpi. Cre expression was mostly restricted to CA1 pyramidal cell layer. VGluT3 and      
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(Figure legend continued) dystrophin or DG immunofluorescence was analyzed in the same sections. D, In mice 
containing homozygously floxed Dag1, β-DG immunostaining was markedly reduced in CA1 pyramidal layer at 
28 dpi. Heterozygous mice showed a moderate reduction in β-DG immunofluorescence. E-G, As observed for β-
DG, Cre expression lead to loss of dystrophin in homozygously floxed mice whereas only a slight decrease was 
observed in heterzygous mice. Reduction of dystrophin labeling was similar at 28 dpi (E), 42 dpi (F) and 84 dpi 
(G). H-J, Representative example images and quantifications of VGluT3 immunostaining in CA1 pyramidal 
layer at 28 dpi (H), 42 dpi (I) and 84 dpi (J). Ipsilateral VGluT3 size and density in homozygously floxed mice 
was significantly reduced compared to both contralateral side and ipsilateral side of heterozygously floxed mice. 
With increased time after injection this reduction of VGluT3 puncta became more prominent. Data points 
represent individual mice. *p<0.05, **p<0.01, ***p<0.001 (see Table 3 for statistical tests). 
Absence of CCK-positive basket cell terminals due to DG ablation impacts pyramidal 
cell inhibitory input and response to cholinergic activation 
If axon terminals from CCK-positive basket cells are indeed lost in DG ablated mice, this should be 
reflected by functional changes of pyramidal cell inhibitory input. To test this hypothesis, acute slices 
were prepared from adult DG cKO and control brains and used for patch-clamp electrophysiological 
recordings from morphologically identified CA1 pyramidal cells (Figure 9). With inhibitors of 
glutamatergic transmission present in the bath, occurrence of sIPSCs was probed in both genotypes. 
As anticipated from immunohistological changes, sIPSC frequency in DG cKO was reduced to about 
half of that in control slices (Figure 9; 8.71 ± 1.52 Hz versus 4.46 ± 0.90 Hz, t26=2.214, p=0.036, 
unpaired t-test). Furthermore, DG cKO pyramidal cells were marked by a significantly smaller sIPSC 
amplitude than that of control cells (61.49 ± 7.90 pA versus 39.18 ± 2.39 pA, t26=2.374, p=0.025, 
unpaired t-test). No significant differences were found between genotypes in sIPSC rise and decay 
times (rise time 1.73 ± 0.09 ms versus 1.63 ± 0.12 ms, t26=0.664, p=0.512, unpaired t-test; decay time 
14.84 ± 0.64 ms versus 14.21 ± 0.53 ms, t26=0.717, p=0.480, unpaired t-test). 
 
Figure 9. Frequency and amplitude of sIPSCs are reduced in dystroglycan cKO pyramidal cells. 
A, Image showing the position of the recording pipette in the hippocampal CA1 region (left, 4x), and an example 
image of a typical CA1 pyramidal cell identified using LED illumination (Alexa Fluor 488, right, 40x). B, 
Representative example traces of whole-cell sIPSC recordings from control mice (left trace) and DG cKO mice 
(right trace). Average sIPSCs are shown above the traces. C, Cumulative frequency plot of inter-event intervals 
of sIPSCs from control (blue line) and DG cKO cell (red line) from the traces in B (left panel) and cumulative 
frequency plot of sIPSC amplitudes from the same cells (right panel). D, Comparison of average sIPSC     
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(Figure legend continued) frequency and amplitude between control and DG cKO slices. DG cKO mice exhibit 
significantly lower sIPSC frequency and amplitude than control mice. Data points represent individual cells. 
*p<0.05. 
The differences observed in baseline sIPSCs could be due to a general reduction of inhibitory 
transmission instead of interneuron subtype-specific loss of terminals. In order to gain insight into the 
origin of reduced inhibitory transmission in DG cKO pyramidal cells, we examined the effect of the 
acetylcholine receptor agonist carbachol on inhibitory currents. In slices, carbachol exposure leads to 
an increase of perisomatic inhibitory transmission in pyramidal cells, which is mediated by direct 
excitation of CCK-positive interneurons (Nagode et al., 2014). Given that CB1 receptor-containing 
terminals are required for increased inhibitory transmission after application of carbachol, this effect 
should be absent in DG cKO mice, if CCK-positive basket terminals are indeed non-functional in 
these mice. Carbachol was bath-applied to DG cKO and control acute slices from which sIPSCs were 
recorded in CA1 pyramidal cells. In control slices, carbachol led to a robust increase in sIPSC 
frequency within minutes after application (Figure 10A-C; frequency: 6.15 ± 1.45 Hz versus 10.53 ± 
2.47 Hz, t7=3.522, p=0.010; amplitude: 63.36 ± 8.84 pA versus 70.35 ± 12.59 pA, t7=0.943, p=0.377; 
paired t-tests). However, no statistically significant effect of carbachol was observed in DG cKO 
pyramidal cells (Figure 10D-F; frequency: 3.45 ± 0.75 Hz versus 4.47 ± 1.56 Hz, t6=0.797, p=0.456; 
amplitude: 45.70 ± 4.17 pA versus 53.03 ± 5.00 pA, t6=1.239, p=0.262; paired t-tests). Together with 
the results from baseline recordings and immunohistochemical analysis, these findings strongly argue 
that functional connectivity between CCK-containing basket cells and pyramidal cells is lost in DG-
ablated mice. 
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Figure 10. Dystroglycan is necessary for carbachol-induced increase of inhibitory currents in pyramidal 
cells. 
A, Representative example traces of sIPSC recordings before (baseline, left trace) and after the application of 
carbachol (CCh, right trace) in control mice. Average sIPSCs are shown above the traces. B, Cumulative 
frequency plots of inter-event intervals (IEI) and amplitudes of sIPSCs from traces in A. C, Comparison of 
average sIPSC frequency and amplitude before and after application of CCh in control slices. Application of 
CCh resulted in typical increase of IPSC frequency in control pyramidal cells but amplitude was not affected by 
CCh. D, Representative example traces of sIPSC recordings before (baseline, left trace) and after the application 
of CCh (right trace) in DG cKO mice. Average sIPSCs are shown above the traces. E, Cumulative frequency 
plots of inter-event intervals (IEI) and amplitudes of sIPSCs from traces in D. F, Comparison of average sIPSC 
frequency and amplitude before and after application of CCh in DG cKO slices. In contrast to control slices, 
application of CCh did not lead to a significant increase of sIPSC frequency in DG cKO pyramidal cells. Data 
points represent individual cells. **p<0.01. 
Persistence of CCK-positive terminals in DG T190M knock-in mice suggests trans-
synaptic DG function is independent of neurexin binding 
The intriguing finding that DG is required for formation and maintenance of CCK-positive terminals 
calls for an assessment of the clinical significance of this observation. In a subgroup of 
dystroglycanopathies, intellectual disability, although severe, is not accompanied by neuronal 
migration deficits (Godfrey et al., 2007). Dag1 T190M knock-in mice are a model of one such form of 
dystroglycanopathy and resemble the symptoms found in patients with the corresponding mutation 
(Dincer et al., 2003; Hara et al., 2011). Interestingly, this mutation abolishes binding of DG to 
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neurexin, a putative presynaptic DG binding partner. We compared markers of CCK-positive 
terminals in CA1 pyramidal layer of homozygous Dag1 T190M mice to wildtype mice (Figure 11). 
Surprisingly, both VGluT3 and CB1 puncta were indistinguishable between Dag1 T190M and 
wildtype mice. Weaker and more diffuse labeling in Dag1 T190M mice using the α-DG glycosylation-
specific antibody 11H6 confirmed that this mutation affects glycosylation of neuronal DG (Figure 
11B). Apposition of β-DG to PV or VGluT3-positive terminals was not changed by T190M mutation 
(Figure 11E). Therefore, DG function for CCK-positive terminals is likely neurexin-independent, 
which suggests a novel presynaptic receptor might be involved in this trans-synaptic connection. 
 
Figure 11. Neurexin- and laminin-binding of α-dystroglycan is not essential for formation of CCK-positive 
basket terminals on pyramidal cells. 
A and B, Triple immunofluorescence labeling of GABAergic markers in CA1 pyramidal layer of Dag1 T190M 
and wildtype mice. A, Antibody to β-DG revealed typical clustered distribution in Dag1 T190M mice. VGluT3 
and PV immunofluorescence was indistinguishable between genotypes. B, Intensity of DG clusters was 
markedly reduced and background staining increased using the α-DG glycosylation-specific antibody 11H6, 
confirming glycosylation deficits of synaptic DG in T190M mice. CB1 and GABAAR γ2 subunit 
immunofluorescence was indistinguishable between genotypes. C and D, Quantification of density and size of 
VGluT3 (C) and CB1 (D) puncta in CA1 pyramidal layer of Dag1 T190M and wildtype mice. Density and size 
of puncta did not differ significantly between genotypes. E, Quantification of β-DG apposition to PV and/or 
VGluT3 in CA1 pyramidal layer. Data represent number of β-DG clusters apposed to PV or VGluT3 or both 
(triple colocalized) as percentage of total β-DG clusters. Apposition of β-DG to presynaptic markers did not 
differ significantly between genotypes. Data points represent individual mice. See Table 2 for statistical tests. 
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Discussion 
Our experiments have yielded five main findings about the synaptic function of DG. Ablation of 
neuronal DG, which also hindered synaptic clustering of dystrophin, led only to minor changes in 
clustering of GABAergic PSD proteins. These alterations might reflect compensatory changes to the 
massive presynaptic defects found in DG-deficient mice. Importantly, DG synaptic function is 
interneuron subtype-specific since loss of synaptic markers was restricted to CCK-expressing basket 
cell terminals. Formation and maintenance of these synapses required neuronal DG, indicating that 
trans-synaptic signaling is important both at the time of developmental synaptogenesis and 
continuously during adulthood. Function of CCK-positive basket cell terminals was likely 
compromised along with specific marker expression, since loss of DG resulted in a reduced baseline 
spontaneous inhibitory activity in pyramidal cells that could not be increased by carbachol. Finally, 
post-phosphorylation glycosylation of DG is not necessary for CCK-positive synapse formation 
because Dag1 T190M knock-in mice showed normal CCK-positive terminals, suggesting that 
presynaptic receptors other than neurexins might be involved in DG trans-synaptic function. 
Postsynaptic GABAergic alterations ascribed to DGC deficits may be secondary to 
innervation defects 
Ablation of DG in primary hippocampal culture has revealed that DG is not necessary for GABAergic 
synapse formation and for clustering of main GABAergic PSD proteins, including GABAARs (Levi et 
al., 2002). Yet, involvement of the DGC in clustering of GABAergic postsynaptic proteins was 
supported by several lines of evidence. Mdx mice, used as a DMD model because of their lack of full-
length dystrophin, were shown to have reduced GABAAR (but not gephyrin) clustering in the 
hippocampus CA1 region (Knuesel et al., 1999). Overexpression of a shorter dystrophin construct in 
vivo rescued the decrease of GABAAR cluster density and size, adding to the notion that dystrophin 
loss directly caused GABAAR clustering defects (Vaillend et al., 2010). Neuroligin 2 (NL2) was 
shown to biochemically interact with dystrophin over the intracellular synaptic scaffolding molecule 
S-SCAM (Sumita et al., 2007). Furthermore, a functional connection between the DGC and NL2 is 
suggested by the observation that in GABAAR α2 subunit KO mice NL2 clustering is only 
compromised in dendritic but not in perisomatic areas (Panzanelli et al., 2011). The modest increase in 
GABAAR α2 subunit density and decrease in GABAAR α1 subunit size found in the present study does 
not correspond to the findings in mdx mice, in which both subunits cluster less efficiently than in 
wildtype mice (Knuesel et al., 1999; Vaillend et al., 2010). Rather, these alterations might reflect a 
subunit composition change because GABAAR γ2 subunit clusters were not affected by ablation of DG 
(except for a minute reduction in cluster size, which might be a reflection of reduced GABAAR α1 
subunit cluster size). The finding that gephyrin clustering was unchanged in DG cKO mice further 
supports the conclusion that overall clustering of synaptic GABAAR subunits was not influenced by 
neuronal DG loss. The discrepancy between our results and published data from mdx mice might be 
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explained by different roles of dystrophin isoforms at the GABAergic PSD. Short dystrophin isoforms 
still present in the mdx model might, by binding to DG, cause the reduction in synaptic GABAAR 
clustering. It is worth noting that the α2 subunit of GABAARs, which is localized preferentially at 
CCK-positive synapses (Nyiri et al., 2001), does not require the DGC or CCK-positive terminals for 
clustering. The DGC is thus likely involved in targeting the α2 subunit to synapses apposed to CCK-
positive terminals but clustering mechanisms seem to be DGC-independent. NL2 clustering was intact 
in DG cKO mice, apart from a slight decrease in cluster size. Therefore, the notion of the DGC as an 
obligatory stabilizer of postsynaptic NL2 clustering by mutual interaction with S-SCAM does not 
hold. Similarly, a role for the DGC in clustering the dystrophin-interacting protein synArfGEF at 
GABAergic synapses was suggested (Fukaya et al., 2011). Not excluding a contribution of the DGC to 
synArfGEF function by clustering additional signaling proteins, synArfGEF does not rely on the DGC 
to form clustered, presumably synaptic structures. 
In the light of the dramatic changes in GABAergic innervation due to DG loss, an indirect presynaptic 
contribution to reduced postsynaptic clustering in dystrophin-deficient models should be considered. 
This hypothesis is supported also by the finding of reduced CCK-positive basket cell markers in mdx 
mice, suggesting that dystrophin plays part in trans-synaptic signaling (Krasowska et al., 2014). The 
role of dystrophin in clustering signaling proteins at CCK-positive terminals is still unexplored, but 
might include retrograde signaling by nitric oxide synthase. Resolution of conventional confocal laser 
scanning microscopy is not sufficient to conclusively answer whether the DGC is restricted to 
synapses from CCK-positive basket cells. Although apposition of DG to PV- and CCK-positive 
terminals was found with approximately equal frequency (Figure 11E), the percentage of CCK-
positive terminals apposed to DG was higher than that of PV-positive terminals (data not shown; 
Figure 4C and 7A). Therefore, it seems likely that the DGC localizes preferentially postsynaptic to 
CCK-positive terminals to regulate synapse formation and function. 
Basket cell type specificity of DG function implies specificity of trans-synaptic 
interaction with presynaptic binding partner 
The selective dependence of the CCK-containing subtype of basket cells on neuronal DG for 
innervating target cells is a major finding of our study and has far-reaching implications. The DGC 
indeed acts as a trans-synaptic complex in central synapses, suggesting that presynaptic, rather than 
extracellular binding partners, enable DGC function in this context. Any such presynaptic adhesion 
molecule would have to be specifically localized at CCK-positive terminals. Interestingly, differential 
splicing of neurexins in PV- and CCK-expressing basket cells was recently reported (Fuccillo et al., 
2015). Transcripts lacking neurexin1α alternative splice inserts 2 and 4, which prevent α-DG binding 
to LSM domains 2 and 6, respectively, were only found in CCK-positive basket cells (Sugita et al., 
2001; Reissner et al., 2014; Fuccillo et al., 2015). This neurexin isoform-specificity of basket cell 
subtypes would provide a mechanism for selective dependence of CCK-positive basket terminals on 
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DG. However, we found terminals from CCK-positive basket cells to be intact in Dag1 T190M knock-
in mice. DG containing the T190M mutation was found to lose neurexin binding capacity (Hara et al., 
2011). This finding thus suggests that a novel presynaptic DG binding partner might be specifically 
localized at CCK-positive terminals. But because the diversity of neurexin isoforms was not 
considered in DG T190M binding assays, the possibility of a specific neurexin-DG trans-synaptic 
complex at CCK-positive terminals remains. 
Continuous trans-synaptic signaling required for maintenance of CCK-positive 
terminals might reflect novel plasticity mechanism 
Stopping trans-synaptic signaling mediated by the DGC by ablating DG in adulthood led to a decrease 
of CCK-positive terminals within weeks. This unexpected result implies that DG function goes beyond 
a potential role in validating newly formed synapses from CCK-positive basket cells. In addition to 
clustering signaling molecules at these synapses, our findings open the possibility that the DGC, by 
forming a trans-synaptic complex, is a direct target to regulate abundance of CCK-positive terminals. 
β-DG is a substrate of MMP-9 in a neuronal activity-dependent manner (Yamada et al., 2001; 
Kaczmarek et al., 2002; Michaluk et al., 2007). Cleavage of DG might therefore represent a 
physiological interneuron subtype-specific plasticity mechanism. In striking agreement with this 
hypothesis, CCK-positive terminals are selectively lost in a model of temporal lobe epilepsy (Wyeth et 
al., 2010). 
Decreased inhibitory input to pyramidal cells in DG-ablated cells confirms functional 
significance of DG signaling for CCK-positive terminals 
The possibility that loss of CCK-specific markers in DG cKO mice is only due to inability of terminals 
to differentiate was ruled out by the finding that DG-ablated pyramidal cells receive reduced inhibitory 
drive. Along with sIPSC frequency, amplitude was markedly reduced, possibly reflecting mistargeting 
of GABAARs in the absence of the DGC. Genesis of carbachol-induced increase of inhibitory currents 
is not fully understood but involves Gad2-positive rather than PV-positive interneurons in the CA1 
region (Nagode et al., 2014). Since the group of Gad2-expressing interneurons includes CCK-positive 
basket cells and carbachol-induced currents are sensitive to depolarization-induced suppression of 
inhibition, our results add to the notion that CCK-positive basket cells play a crucial role in carbachol-
induced activity. Activity patterns elicited by carbachol correlate with behaviorally relevant theta 
oscillations. Mechanisms of theta oscillation generation should thus be considered in future 
investigations of the etiology of intellectual disability associated with muscular dystrophies. 
Conclusions 
Our investigation of the role of neuronal DG in GABAergic synapses has revealed a surprising 
interneuron type-specific function of DG in trans-synaptic signaling. It has shown that GABAergic 
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postsynaptic diversity is functionally related to interneuron subtype heterogeneity and supports the 
emerging notion of a cell type-specific molecular code of synapse formation. Future studies will have 
to further characterize signaling and plasticity enabled by the DGC and delineate its behavioral 
consequences. Taking the interneuron-specific role of DG into consideration will help elucidate the 
mechanisms underlying intellectual disability observed in muscular dystrophies without 
developmental brain malformations.  
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Abstract 
Correct neurotransmitter-receptor matching is of fundamental importance for the function of chemical 
synapses. In vivo, temporal and spatial cues as well as trans-synaptic signaling ensure that pre- and 
postsynaptic specializations are appropriately matched. In dissociated neuronal cultures the absence of 
spatial and temporal cues causes the emergence of mismatched synapses, where GABAergic 
postsynaptic structures are in part apposed to glutamatergic presynaptic terminals and vice versa. This 
mismatch offers an opportunity to study the mechanisms that regulate correct synaptic apposition. We 
report here that the IQ motif and Sec7 domain-containing postsynaptic protein synArfGEF (IQSEC3; 
BRAG3) is specifically involved in the regulation of mismatched GABAergic PSD proteins. CRISPR-
mediated ablation of synArfGEF in rat primary hippocampal neurons caused an increase in the 
proportion of eGFP-gephyrin clusters apposed to VGluT-positive presynaptic terminals. 
Overexpression of synArfGEF constructs harboring mutations that ablate Sec7 domain or IQ motif 
function revealed that synArfGEF catalytic activity suppresses GABAergic PSD apposition to 
glutamatergic terminals. Neurons co-expressing eGFP-gephyrin with synArfGEF Sec7 mutant 
displayed a dramatically increased fraction of mismatched eGFP-gephyrin clusters compared to other 
constructs. Along with eGFP-gephyrin, endogenous GABAA receptor cluster mismatching was also 
increased by synArfGEF Sec7 mutant overexpression. Conversely, GFP-PSD-95 clusters were 
unaffected by overexpression of any of the synArfGEF constructs. GABAergic PSD mismatch 
phenotype was recapitulated by Arf6 mutant overexpression, suggesting that Arf6 is a substrate for 
synArfGEF in this process. In addition, we demonstrate binding of gephyrin to synArfGEF near the IQ 
motif, which in turn binds calmodulin at low Ca2+ concentrations. N-terminal coiled-coil domain in 
synArfGEF was necessary for gephyrin binding and affected efficiency of calmodulin binding, 
indicating that synArfGEF is present in different conformational states. Dendritic aggregation of 
synArfGEF upon NMDA application and the presence of dendritically localized synArfGEF mRNA 
further suggested that synArfGEF function is activity-dependent. Taken together, these findings 
provide the first description of a postsynaptic protein which specifically regulates correct apposition of 
the GABAergic PSD.  
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Introduction 
Alignment of presynaptic terminals of each neurotransmitter with postsynaptic densities (PSD) 
containing the corresponding postsynaptic receptors is a fundamental requirement for 
neurotransmission at chemical synapses. Most neurons in the mammalian central nervous system 
(CNS) are innervated by axon terminals with a wide range of neurochemical compositions and 
synapses employing different neurotransmitter systems are often in close proximity. Yet, mismatched 
pre- and postsynaptic structures are virtually absent in vivo. Temporal differences in synapse 
formation between neurotransmitter systems do not fully account for correct apposition since synapse 
formation and elimination are life-long processes (Tyzio et al., 1999; Khazipov et al., 2001; Caroni et 
al., 2014). Molecular mechanisms must therefore contribute to the fidelity of neurotransmitter-specific 
synaptic apposition. 
Synapse formation is initiated by cell adhesion through homophilic trans-synaptic adhesion 
complexes, which are not neurotransmitter-specific (Missler et al., 2012). Differentiation of 
postsynaptic structures into specializations suited for a given presynaptic neurotransmitter is achieved 
after initial contact formation by signaling molecules, of which only few are known to date. One of the 
best described mechanisms of neurotransmitter-specific induction of postsynaptic differentiation is 
dependent on alternative splicing of neurexin and neuroligin (NL). For instance, isoform-specific 
splice inserts in NL extracellular domains interact with neurexins, promoting neurotransmitter-specific 
presynaptic differentiation. Thus, splice insert “B” is only present in the glutamatergic-selective NL1 
and promotes glutamatergic presynaptic development (Chih et al., 2006). Likewise, the presence of 
neurexin splice insert 4 determines the type of postsynaptic differentiation that is promoted by 
neurexins. Beyond their interaction with neurexins, neuroligins are also instructive in the assembly of 
postsynaptic proteins. The cytoplasmic tail of NL2, which is localized mostly at GABAergic synapses, 
binds to gephyrin in GABAergic PSDs whereas NL1 clusters N-methyl-D-aspartate (NMDA) 
receptors in glutamatergic synapses (Poulopoulos et al., 2009). While other trans-synaptic molecules 
are known to be involved in promotion of neurotransmitter-specific differentiation, factors responsible 
for suppressing mismatched synaptic structures are not known thus far. 
Although in vivo misalignment of pre- and postsynaptic structures is very rare, formation of 
mismatched synapses is common in dissociated neuronal cultures (Rao et al., 2000; Brunig et al., 
2002; Christie et al., 2002). Both GABAA receptors (GABAAR) and AMPA receptors are found 
opposed to inappropriate axon terminals. Appearance of mismatched synapses in dissociated cultures 
is a consequence of the lack of spatial and temporal cues that guide synapse formation in vivo. 
However, although the altered situation in dissociated neurons does not directly correspond to the 
situation in vivo, the presence of mismatched synapses in neuronal cultures provides an opportunity to 
study the molecular underlinings of synapse validation. The observation that the fraction of 
mismatched synapses in primary neurons is reduced with time in culture suggests that correction 
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mechanisms ensure appropriate apposition after synapse formation. Since drugs affecting synaptic 
transmission have a strong influence on the abundance of mismatched synapses, such mechanisms are 
likely activity-dependent (Anderson et al., 2004). 
SynArfGEF (IQSEC3; BRAG3) is a guanine nucleotide exchange factor (GEF) for small GTPases of 
the ADP-ribosylation factor (Arf) family and is strongly expressed in the brain (Kikuno et al., 1999). 
The protein was first described as part of the glutamatergic PSD because of immunoreactivity in the 
PSD fraction and the presence of a C-terminal PDZ-domain binding motif (Inaba et al., 2004). Later 
investigations concluded that synArfGEF is principally located at GABAergic postsynaptic sites, on 
the basis of immunohistochemical analyses on light and electron microscopy levels and due to its 
binding to dystrophin (Fukaya et al., 2011; Sakagami et al., 2013). As all Arf GEFs, synArfGEF 
contains a catalytic Sec7 domain. The specificity of its GEF function is still unclear, since rat 
synArfGEF showed activity for Arf6 but not Arf1 whereas the opposite was reported for the human 
homolog (Hattori et al., 2007; Fukaya et al., 2011). Interestingly, the close synArfGEF homologs 
IQSEC1 and IQSEC2 are located in the glutamatergic PSD and regulate endocytosis of GluA2- and 
GluA1-containing AMPA receptors, respectively (Scholz et al., 2010; Myers et al., 2012). SynArfGEF 
functions at the synapse were not yet described but the nearly identical domain structure of 
synArfGEF suggests parallels in its role at the GABAergic PSD. 
Here, we explored the molecular mechanisms governing the correct alignment of pre- and postsynaptic 
structures in primary neuronal cultures. In particular, we addressed the question whether a 
postsynaptic protein like synArfGEF is capable of regulating mismatched postsynaptic proteins and 
whether such regulation is neurotransmitter-specific. Because it is well established that neuronal 
activity plays a crucial role in synapse formation, the involvement of activity-dependent processes in 
regulation of mismatched synapses was considered. By taking an overexpression approach using 
various mutated and truncated forms of synArfGEF, we demonstrate that the catalytic function of 
synArfGEF specifically controls misalignment of GABAergic PSD proteins with glutamatergic axon 
terminals. Similar alterations in mismatched synapses were found with overexpression of Arf6 
mutants, suggesting that activation of Arf6 by synArfGEF is an essential step in this pathway. 
Colocalization and biochemical interaction with gephyrin validated the proximity of synArfGEF to 
GABAergic postsynaptic structures. Furthermore, the findings of Ca2+-dependent calmodulin binding 
to synArfGEF and alterations in synArfGEF distribution upon NMDA treatment confirmed the notion 
that regulation of mismatched synapses is an activity-dependent process. Taken together, our 
experiments uncovered a neurotransmitter-specific process aimed at controlling mismatched 
GABAergic postsynaptic proteins in primary neuronal cultures.  
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Materials and methods 
Constructs 
pCIneo-FLAG-synArfGEF plasmid was provided by Dr. Hiroyuki Sakagami and encodes FLAG-
tagged rat synArfGEF (IQSEC3; NCBI NM_207617.1). The insert was PCR amplified and subcloned 
into the same vector using restriction sites EcoRI and NotI to avoid double insertion and remove part 
of synArfGEF 3’-UTR which was present in the original plasmid. Site-directed mutagenesis of the 
resulting plasmid was achieved through whole-plasmid amplification using point-mutated primers 
with Pfu Ultra Hotstart DNA Polymerase (Agilent, Santa Clara, CA). Template was digested with 
DpnI, DNA purified with GenElute PCR Clean-up kit (Merck, Darmstadt, Germany) and 
electrocompetent E. coli were transformed with purified mutated plasmids. Inserts were validated by 
control digestion and by sequencing. ΔPH deletion construct was created by whole-plasmid 
amplification with Pfu Ultra Hotstart DNA polymerase using 5‘-phosphorylated primers on either side 
of PH domain. Truncations were created by PCR amplification synArfGEF regions and subcloning 
into pCIneo-FLAG vector using restriction sites EcoRI and NotI. For mCherry-synArfGEF fusion 
constructs, FLAG sequence was removed in pCIneo-FLAG-synArfGEF constructs using restriction 
sites NheI and EcoRI and replaced by directional cloning of PCR-amplified mCherry containing 
restriction sites NheI at 5’-end and EcoRI at 3’-end. For targeting synArfGEF by CRISPR-mediated 
gene modification, pCMV-Cas9-RFP all-in-one plasmids were purchased from Merck. These plasmids 
allow the combined expression of Cas9 and RFP under the control of the CMV promoter and the  
expression of the following gRNA under the control of the U6 promoter: gRNA 1 5’-
CGTCTAGACGAGCTGAGCGCGG-3’, gRNA 2 5’-GCGGCCCAGGAACCGCTTCAGG-3’. Both 
gRNAs target exon 1 of IQSEC3 and exhibit 100% homology between rat and mouse. The identical 
pCMV-Cas9-RFP plasmid without gRNA expression was used as a control plasmid. 
HEK cell transfection 
HEK293T cells were kept in Dulbecco’s Modified Eagle Medium (DMEM; Thermo Fisher Scientific, 
Waltham, MA) containing 10% fetal calf serum (FCS) at 37 °C in 5% CO2. Prior to transfection, HEK 
cells were passaged and grown to approximately 60% confluency. Medium was replaced with fresh 
DMEM containing 10% FCS 2 h before transfection. A total of 3 µg of DNA was mixed with 
polyethylenimine (PEI) in 150 mM NaCl solution to a final PEI concentration of 75 µg/mL. After a 30 
min incubation at room temperature (RT), the mix was added dropwise to HEK cells. HEK cells were 
kept in culture for 24 h before lysis. 
Western blotting 
HEK cells were rinsed carefully with ice-cold PBS and lysed in 50 mM Tris (pH 7.6), 120 mM NaCl, 
0.5% NP-40 containing protease inhibitors (Complete Mini Protease Inhibitor Cocktail [Roche, Basel, 
Switzerland]) by shaking on a compensator for 20 min at 4 °C. Lysates were centrifuged at 20’000 
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RPM for 20 min at 4 °C and supernatants were stored at -80 °C. Samples were mixed with Laemmli 
buffer, boiled at 90 °C and run on tris-glycine polyacrylamide gels. Proteins were transferred to 
polyvinylidene fluoride (PVDF) membranes. Primary antibodies were incubated in tris-buffered saline 
with 0.05% Tween 20 (TBST) including 5% Western Blocking Solution (Roche) ON at 4 °C. 
Membranes were washed 5 times in TBST. Horseradish peroxidase-coupled donkey secondary 
antibodies (1:20’000) were incubated for 1h at RT and membranes were washed again 5 times in 
TBST. SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific, Waltham, MA) 
was applied and membranes were developed on X-ray film (Fujifilm, Tokyo, Japan). 
Immunoprecipitation 
HEK cell lysates were incubated with 1 µg of immunoprecipitation antibody on a rotator for 3 h at 4 
°C. Protein G-agarose (for immunoprecipitation antibodies raised in mouse) or protein A-agarose (for 
immunoprecipitation antibodies raised in rabbit) beads in EBC buffer (50 mM Tris, 120 mM NaCl, 
0.5% NP-40) were added to lysates and the samples rotated again for 1 h at 4 °C. After a wash in high 
salt buffer (50 mM Tris, 500 mM NaCl, 1% NP-40), the beads were washed twice with EBC buffer. 
Immunoprecipitates were eluted from beads by heating to 90 °C in Laemmli buffer for 3 min. 
Primary hippocampal cultures 
Pregnant Wistar rats were anaesthetized at E18 with isoflurane (Attane; Piramal, Mumbai, India) and 
sacrificed by cervical dislocation. Embryonic hippocampi were dissected on ice. Care was taken not to 
contaminate hippocampi with neocortical cells. After digestion of tissue with 0.5 mg/mL papain and 
10 µg/mL DNase I for 15 min at 37 °C, cells were dissociated by gently mixing with a Pasteur pipette. 
Cells were diluted in DMEM + GlutaMAX-I (Thermo Fisher Scientific) including 10% FCS, 2 mM L-
glutamine, 0.1 mg/mL gentamicin and 2.5 µg/mL fungizone and plated on poly-L-lysine-coated 
coverslips at a density of approximately 35’000 cells per coverslip. After 2 h incubation at 37 °C / 5% 
CO2, coverslips were transferred to 12-well dishes containing cell culture medium (15 mM HEPES, 
15% NU serum [Corning Incorporated, Corning, NY], 0.45% glucose, 1 mM Na-pyruvate, 2 mM L-
glutamine and B27 [1x; Thermo Fisher Scientific] in Minimum Essential Medium [Thermo Fisher 
Scientific]) and returned to the incubator until use. 
Transfection of cultured neurons 
Opti-MEM medium (Thermo Fisher Scientific) was mixed with 500 ng of endotoxin-free DNA per 
plasmid and coverslip to be transfected. After a 5 min incubation of lipofectamine 2000 (Oz 
Biosciences, Marseille, France) in Opti-MEM, the mix was added to the DNA solution for a final 
dilution of 1:30. Magnetofection reagent (Oz Biosciences) was added at a final dilution of 1:300 to the 
DNA / lipofectamine 2000 mixture and the solution was incubated at RT for 15 min. The transfection 
solution was added dropwise to coverslips in 1 mL of cell culture medium and cells incubated at 37 °C 
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/ 5% CO2 for 40 min. Coverslips were transferred to 1 mL of conditioned medium and returned to the 
incubator until use. 
Treatments of cell cultures 
Compounds were added to cell culture medium and cells returned to the incubator until fixation for the 
following durations: Ionomycin (5 µM) for 3 min, N-methyl-D-aspartate (NMDA; 30 µM) for 30 min, 
(2R)-amino-5-phosphonopentanoate (AP5; 50 µM) for 30 min, (S)-3,5-dihydroxyphenylglycine 
(DHPG; 100 µM) for 30 min, tetrodotoxin (TTX; 1 µM) for 24h. 
Immunocytochemistry 
Following a quick rinse in PBS to remove residual cell culture medium, cells were fixed immediately 
in 4% PFA in PBS for 10 min at RT. Coverslips were rinsed again in PBS and cells permeabilized in 
PBS containing 10% normal goat serum (NGS) and 0.15% Triton X-100 for 5 min. Cells were 
incubated with primary antibodies diluted in PBS containing 10% NGS for 90 min at RT. After 
washing coverslips 3 times in PBS for 5 min under agitation, cells were incubated with secondary 
antibodies diluted in PBS for 45 min. Secondary antibodies were raised in goat and were coupled to 
the following fluorophores: Alexa Fluor 488 (1:1000; Jackson ImmunoResearch, West Grove, PA), 
Cy3 (1:500; Jackson ImmunoResearch), Alexa Fluor 647 (1:1000; Jackson ImmunoResearch). 
Coverslips were washed 3 times in PBS for 5 min under agitation, dried and mounted with 
Fluorescence Mounting Medium (Dako, Carpinteria, CA). 
Image acquisition and analysis 
All specimens were imaged using confocal laser scanning microscopy (LSM 700 and LSM 710, Carl 
Zeiss, Oberkochen, Germany). Images were taken using a 40x objective with a numerical aperture of 
1.4 and had a pixel size of 112 x 112 nm2. For quantification of synaptic markers, individual dendrites 
were framed by a region of interest with 2.5 µm thickness and clusters quantified by an automated 
macro in ImageJ (NIH, Bethesda, MD). To determine apposition of pre- and postsynaptic clusters, 
presynaptic marker size was enlarged by 1 pixel and colocalization with postsynaptic marker sampled. 
All imaging and quantification parameters were kept constant between conditions. 
Antibodies 
Primary antibodies used in Western blots: Mouse anti-FLAG (1:5000; clone M2; Merck), rabbit anti-
GFP (1:5000; Synaptic Systems, Göttingen, Germany), rabbit anti-mCherry (1:1000; Abcam, 
Cambridge, UK). Primary antibodies used for immunocytochemistry: Mouse anti-FLAG (1:5000; 
clone M2; Merck), rat anti-hemagglutinin (HA; 1:2000; clone 3F10; Roche), mouse anti-gephyrin 
(1:1000; Synaptic Systems), guinea pig anti-GABAAR α2 subunit (1:5000; (Fritschy and Mohler, 
1995)), guinea pig anti-GABAAR γ2 subunit (1:5000; (Fritschy and Mohler, 1995)), rabbit and guinea 
pig anti-synArfGEF (both 1:1000; gift from Dr. Hiroyuki Sakagami (Fukaya et al., 2011)), rabbit anti-
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VGAT (1:3000; Synaptic Systems), rabbit anti-VGluT1 (1:5000; Synaptic Systems), rabbit anti-
VGluT2 (1:5000; Synaptic Systems). 
Calmodulin binding assay 
HEK cells transfected with FLAG-tagged synArfGEF constructs were lysed in the presence of either 2 
mM CaCl2 or 2 mM EGTA. To avoid decreasing CaCl2 or EGTA concentrations in further steps in the 
assay, all solutions before elution contained either 2 mM CaCl2 or 2 mM EGTA. After sparing a 
sample of each lysate as loading control, lysates were mixed with Calmodulin Sepharose beads (GE 
Healthcare, Little Chalfont, UK) and incubated on a rotator for 3 h at 4 °C. Beads were washed 3 times 
in 50 mM Tris, 150 mM NaCl, 1% Triton X-100 containing protease inhibitors (Complete Mini 
Protease Inhibitor Cocktail [Roche]). For elution, beads were incubated in 50 mM Tris, 150 mM NaCl 
containing high concentration of the opposite condition (10 mM EGTA or 10 mM CaCl2) for 30 min 
at RT on a rotator. Supernatant containing pull-down proteins was mixed with Laemmli buffer, heated 
to 90 °C for 3 min and used for Western blot analysis. 
Fluorescence in situ hybridization 
Primary hippocampal cultures were transfected with plasmids encoding FLAG-tagged synArfGEF and 
a GFP marker at days in vitro (DIV) 12. At DIV 19, cells were fixed with 4% PFA in PBS for 15 min 
at RT. The following steps were performed using QuantiGene ViewRNA ISH Cell Assay (Affymetrix, 
Santa Clara, CA) according to the manufacturer’s instructions. Cells were permeabilized using 
“Detergent Solution QC” for 5 min at RT. IQSEC3 transcripts were detected with Type 1 probes, 
whereas NLGN2, GPHN and ARHGEF9 probes were Type 6 probes. This allowed detection of 
IQSEC3 signal with peak intensity at 550 nm together with detection of other probes at 650 nm. 
Probes were incubated for 3 h at 40 °C and PreAmplifier, Amplifier as well as Label Probe Mix were 
incubated for 40 min at 40 °C. Coverslips were mounted with Fluorescence Mounting Medium 
(Dako).  
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Results 
Gephyrin interacts with synArfGEF near its IQ motif 
SynArfGEF was described as a dystrophin-interacting protein because of its capability to bind 
dystrophin WW domains and due to the colocalization of both proteins in primary hippocampal 
neurons (Fukaya et al., 2011). Immunohistochemical analyses of brain and retina sections, however, 
have revealed a distribution pattern reminiscent of more broadly distributed GABAergic postsynaptic 
proteins, such as gephyrin (Fukaya et al., 2011; Sakagami et al., 2013). For this reason, we probed 
synArfGEF-gephyrin interaction in heterologous cells. According to known functions of domains 
found in synArfGEF homologs, mutations and truncations of synArfGEF were generated (Figure 1A). 
First, synArfGEF interaction with gephyrin domains was assessed. Full-length synArfGEF was 
expressed together with full-length gephyrin, gephyrin GC- or E-domain in HEK293T cells and 
lysates used for co-immunoprecipitation assays. Full length gephyrin and its GC-domain but not E-
domain were found to co-immunoprecipitate with synArfGEF (Figure 1B). To gain insight into the 
site of gephyrin interaction on synArfGEF, synArfGEF constructs were used in interaction assays 
together with enhanced green fluorescent protein (eGFP)-tagged full-length gephyrin (Figure 1C-F). 
Mutation of the IQ motif (I318A/Q319A/R323A), a serine residue undergoing phosphorylation 
(S348), the catalytically essential glutamate residue in Sec7 domain (E749K) or the dystrophin-
interacting PP motif (P1165A/P1166A/Y1168A) had no effect on gephyrin binding efficiency (Figure 
1C-D)(Cherfils et al., 1998; Trinidad et al., 2006; Fukaya et al., 2011; Myers et al., 2012). Interaction 
with gephyrin was also retained when using a synArfGEF construct lacking the pleckstrin homology 
(PH) domain. However, deletion of the first N-terminal 181 amino acids in synArfGEF caused a 
drastic reduction of eGFP-gephyrin detected in the immunoprecipitate (Figure 1D). In order to 
determine the minimal domain requirement of synArfGEF for gephyrin interaction, synArfGEF 
truncations were made and their binding assessed. Surprisingly, the domain containing the IQ motif 
was sufficient for gephyrin binding but the coiled coil (CC)-containing N-terminal part alone was not 
able to bind gephyrin (Figure 1E-F). Within the IQ motif containing domain, the region close to the IQ 
motif was found to bind gephyrin whereas the region close to the Sec7 domain did not. Expression of 
an intermediate region (IQ fragment 2; Figure 1A) and of the isolated Sec7 domain was not strong 
enough to assess binding capability to gephyrin. Together, these results show that synArfGEF binds to 
gephyrin near the IQ motif and that the N-terminal CC domain is required for efficient binding. 
Figure 1. SynArfGEF interacts with gephyrin G- or C-domain near the IQ motif. 
A, Schematic overview of synArfGEF constructs and summary of gephyrin interaction results. Binding to 
gephyrin is indicated by “+”, “(+)” indicates weaker binding compared to wildtype synArfGEF and “-“ indicates 
absence of binding. B-F, Representative Western blots of co-immunoprecipitation (co-IP) experiments 
performed to assess synArfGEF interaction with gephyrin. In all experiments constructs were expressed in 
HEK293T cells and lysates used for co-IP using mouse anti-FLAG antibody bound to agarose beads. Two 
negative controls were employed to exclude unspecific binding. Anti-FLAG antibody was replaced by unspecific 
mouse IgG but both constructs were expressed. In addition, the construct to be immunoprecipitated was not 
expressed but immunoprecipitation antibody was present. B, GFP-tagged full-length gephyrin as well as 
gephyrin CG-domain was co-immunoprecipitated with FLAG-tagged synArfGEF. For gephyrin E-domain, no 
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(Figure legend continued) GFP-immunoreactive band was found after immunoprecipitation. C, Mutation of IQ 
motif, Sec7 catalytic domain and PP motif as well as deletion of PH domain do not hinder binding of synArfGEF 
to gephyrin. D, Mutation of synArfGEF S348 does not affect binding to gephyrin but N-terminal CC domain is 
necessary for efficient interaction with gephyrin. E, IQ domain is sufficient for gephyrin binding and CC 
domain, which is missing in N-terminal deletion, itself does not bind gephyrin. For constructs encoding Sec7 
domain and Sec7 domain containing E749K mutation expression in HEK293T cells was too week to assess 
interaction by co-IP. F, Gephyrin binds to region near IQ motif in synArfGEF. Only IQ fragment 1 was detected 
in immunoprecipitates but not IQ fragment 3. Expression of IQ fragment 2 in HEK293T cells was too weak to 
assess binding to gephyrin. 
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CRISPR-mediated gene ablation reveals a role of synArfGEF in regulation of gephyrin 
presynaptic apposition 
The extensive colocalization with GABAergic PSD proteins, biochemical interaction with gephyrin 
and the function as an Arf6 GEF suggested an important role for synArfGEF in regulation of the 
GABAergic PSD. Strategies to ablate synArfGEF function were thus explored. Downregulation of 
synArfGEF levels through RNA interference (RNAi) was not successful, despite testing of multiple 
published and unpublished shRNA sequences (Bloodgood et al., 2013). For this reason, synArfGEF 
was targeted at the genomic level through clustered regularly interspersed short palindromic repeats 
(CRISPR)-mediated gene modification. Two guide RNA (gRNA) sequences were designed, targeting 
exon 1 of the IQSEC3 (synArfGEF) gene to maximize chances of ablation of a functional gene 
product. Together with Cas9 and RFP, gRNAs were expressed from single plasmids transfected in rat 
primary hippocampal neurons at DIV 8. To allow sufficient time for functional consequences of 
potential gene ablation, cultures were analyzed at DIV 22 (Incontro et al., 2014). 
Figure 2. CRISPR-mediated synArfGEF ablation reveals a role in regulation of gephyrin apposition. 
A-B, Validation of CRISPR-mediated synArfGEF ablation in primary hippocampal neurons. Cells were 
transfected at DIV 8 and analyzed at DIV 22. A, Representative images of neuronal somata transfected with 
plasmids expressing Cas9, RFP and synArfGEF-specific gRNAs or Cas9 and RFP only (control). Two validated 
anti-synArfGEF antibodies were used to assess synArfGEF expression level of transfected cells. Most control-
transfected cells were marked by bright somatic synArfGEF immunolabeling whereas synArfGEF-specific 
gRNA-expressing cells showed similar immunofluorescence levels as background. B, Quantification of anti-
synArfGEF immunofluorescence intensities of transfected neuronal somata and surrounding untransfected area. 
With both synArfGEF antibodies (raised in rabbit and guinea pig, respectively), drastically reduced somatic 
immunofluorescence intensity was found for both gRNAs compared to cells expressing control plasmid. No 
statistically significant differences were found in background immunofluorescence levels surrounding 
transfected cells. Bars represent means and whiskers represent standard errors of the mean. C-G, Analysis of 
eGFP-gephyrin clustering and apposition to presynaptic markers in primary hippocampal neurons co-expressing 
CRISPR plasmids and eGFP-gephyrin. Cells were transfected at DIV 8 and analyzed at DIV 22. C, 
Representative images of dendrites of co-transfected neurons labelled either with anti-VGAT or with anti-
VGluT1 and anti-VGluT2 antibodies. In control conditions, around half of eGFP-gephyrin clusters are not 
apposed to VGAT (arrowhead). eGFP-gephyrin clusters misapposed to VGluT1+2 puncta constitute around one 
third of all clusters in control cells (arrow). Such mismatched eGFP-gephyrin clusters are more abundant in cells 
co-expressing synArfGEF-specific gRNAs. D, Quantification of total dendritic eGFP-gephyrin cluster densities 
revealed no statistically significant changes between transfected constructs. E, Quantification of absolute VGAT-
apposed and -nonapposed eGFP-gephyrin cluster densities and fraction of VGAT-apposed clusters as percent of 
total clusters. VGAT apposition was unchanged by co-expression of synArfGEF-targeting gRNAs. F, 
Quantification of VGluT1+2 apposition showed that the fraction of VGluT1+2-apposed eGFP-gephyrin clusters 
was increased in synArfGEF-ablated cells, mirrored by corresponding changes in absolute VGluT1+2-apposed 
and -nonapposed eGFP-gephyrin cluster densities. G, Quantification of overall eGFP-gephyrin cluster size and 
intensity in synArfGEF-ablated and control dendrites. Expression of synArfGEF-targeting gRNAs led to a small 
but statistically significant increase in both cluster size and intensity. In box plots, lines, crosses, boxes and 
whiskers represent median, mean, 25-75 percentile and 10-90 percentile, respectively. Data points represent 
individual cells. *p<0.05, ***p<0.001. 
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Two validated anti-synArfGEF antibodies were used to determine synArfGEF levels in neurons 
transfected with plasmids containing one of the synArfGEF-targeting gRNAs or Cas9 and RFP only 
(Figure 2A)(Fukaya et al., 2011). Strong immunolabeling was observed frequently in cells 
overexpressing control plasmid. Cells expressing synArfGEF-targeting gRNAs, on the other hand, 
showed background level immunofluorescence intensity. Immunofluorescence intensity in the 
surrounding area of transfected cells was similar between conditions (Figure 2B). These findings 
strongly suggest that CRISPR-mediated gene modification led to ablation of synArfGEF in a majority 
of gRNA-expressing cells and that 14 DIV after transfection synArfGEF protein levels were strongly 
reduced. 
As a readout of the consequences of synArfGEF ablation for the GABAergic PSD, eGFP-gephyrin 
was co-expressed with CRISPR plasmids. Overall eGFP-gephyrin cluster density was not affected by 
co-expression of gRNAs (Figure 2 C-D). However, when GABAergic and glutamatergic presynaptic 
terminals were visualized separately with VGAT and VGluT1+2 immunolabeling, respectively, 
differences in the frequency of apposition of gephyrin clusters to the two classes of presynaptic 
terminals were unveiled between synArfGEF-ablated and control cells. Specifically, eGFP-gephyrin 
clusters apposed to VGluT1+2-positive terminals (mismatched synapses), which constitute around one 
third of clusters in control cells, were increased to around 50% in cells expressing either of the two 
gRNAs (arrows in Figure 2C and Figure 2F). Yet, the fraction of gephyrin clusters apposed to VGAT-
positive terminals was not affected by CRISPR-mediated synArfGEF ablation. These findings suggest 
that the mechanisms ensuring appropriate matching between presynaptic GABAergic / glutamatergic 
terminals and the corresponding postsynaptic density are regulated by SynArfGEF. Interestingly, loss 
of synArfGEF led to a minute increase of eGFP-gephyrin cluster size and intensity, suggesting a 
function for synArfGEF in aggregation or degradation of gephyrin (Figure 2G).  
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Figure 
 
Conditions 
 
One-way ANOVA 
Bonferroni’s multiple 
comparison test 
2B Rab anti-synArfGEF, cell soma F=38.773, p<0.001 Control vs gRNA 1, t=7.186 
Control vs gRNA 2, t=7.519 
 Rab anti-synArfGEF, background F=0.263, p=0.770 - 
 GP anti-synArfGEF, cell soma F=32.697, p<0.001 Control vs gRNA 1, t=6.704 
Control vs gRNA 2, t=6.807 
 GP anti-synArfGEF, background F=0.192, p=0.826 - 
2D Total cluster density F=0.095, p=0.909 - 
2E VGAT-apposed F=1.117, p=0.340 - 
 VGAT-nonapposed F=1.224, p=0.308 - 
 Percent VGAT-apposed F=0.501, p=0.611 - 
2F VGluT1+2-apposed F=3.43, p=0.045 Control vs gRNA 1, t=1.820 
Control vs gRNA 2, t=2.557 
 VGluT1+2-nonapposed F=4.350, p=0.021 Control vs gRNA 1, t=2.869 
Control vs gRNA 2, t=0.914 
 Percent VGluT1+2-apposed F=8.707, p=0.001 Control vs gRNA 1, t=4.065 
Control vs gRNA 2, t=2.927 
3B Total cluster density F=12.461, p<0.001 Empty vector vs synArfGEF, t=1.305 
Empty vector vs Sec7 mut., t=4.748 
Empty vector vs IQ mut., t=0.043 
3C VGAT-apposed F=0.406, p=0.749 - 
 VGAT-nonapposed F=28.295, p<0.001 Empty vector vs synArfGEF, t=1.468 
Empty vector vs Sec7 mut., t=7.363 
Empty vector vs IQ mut., t=0.222 
 Percent VGAT-apposed F=14.635, p<0.001 Empty vector vs synArfGEF, t=1.447 
Empty vector vs Sec7 mut., t=5.022 
Empty vector vs IQ mut., t=0.496 
3D VGluT1+2-apposed F=15.525, p<0.001 Empty vector vs synArfGEF, t=0.944 
Empty vector vs Sec7 mut., t=5.662 
Empty vector vs IQ mut., t=0.741 
 VGluT1+2-nonapposed F=0.447, p=0.720 - 
 Percent VGluT1+2-apposed F=16.203, p<0.001 Empty vector vs synArfGEF, t=0.931 
Empty vector vs Sec7 mut., t=5.815 
Empty vector vs IQ mut., t=1.217 
4B Total cluster density F=2.775, p=0.042 Empty vector vs synArfGEF, t=0.094 
Empty vector vs Sec7 mut., t=0.541 
Empty vector vs IQ mut., t=2.579 
4C VGAT-apposed F=2.281, p=0.084 - 
 VGAT-nonapposed F=2.498, p=0.064 - 
 Percent VGAT-apposed F=1.604, p=0.193 - 
4D VGluT1+2-apposed F=2.597, p=0.056 - 
 VGluT1+2-nonapposed F=0.486, p=0.693 - 
 Percent VGluT1+2-apposed F=1.165, p=0.327 - 
5A VGAT density F=0.678, p=0.566 - 
 VGAT apposed to eGFP-gephyrin F=0.378, p=0.769 - 
5B VGluT1+2 density F=2.282, p=0.080 - 
 VGluT1+2 apposed to eGFP-gephyrin F=12.803, p<0.001 Empty vector vs synArfGEF, t=0.079 
Empty vector vs Sec7 mut., t=5.597 
Empty vector vs IQ mut., t=1.008 
6B VGAT-apposed F=1.674, p=0.181 - 
 VGAT-nonapposed F=7.558, p<0.001 Neighb. untr. vs synArfGEF, t=0.106 
Neighb. untr. vs Sec7 mut., t=3.698 
SynArfGEF vs Sec7 mut., t=3.888 
 Percent VGAT-apposed F=7.164, p<0.001 Neighb. untr. vs synArfGEF, t=0.130 
Neighb. untr. vs Sec7 mut., t=4.146 
SynArfGEF vs Sec7 mut., t=3.314 
6D VGluT1+2-apposed F=5.117, p=0.005 Neighb. untr. vs synArfGEF, t=0.935 
Neighb. untr. vs Sec7 mut., t=3.148 
SynArfGEF vs Sec7 mut., t=2.569 
 VGluT1+2-nonapposed F=1.057, p=0.379 - 
 Percent VGluT1+2-apposed F=8.243, p<0.001 Neighb. untr. vs synArfGEF, t=0.961 
Neighb. untr. vs Sec7 mut., t=3.862 
SynArfGEF vs Sec7 mut., t=3.501 
7B Total cluster density F=2.543, p=0.059 - 
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7C VGAT-apposed F=1.779, p=0.159 - 
 VGAT-nonapposed F=4.159, p=0.009 Untr. vs Arf6 CA, t=1.105 
Untr. vs Arf6 DN, t=2.452 
Arf6 CA vs Arf6 DN, t=3.371 
 Percent VGAT-apposed F=6.523, p<0.001 Untr. vs Arf6 CA, t=1.088 
Untr. vs Arf6 DN, t=3.284 
Arf6 CA vs Arf6 DN, t=4.119 
7D VGluT1+2-apposed F=6.625, p<0.001 Untr. vs Arf6 CA, t=0.283 
Untr. vs Arf6 DN, t=3.382 
Arf6 CA vs Arf6 DN, t=4.115 
 VGluT1+2-nonapposed F=0.809, p=0.493 - 
 Percent VGluT1+2-apposed F=6.106, p<0.001 Untr. vs Arf6 CA, t=0.979 
Untr. vs Arf6 DN, t=2.866 
Arf6 CA vs Arf6 DN, t=3.808 
8A Total cluster density F=1.125, p=0.330 - 
8B VGAT-apposed F=0.528, p=0.593 - 
 VGAT-nonapposed F=4.606, p=0.015 Arf6 vs Arf6 CA, t=1.244 
Arf6 vs Arf6 DN, t=1.833 
Arf6 CA vs Arf6 DN, t=3.011 
 Percent VGAT-apposed F=5.372, p=0.008 Arf6 vs Arf6 CA, t=2.077 
Arf6 vs Arf6 DN, t=1.230 
Arf6 CA vs Arf6 DN, t=3.246 
8C VGluT1+2-apposed F=0.203, p=0.817 - 
 VGluT1+2-nonapposed F=0.149, p=0.862 - 
 Percent VGluT1+2-apposed F=1.253, p=0.301 - 
  Unpaired t-test 
10D SynArfGEF t18=3.067, p=0.007 
 Sec7 mutant t20=2.912, p=0.009 
 IQ mutant t19=3.981, p<0.001 
10E % VGluT1+2-apposed, synArfGEF t18=0.782, p=0.445 
 % VGluT1+2-apposed, Sec7 mutant t20=0.646, p=0.526 
 % VGluT1+2-apposed, IQ mutant t19=0.679, p=0.506 
 % Gephyrin-colocalized, synArfGEF t18=0.548, p=0.590 
 % Gephyrin-colocalized, Sec7 mutant t20=0.718, p=0.481 
 % Gephyrin-colocalized, IQ mutant t19=1.786, p=0.090 
Table 1. Results of statistical tests performed on cluster density values. 
F and t represent test statistics for one-way ANOVA and Bonferroni’s multiple comparison test / unpaired t-test, 
respectively. 
Figure Conditions Kruskal-Wallis test Dunn’s multiple comparison test 
2G eGFP-gephyrin cluster size n=9632, H=7.526, 
p=0.023 
Control vs gRNA 1, y=-132.474, p>0.05 
Control vs gRNA 2, y=-181.828, p<0.05 
 eGFP-gephyrin cluster intensity n=9632, H=8.254, 
p=0.016 
Control vs gRNA 1, y=-135.565, p>0.05 
Control vs gRNA 2, y=-191.465, p<0.05 
3E eGFP-gephyrin cluster size n=7027, H=30.161, 
p<0.001 
E. v. vs synArfGEF, y=213.368, p<0.01 
E. v. vs Sec7 mut., y=317.373, p<0.001 
E. v. vs IQ mut., y=316.009, p<0.001 
4E GFP-PSD-95 cluster size n=9707, H=2.866, 
p=0.413 
- 
Table 2. Results of statistical tests performed on cluster size values. 
H and y represent test statistics for Kruskal-Wallis test and Dunn’s multiple comparison test, respectively.
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Figure 3. Catalytic function of synArfGEF selectively regulates mismatched gephyrin cluster density. 
FLAG-tagged synArfGEF constructs or empty vector was co-expressed with eGFP-gephyrin in primary 
hippocampal neurons at DIV 8 and apposition to VGAT or VGluT1+2 immunofluorescent puncta assessed at 
DIV 15. A, Representative images of dendrites of transfected cells. SynArfGEF Sec7 mutant-overexpressing 
cells exhibit an increased amount of VGAT-nonapposed eGFP-gephyrin clusters (arrowheads) in comparison to 
all other constructs. VGluT1+2-apposed eGFP-gephyrin clusters (arrows) are also more abundant in cells 
overexpressing Sec7 mutant. B, Quantification of total dendritic eGFP-gephyrin cluster densities. 
Overexpression of synArfGEF Sec7 mutant led to an increase in eGFP-gephyrin cluster density whereas 
synArfGEF wildtype or IQ mutant did not significantly change eGFP-gephyrin cluster density. C, Quantification 
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(Figure legend continued) of eGFP-gephyrin VGAT apposition. VGAT-apposed eGFP-gephyrin cluster density 
showed no significant differences between constructs. In contrast, VGAT-nonapposed eGFP-gephyrin clusters 
displayed an increased density in Sec7 mutant-expressing cells compared to all other constructs, resulting in a 
decreased percentage of VGAT-apposed eGFP-gephyrin clusters. D, Quantification of eGFP-gephyrin 
VGluT1+2 apposition. VGluT1+2-apposed eGFP-gephyrin cluster density was increased by overexpression of 
Sec7 mutant but in VGluT1+2-nonapposed eGFP-gephyrin clusters no significant differences were found 
between groups. The increase of VGluT1+2-apposed eGFP-gephyrin cluster density in Sec7 mutant-expressing 
neurons is reflected in a higher percentage of VGluT1+2-apposed eGFP-gephyrin clusters. E, Quantification of 
overall eGFP-gephyrin cluster size in cells co-expressing synArfGEF constructs. Compared to empty vector, all 
synArfGEF constructs caused a small but statistically significant reduction of cluster size when co-expressed 
with eGFP-gephyrin. In box plots, lines, crosses, boxes and whiskers represent median, mean, 25-75 percentile 
and 10-90 percentile, respectively. Data points represent individual cells. **p<0.01, ***p<0.001. 
Regulation of mismatched PSD proteins by synArfGEF depends on its catalytic function 
and is restricted to GABAergic postsynaptic proteins 
Similar to glutamate receptor regulation by synArfGEF homologs, the role of synArfGEF in regulation 
of gephyrin presynaptic apposition might depend on its catalytic function (Scholz et al., 2010; Myers 
et al., 2012). To test this possibility, FLAG-tagged synArfGEF constructs were overexpressed in 
primary hippocampal neurons together with eGFP-gephyrin at DIV 8 and analyzed at DIV 15. Again, 
cultures were labeled with anti-VGAT or anti-VGluT1+2 antibodies to distinguish between 
GABAergic synapses and mismatched synapses (gephyrin clusters apposed to glutamatergic 
terminals). This approach revealed a dramatic elevation of eGFP-gephyrin clusters nonapposed to 
VGAT-positive terminals in cells overexpressing synArfGEF Sec7 mutant in comparison to cells 
transfected with empty vector or with other synArfGEF constructs (Figure 3A and C). A reduction of 
the percentage of VGAT-apposed gephyrin clusters paralleled the cluster density results in Sec7 
mutant-overexpressing cells. VGluT1+2-apposed eGFP-gephyrin cluster density was increased to a 
similar extent as VGAT-nonapposed cluster density, demonstrating that many VGAT-nonapposed 
clusters are mismatched (Figure 3D). Sec7 mutant-transfected cells were also marked by an increase in 
overall eGFP-gephyrin cluster density, consistent with the notion that Sec7 mutant overexpression 
promotes mismatched gephyrin clustering (Figure 3B). Surprisingly, overexpression of wildtype 
synArfGEF and IQ motif mutant did not lead to changes in overall eGFP-gephyrin cluster density or in 
apposition of eGFP-gephyrin clusters. Finally, eGFP-gephyrin cluster size was reduced in cells 
transfected with any of the synArfGEF constructs, indicating that this reduction is caused by binding 
of constructs to gephyrin and not by synArfGEF catalytic activity (Figure 3E). 
Figure 4. SynArfGEF catalytic function is not involved in regulation of presynaptic apposition of 
glutamatergic postsynaptic density. 
FLAG-tagged synArfGEF constructs were co-expressed with GFP-PSD-95 in primary hippocampal neurons at 
DIV 8 and apposition to presynaptic markers analyzed at DIV 15. A, Representative images of dendrites of 
transfected cells immunolabeled either for VGAT or VGluT1+2. The majority of GFP-PSD-95 clusters is 
apposed to VGluT1+2 puncta but a minor fraction of clusters is misapposed to VGAT (arrows) or is not apposed 
to VGluT1+2 (arrowheads). B-E, Quantification of clustering and apposition parameters of GFP-PSD95. In all 
analyses, there were no statistically significant differences found between constructs. B, Quantification of total 
dendritic GFP-PSD-95 cluster densities. C, Quantification of VGAT apposition of GFP-PSD-95. D, 
Quantification of VGluT1+2 apposition of GFP-PSD-95. E, Quantification of overall GFP-PSD-95 cluster size. 
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(Figure legend continued) In box plots, lines, crosses, boxes and whiskers represent median, mean, 25-75 
percentile and 10-90 percentile, respectively. Data points represent individual cells. 
SynArfGEF exhibits a PDZ domain-binding motif at the C-terminal end and was first described as a 
glutamatergic PSD protein (Inaba et al., 2004). The observed phenotype could be a manifestation of a 
more general function of synArfGEF in synapse validation, both for GABAergic and glutamatergic 
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PSD proteins. For this reason, we co-expressed synArfGEF constructs with GFP-PSD-95 and 
examined apposition to presynaptic markers (Figure 4). In these experiments, synArfGEF catalytic 
function did not affect the density of mismatched (VGAT-apposed) PSD-95 clusters. Instead, GFP-
PSD-95 clusters were about 5 times more frequently apposed to VGluT1+2- than to VGAT-positive 
terminals in all conditions (Figure 4A-D). In addition, GFP-PSD-95 cluster size was not affected by 
overexpression of synArfGEF constructs (Figure 4E). SynArfGEF catalytic function thus seems to be 
specifically required for regulation of presynaptic terminal apposition to the GABAergic PSD. 
Regulation of gephyrin presynaptic apposition by synArfGEF raises the question whether such control 
is exerted through trans-synaptic signaling or whether purely postsynaptic mechanisms are involved. 
Quantification of presynaptic marker density reveals that innervation density is not affected by 
synArfGEF overexpression (Figure 5). In terms of fraction of presynaptic markers misapposed to 
eGFP-gephyrin, only VGluT1+2 puncta exhibit an increase upon Sec7 mutant overexpression. This is 
consistent with the notion that synArfGEF has a postsynaptic role in regulation of GABAergic PSD 
apposition. 
 
Figure 5. Fraction of mismatched glutamatergic presynaptic terminals but not innervation density is 
affected by synArfGEF catalytic function. 
A, Quantification of VGAT puncta densities and percentage of VGAT puncta apposed to eGFP-gephyrin. Co-
expression of synArfGEF constructs had no statistically significant effect on puncta density or percentage of 
apposition to eGFP-gephyrin. B, Quantification of VGluT1+2 puncta densities and percentage of VGluT1+2 
puncta apposed to eGFP-gephyrin. Percentage of VGluT1+2 puncta apposed to eGFP-gephyrin was increased in 
Sec7 mutant-overexpressing cells compared to all other groups but absolute VGluT1+2 densities were 
unaffected by synArfGEF construct co-expression. Data points represent individual cells. ***p<0.001. 
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To exclude the possibility that synArfGEF function is restricted to downregulation of gephyrin at 
mismatched sites, overexpression experiments were repeated without eGFP-gephyrin co-expression. 
Instead, GABAAR γ2 subunit was immunolabeled in these cultures to assess consequences of 
synArfGEF wildtype and Sec7 mutant overexpression for GABAAR apposition (Figure 6). 
Neighboring non-transfected dendrites were used in both conditions as internal controls. As with 
eGFP-gephyrin co-expression, Sec7 mutant-transfected cells exhibited higher proportion of 
mismatched γ2 subunit clusters (apposed to VGluT1+2-positive terminals) than untransfected 
dendrites. Along with gephyrin apposition, synArfGEF catalytic function thus contributes to regulate 
the apposition of GABAAR clusters to neurotransmitter-specific presynaptic terminals. 
 
Figure 6. Presynaptic apposition of GABAA receptors is regulated by synArfGEF catalytic function. 
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(Figure legend continued) Primary hippocampal neurons were transfected with synArfGEF wildtype or Sec7 
mutant constructs at DIV 8 and presynaptic apposition of GABAAR γ2 subunit clusters analyzed at DIV 15. 
Untransfected dendrites neighboring transfected cells served as control. A, Representative images of dendrites of 
cells transfected with synArfGEF constructs (upper panels) and untransfected neighboring dendrites (lower 
panels) immunolabeled for VGAT. Note the high abundance of GABAAR γ2 subunit clusters not apposed to 
VGAT (arrowheads) in dendrites of cells transfected with Sec7 mutant. B, Quantification of GABAAR γ2 
subunit cluster VGAT apposition. Compared to untransfected neighboring dendrites and to cells overexpressing 
wildtype synArfGEF, cells overexpressing Sec7 mutant show elevated VGAT-nonapposed cluster densities, 
reflected in a lower percentage of VGAT-apposed clusters. C, Representative images of dendrites of cells 
transfected with synArfGEF constructs (upper panels) and untransfected neighboring dendrites (lower panels) 
immunolabeled for VGluT1+2. Note the high abundance of GABAAR γ2 subunit clusters apposed to VGluT1+2 
puncta (arrows) in dendrites of cells overexpressing Sec7 mutant. D, Quantification of GABAAR γ2 subunit 
cluster VGluT1+2 apposition. Sec7 mutant-transfected cells showed significantly higher density of VGluT1+2-
apposed GABAAR γ2 subunit clusters compared to untransfected cells and to cells transfected with wildtype 
synArfGEF. The increase in VGluT1+2-apposed cluster density is mirrored by a higher percentage of 
VGluT1+2-apposed clusters. Data points represent individual cells. *p<0.05, **p<0.01, ***p<0.001. 
Recapitulation of synArfGEF phenotype by Arf6 mutant overexpression suggests 
regulation of mismatched GABAergic PSDs might be mediated by Arf6 activation 
If Arf6 is the target of synArfGEF catalytic activity for regulation of GABAergic PSD apposition, 
abolition of Arf6 activity alone should replicate the apposition phenotype of the Sec7 mutant. 
Overexpression of Arf6 in its wildtype form, and to a larger extent overexpression of constitutively 
active (CA; Q67L) or dominant negative (DN; T27N) Arf6 mutants, affects neuronal morphology 
(Hernandez-Deviez et al., 2002; Miyazaki et al., 2005). Neurite and spine outgrowth seem to be 
regulated by Arf6, since these processes are promoted by Arf6 DN and inhibited by Arf6 CA 
overexpression, respectively. For this reason, primary hippocampal neurons overexpressing HA-
tagged Arf6 variants were probed with antibodies to GABAAR α2 subunit to assure that formation of 
the GABAergic PSD is not affected by morphology changes. Indeed, GABAAR α2 subunit clusters 
were observed on dendrites of Arf6-expressing neurons to the same extent as on non-transfected 
neurons (Figure 7A). To facilitate the assessment of GABAergic PSD abundance and apposition, 
eGFP-gephyrin was co-expressed with Arf6 constructs. As expected from observations of GABAAR 
α2 subunit clustering, eGFP-gephyrin overall density did not exhibit a statistically significant change 
with Arf6 construct overexpression (Figure 7B). Analysis of presynaptic apposition, however, 
uncovered that in Arf6 DN-expressing cells a smaller fraction of eGFP-gephyrin clusters is correctly 
apposed and a larger fraction present in mismatched synapses, both compared to Arf6 CA-expressing 
cells and to cells expressing eGFP-gephyrin only (Figure 7C-D). Similar to results from synArfGEF 
overexpression experiments, these alterations were caused by an increase in the proportion of 
mismatched gephyrin clusters apposed to VGluT1+2-positive terminals. Therefore, Arf6 activity is 
sufficient for regulation of GABAergic PSD presynaptic apposition, indicating that Arf6 is a likely 
target of synArfGEF in this process. 
To corroborate the finding that Arf6 activation controls matching of the GABAergic PSD with 
presynaptic structures, GABAAR γ2 subunit was immunolabeled and apposition assessed in Arf6-
overexpressing neurons (Figure 8). As with co-expression of eGFP-gephyrin, total γ2 subunit cluster 
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density was not affected by Arf6 construct overexpression. However, apposition to VGAT-positive 
terminals was again reduced in Arf6 DN- compared to Arf6 CA-overexpressing cells whereas an 
increased proportion of mismatched clusters was observed. Unexpectedly, although mean percentage 
of mismatched clusters was higher in Arf6 DN- than in Arf6 CA-expressing cells, no statistically 
significant difference was found in the fraction of γ2 subunit clusters apposed to VGluT1+2-positive 
terminals. 
 
Figure 7. Arf6 is involved in regulation of gephyrin presynaptic apposition. 
A, GABAAR clusters are present on neurons overexpressing Arf6 constructs. Primary hippocampal neurons were 
transfected with HA-tagged Arf6 wildtype, constitutively active (CA) mutant or dominant negative (DN) mutant 
and GABAAR clustering assessed by α2 subunit immunolabeling. B, Quantification of total eGFP-gephyrin 
cluster densities in cells co-expressing Arf6 constructs or expressing eGFP-gephyrin alone. Primary 
hippocampal cultures were transfected at DIV 8 and cells analyzed at DIV 15. Co-expression of Arf6 constructs 
had no effect on eGFP-gephyrin cluster density. C, Representative images and quantifications of eGFP-gephyrin 
apposition to VGAT. Cells co-expressing HA-Arf6 DN displayed a higher density of VGAT-nonapposed 
clusters and a lower percentage of VGAT-apposed clusters than cells co-expressing HA-Arf6 CA. Arrowheads 
Study II 
81 
(Figure legend continued) indicate eGFP-gephyrin cluster not apposed to VGAT. D, Representative images and 
quantifications of eGFP-gephyrin apposition to VGluT1+2. Cells co-expressing HA-Arf6 DN displayed a higher 
density and percentage of eGFP-gephyrin clusters apposed to VGluT1+2 than cells co-expressing HA-Arf6 CA. 
Arrows indicate eGFP-gephyrin clusters apposed to VGluT1+2. Data points represent individual cells. **p<0.01, 
***p<0.001. 
 
Figure 8. Arf6 is involved in regulation of GABAA receptor presynaptic apposition. 
Primary hippocampal neurons were transfected at DIV 8 with Arf6 constructs and GABAAR clustering assessed 
at DIV 15 by immunolabeling of γ2 subunit. A, Quantification of total dendritic GABAAR γ2 subunit cluster 
densities in cells transfected with Arf6 constructs. No significant differences were found between groups. B, 
Representative images and quantifications of GABAAR γ2 subunit VGAT apposition in cells overexpressing 
Arf6 constructs. HA-Arf6 CA and HA-Arf6 DN-transfected cells differed significantly in apposition, with DN 
mutant showing higher VGAT-nonapposed γ2 subunit density and lower percentage of VGAT-apposed γ2 
subunit clusters. Arrowheads indicate GABAAR γ2 subunit clusters not apposed to VGAT. C, Representative 
images and quantifications of GABAAR γ2 subunit VGluT1+2 apposition in cells overexpressing Arf6 
constructs. No significant differences were found between groups. Arrows indicate GABAAR γ2 subunit clusters 
apposed to VGluT1+2. Data points represent individual cells. *p<0.05, **p<0.01. 
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The N-terminal coiled-coil domain and the IQ motif are involved in synArfGEF 
aggregation 
Our findings demonstrated a role for synArfGEF catalytic function specifically in regulating the 
correct apposition of the GABAergic PSD to GABAergic terminals. On the other hand, co-IP results 
point to a direct binding of gephyrin with synArfGEF near its IQ motif. This interaction is also 
supported by extensive colocalization of eGFP-gephyrin and synArfGEF when co-expressed in 
neurons (data not shown). The N-terminal CC-domain necessary for this interaction has been 
demonstrated to be essential for homomultimerization (Myers et al., 2012). This line of evidence 
suggests a relationship between synArfGEF homomultimerization and gephyrin interaction. FLAG-
tagged synArfGEF constructs overexpressed in primary hippocampal neurons formed large somatic 
aggregates, reminiscent of aggregates formed by overexpressed gephyrin (Figure 9A). Somatic 
synArfGEF aggregates were consistently immunopositive for endogenous gephyrin. Strikingly, 
deletion of the N-terminus abolished the majority of somatic aggregates and so did mutation of the IQ 
motif. The remaining somatic aggregates, however, consisted of small aggregates for ΔN construct 
and of large aggregates in the case of the IQ mutant. Mutation of S348, the catalytic glutamate residue 
in the Sec7 domain, the PP motif or deletion of the PH domain did not influence somatic synArfGEF 
aggregation. Since individual domains overexpressed in neurons did not form somatic aggregates, 
large somatic aggregates might be formed only by synArfGEF constructs that retain the ability of 
gephyrin interaction as well as homodimerization capability. The importance of N-terminal CC-
domain for homomultimerization is further stressed by a lower propensity of mCherry-tagged 
synArfGEF to co-immunoprecipitate with ΔN construct than with other constructs (Figure 9B). To 
clarify whether synArfGEF aggregates would be formed in heterologous cells, FLAG-tagged 
synArfGEF or IQ mutant was overexpressed in HEK293T cells (Figure 9C). FLAG immunolabeling 
revealed a granular distribution of synArfGEF constructs that was unaffected by application of the 
ionophore ionomycin. Together, these results suggest that synArfGEF homomultimerization is 
connected to gephyrin interaction and depends on neuron-specific factors. 
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Figure 9. SynArfGEF builds somatic aggregates immunopositive for gephyrin which depend on N-
terminus and IQ motif when overexpressed in primary hippocampal neurons. 
A, Representative images and quantifications of somatic aggregates of FLAG-tagged synArfGEF constructs. 
Neuronal somata were blindly divided into cells containing small aggregates, large aggregates or both. Most 
cells overexpressing wildtype synArfGEF contain small or large aggregates. Deletion of CC-domain containing 
N-terminus or mutation of IQ motif results in diffuse somatic distribution of synArfGEF in most transfected 
cells. Small aggregates remain in synArfGEF ΔN and large aggregates remain in IQ mutant. Overexpression of 
individual synArfGEF domains is not sufficient for formation of somatic aggregates. B, Ability of synArfGEF 
multimerization was assessed by co-IP of mCherry-tagged synArfGEF with FLAG-tagged synArfGEF 
constructs. mCherry-synArfGEF was co-immunoprecipitated with all FLAG-synArfGEF constructs. C, 
Overexpression of synArfGEF constructs in HEK293T cells does not result in formation of aggregates but in 
granular distribution throughout cells. Application of 5 µM ionomycin for 3 min before fixation had no effect on 
granular synArfGEF distribution. 
SynArfGEF interactions, response to NMDA and dendritically localized mRNA point 
towards the dependence of synArfGEF function on neuronal activity 
Because gephyrin binding was localized to the region near the IQ motif and due to altered somatic 
aggregation of synArfGEF IQ mutant, the functional importance of the IQ motif in synArfGEF was 
examined using calmodulin binding assays. This motif is present in multiple proteins that bind 
calmodulin at low Ca2+ concentrations (apocalmodulin). SynArfGEF constructs were expressed in 
HEK cells and lysates incubated with calmodulin-bound beads either in the presence of 2 mM Ca2+ or 
2 mM EGTA. Indeed, binding of synArfGEF to calmodulin was observed in low Ca2+ conditions 
(Figure 10A). This interaction was completely abolished with synArfGEF IQ mutant, confirming that 
binding takes place at the IQ motif. Interestingly, in the case of synArfGEF ΔN, a strongly increased 
pull-down efficiency was observed, indicating that synArfGEF multimerization is linked to 
calmodulin binding. To address whether Ca2+-dependent calmodulin binding might play part in a 
physiological process to control synArfGEF conformation, the impact of various drugs on FLAG-
synArfGEF distribution was tested (Figure 10B). Dendritic synArfGEF distribution was altered by 
NMDA, but not by the application of AP5, DHPG or TTX. NMDA treatment of neurons transfected 
with mCherry-tagged synArfGEF constructs also induced distribution changes, in particular increased 
dendritic aggregation (Figure 10C-D). IQ mutant synArfGEF showed a similar increase in aggregation 
as wildtype and Sec7 mutant synArfGEF, ruling out the possibility that aggregation changes are 
directly caused by calmodulin interactions. Aggregation changes might be dependent on gephyrin 
interaction or be restricted to sites of glutamatergic innervation. Therefore, synArfGEF colocalization 
with gephyrin and apposition to VGluT1+2 was analyzed in NMDA-treated or sham-treated cultures. 
In both cases, no statistically significant differences were found between treatment conditions (Figure 
10E). 
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Figure 10. Apocalmodulin binds to synArfGEF IQ motif and NMDA receptor activity promotes 
synArfGEF dendritic aggregation. 
A, Representative Western blot of calmodulin pull-down of synArfGEF constructs in high and low Ca2+ 
conditions. SynArfGEF binds to calmodulin more efficiently in low Ca2+ conditions and requires IQ motif for 
interaction. SynArfGEF constructs were overexpressed in HEK293T cells and lysates used for calmodulin pull-
down assay in the presence of 2 mM CaCl2 or 2 mM EGTA. B, Representative images of FLAG-tagged 
synArfGEF in dendrites of transfected primary hippocampal neurons in the presence of the indicated 
compounds. Application of NMDA (30 µM, 30 min) promoted aggregation of dendritic synArfGEF. No change 
in synArfGEF immunolabeling was observed after application of AP5 (50 µM, 30 min), DHPG (100 µM, 30 
min) or TTX (1 µM, 24 h). C, Representative images of primary hippocampal neurons transfected with 
mCherry-tagged synArfGEF constructs and treated with NMDA (30 µM, 30 min) or sham treated. D, 
Quantification of mCherry-synArfGEF dendritic aggregates revealed an approximately two-fold increase of 
aggregate density after NMDA treatment compared to sham treated cells. E, Quantification of VGluT1+2 
apposition and gephyrin colocalization of mCherry-synArfGEF aggregates. No significant differences were 
found between treatment conditions. **p<0.01, ***p<0.001. 
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Figure 11. Fluorescence in situ hybridization confirms the presence of dendritically located synArfGEF 
mRNA. 
A, Validation of IQSEC3 (synArfGEF) probe specificity. Primary hippocampal neurons were transfected with 
FLAG-tagged synArfGEF construct at DIV 12 and processed for fluorescence in situ hybridization at DIV 19. A 
massive increase in signal intensity in transfected cells (arrowheads) with IQSEC3 probe but not with NLGN2 
probe confirmed IQSEC3 probe specificity to synArfGEF mRNA. Dendritically located IQSEC3 signal is 
highlighted by arrows. B, Comparison of synArfGEF mRNA localization with other transcripts of GABAergic 
PSD proteins in untransfected primary hippocampal cultures at DIV 19. In relation to somatic signal intensity, 
dendritic localization of transcripts (arrows) was more prominent for synArfGEF (IQSEC3) than for collybistin 
(ARHGEF9), gephyrin (GPHN) and GABAAR α1 subunit (GABRA1) transcripts. 
Ca2+-dependent calmodulin binding and distribution changes upon NMDA treatment suggests activity-
dependence of synArfGEF function. As a target of NPAS4, synArfGEF transcription was shown to 
depend on neuronal activity (Bloodgood et al., 2013). Local translation of synArfGEF transcripts 
would provide an additional level of activity-dependent regulation. Therefore, synArfGEF messenger 
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RNA (mRNA) cellular distribution was examined by the use of fluorescence in situ hybridization 
(FISH). Primary hippocampal neurons at DIV 19 displayed strong synArfGEF (IQSEC3) signal 
(Figure 11A). SynArfGEF but not neuroligin 2 (NLGN2) signal intensity was markedly higher in 
neurons transfected at DIV 11 with FLAG-synArfGEF, confirming specificity of synArfGEF probes. 
Importantly, synArfGEF signal was abundant in dendrites (arrows in Figure 11B). Dendritically 
localized signal was less frequently observed using collybistin (ARHGEF9) or gephyrin (GPHN) 
probes and virtually absent using GABAAR α1 subunit (GABRA1) probes. These results confirm that 
synArfGEF mRNA is localized in dendrites and open the possibility of activity-dependent synArfGEF 
translation. 
 
 
Figure 12. Model of synArfGEF function at mismatched GABAergic postsynaptic structures. 
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Discussion 
Our study of synArfGEF function in primary hippocampal neurons provides evidence of activity-
dependent control of mismatched GABAergic postsynaptic proteins by synArfGEF. Catalytic activity 
is implicated in this regulation by the strong effect of Sec7 domain mutation as well as the 
recapitulation of the misapposition phenotype by Arf6 overexpression. SynArfGEF function is 
restricted to misapposed GABAergic PSDs since PSD-95 apposition to GABAergic or glutamatergic 
terminals was not affected. However, NMDA-induced synArfGEF distribution changes, Ca2+-
dependent calmodulin binding and the finding that correctly matched GABAergic PSDs were 
unaffected in all experiments strongly suggests that proximity to glutamatergic structures enables 
synArfGEF function. Gephyrin binding was found to be near the calmodulin binding site and 
dependent on an N-terminal CC domain involved in synArfGEF homomultimerization. This points to 
a mechanism by which synArfGEF undergoes conformational changes upon neuronal activity to 
regulate mismatched GABAergic postsynaptic proteins (Figure 12). 
SynArfGEF interaction with gephyrin is likely to be essential for regulation of 
mismatched GABAergic PSDs 
A physiologically relevant interaction of synArfGEF with gephyrin is suggested by several findings. 
First, co-IP experiments in heterologous cells revealed binding that depended on domains with known 
functions. Secondly, co-expression of both proteins in primary neurons leads to extensive 
colocalization in all subcellular domains. Thirdly, somatic synArfGEF aggregates formed upon 
overexpression are immunopositive for endogenous gephyrin. These observations are in line with 
large overlap of other GABAergic markers reported in various parts of the CNS (Fukaya et al., 2011; 
Sakagami et al., 2013). Dystrophin interaction may be involved in accumulating synArfGEF at 
dystrophin-containing synapses. However, the restricted dystrophin distribution in cortical areas 
excludes an obligatory role for dystrophin in synArfGEF clustering (Lidov et al., 1990; Knuesel et al., 
1999). Along the same lines, localization of synArfGEF containing mutated PP motif necessary for 
dystrophin interaction did not differ from wildtype and synArfGEF clustering was unaffected in 
cerebral cortex of mice with pyramidal cell-specific loss of the DGC. Gephyrin binding to synArfGEF 
was recently reported on the basis of yeast-two-hybrid and co-IP experiments and also identified the 
IQ motif area as the minimally-required area for interaction (Um et al., 2016). Furthermore, gephyrin 
downregulation in primary neurons caused a reduction in synArfGEF clustering, arguing that this 
interaction is necessary for synArfGEF synaptic localization. Substantial evidence has thus 
accumulated that synArfGEF is present in the GABAergic PSD due to specific gephyrin interaction 
near the IQ motif. 
Paradoxically, Um et al. (2016) have found an overall increase of gephyrin and GAD67 puncta density 
upon synArfGEF overexpression, an effect which was dependent on gephyrin binding as well as on 
synArfGEF catalytic activity. The reasons for the discrepancy to our results are not clear, since the 
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same isoform of rat synArfGEF was used in primary hippocampal cultures. Still, the use of the 
chicken beta-actin enhancer and the resulting massive overexpression of synArfGEF in their 
experiments might explain some of these differences. None of our ablation and overexpression 
experiments have yielded results that implicate synArfGEF in the regulation of correctly apposed 
GABAergic proteins, despite the preferential GABAergic localization of synArfGEF. Even the 
increase in overall eGFP-gephyrin cluster density upon Sec7 mutant overexpression is a reflection of 
elevated density of mismatched GABAergic synapses. Further experiments will have to clarify 
whether synArfGEF can contribute to overall GABAergic synapse development, and under what 
conditions. 
Mechanisms underlying the selectivity of synArfGEF function to mismatched 
GABAergic PSDs 
Interaction with gephyrin might reflect a mechanism to target synArfGEF to the GABAergic PSD 
rather than an interaction implicating direct gephyrin regulation. Indeed, gephyrin binding might even 
have an inhibitory effect on synArfGEF catalytic activity, since the multimeric form of synArfGEF 
(containing the N-terminus) bound to gephyrin seems to be catalytically inactive in correctly apposed 
gephyrin clusters. Other factors must be present at mismatched sites, allowing their suppression 
through synArfGEF activity. Calmodulin is a likely candidate to take this role, because of the binding 
near the gephyrin-binding site in low Ca2+ conditions. Binding of calmodulin was also enhanced in the 
ΔN truncation, further suggesting that this interaction competes with gephyrin binding and represents 
a monomeric inactive state (Myers et al., 2012). The cycling of calmodulin-synArfGEF interaction 
with different Ca2+ concentrations might enable an active conformational state which allows activation 
of Arf6 in the mismatched GABAergic PSD. Involvement of calmodulin in formation of such an 
active state would also account for the fact that neuronal activity was implicated in the fidelity of 
GABAergic apposition (Anderson et al., 2004). Two conditions, both of which are given in the 
mismatched GABAergic PSD, would therefore have to be fulfilled for synArfGEF activity: 
Abundance of synArfGEF clustered by gephyrin and unbinding of calmodulin from synArfGEF 
through neuronal activity. Increased dendritic aggregation caused by NMDA is in agreement with such 
a model. Unexpectedly, however, IQ mutant synArfGEF also responded to NMDA with increased 
dendritic aggregation. This suggests that aggregation is not a direct consequence of calmodulin release 
from synArfGEF but might be caused by modification of synArfGEF through other activity-dependent 
factors. NMDA experiments should be repeated with ΔN and S348 mutant constructs to further 
characterize mechanism of these aggregation changes. S348 was identified as a target of protein kinase 
C (PKC) and would be well suited to modulate synArfGEF conformation or gephyrin binding because 
of its proximity to the IQ motif (Trinidad et al., 2006). Alternatively, activity-dependent translation of 
dendritically localized synArfGEF mRNA might underlie the altered immunolabeling after NMDA 
treatment. 
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The fact that Arf6 catalytic mutants replicated the misapposition phenotype of the Sec7 mutant 
strongly suggests that Arf6 acts as a substrate of synArfGEF in this context. Arf6 is also the target of 
IQSEC1 and IQSEC2, leading to the internalization of GluA2 and GluA1 subunits, respectively. In 
order for synArfGEF to achieve GABAergic PSD-specific regulation, activation of Arf6 would have 
to be restricted to GABAergic PSD-containing nanodomains. It is unclear how this specificity is 
ensured in mismatched synapses presumably containing glutamatergic PSD proteins close to 
GABAergic proteins, but spatial restriction of synArfGEF to GABAergic elements might be one level 
of control. Arf6 is a membrane-bound GTPase which has diverse functions in neurons and is 
controlled by a multitude of GEF and GTPase-activating proteins (GAPs) (Jaworski, 2007). 
Downstream effectors of Arf6 regulate actin dynamics and both clathrin-dependent and -independent 
plasma membrane endocytosis. Therefore, direct regulation of gephyrin clustering as well as 
regulation of GABAergic PSD proteins through internalization of GABAARs are possible 
consequences of synArfGEF-mediated activation of Arf6. 
Putative in vivo functions of synArfGEF 
The absence of spatial and temporal cues is likely the main underlying cause for the formation of 
mismatched synapses in primary neuronal cultures. Therefore, it is unclear whether the regulation of 
misapposition by synArfGEF has a physiological relevance in vivo. However, it is conceivable that 
formation of mismatched synapses by loss of guidance cues follows different principles than what was 
uncovered by loss of synArfGEF or overexpression of the Sec7 mutant. This notion is supported by 
the observation that overexpression of wildtype synArfGEF did not lead to a statistically significant 
reduction of mismatched synapses, since mismatched synapses caused by other mechanisms might not 
be under the influence of synArfGEF regulation. In vivo, synArfGEF function might be restricted to 
synapses that are closely apposed to synapses employing a different neurotransmitter system. 
GABAergic synapses that are located on dendritic spines are often in close proximity to glutamatergic 
synapses and therefore synArfGEF might be involved in the regulation of PSD spine nanodomains 
(Chen et al., 2012; van Versendaal et al., 2012). Although complicated by high synaptic density in 
vivo, increased focus on synaptic mismatch in intact tissue might thus lead to a better understanding of 
the mechanisms underlying neurotransmitter-specific PSD regulation. On the one hand, synArfGEF 
knockout mice will be instrumental in the elucidation of the physiological roles of synArfGEF. On the 
other hand, the development of in vivo models of synaptic mismatch would allow to probe the 
involvement of genes required to correct misapposition, by design of rescue experiments. This might 
be achievable through blockade of neuronal activity, as mismatch of GABAergic terminals with 
glutamatergic postsynaptic structures was observed in Purkinje cells of TTX-infused cerebella (Cesa et 
al., 2008). However, to the best of our knowledge, occurrence of postsynaptic GABAergic structures 
misapposed to glutamatergic axon terminals was not yet demonstrated in vivo. 
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Conclusions 
Strikingly, in a recent transcriptomic analysis, synArfGEF was found to be the gene which is most 
strongly downregulated in schizophrenia, autism and bipolar disorder (Ellis et al., 2016). Major issues 
that have to be addressed on the path to potential translational applications of our findings include the 
question of Arf subtype activation of human synArfGEF and the uncertainty of mismatch-regulating 
mechanisms in vivo. So far, the physiological and behavioral consequences of receptor-transmitter 
mismatch in vivo are unexplored. However, in the light of association of synArfGEF expression levels 
with major synaptic disorders in humans, a role for synaptic mismatch in the etiology of these 
disorders should be considered in future investigations.  
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GENERAL DISCUSSION 
The studies carried out in this thesis aimed to characterize the relationship between interneuron cell 
type diversity and variations of postsynaptic GABAergic molecular composition in the context of 
specificity of synapse formation. In particular, the main findings of the two studies relate the 
molecular heterogeneity of GABAergic PSDs to the selectivity of synapse formation and maintenance 
within neurotransmitter systems and to the sorting mechanisms that assure segregated assembly of 
postsynaptic proteins between neurotransmitter systems. The unsuspected roles of postsynaptic 
GABAergic PSD components in subsets of synapses defined by their presynaptic cellular partners, 
demonstrate that presynaptic diversity is mirrored by a functional postsynaptic diversity in 
GABAergic synapses. 
Two GABAergic PSD proteins with unknown function and a restricted distribution within GABAergic 
synapses were selected to approach the research question. Although there is evidence suggesting that 
DG and synArfGEF are present in a molecular complex, the results of the present studies point 
towards distinct roles in determining specificity of GABAergic synapses. 
The ablation of neuronal DG in the forebrain revealed that the DGC is essential for the formation of 
functional GABAergic axon terminals from the group of CCK-positive basket cells, but not from other 
GABAergic interneurons. Postsynaptic proteins were only marginally affected by loss of DG in their 
capacity to cluster opposite GABAergic terminals, contrary to results from previous studies, which 
hinted at a crucial role for the DGC in clustering of GABAARs or NL2. The absence of CCK-positive 
terminals was mirrored by a decrease of sIPSCs in pyramidal cells and the inability of CCh to induce 
such inhibitory events, demonstrating that the lack of immunohistochemical markers correlated with a 
functional loss of terminals. Importantly, the finding that CCK-positive terminals were also 
compromised by ablation of DG during adulthood implied that continuous trans-synaptic signaling is 
necessary for GABAergic axon terminal function. Finally, CCK-positive terminals persisted in DG 
T190M KI mice, opening the possibility that presynaptic receptors other than neurexins might bind to 
DG to enable its trans-synaptic function. This study is the first to show that GABAergic postsynaptic 
proteins can mediate continuous trans-synaptic and subtype-specific signaling, which is essential for 
the function of GABAergic presynaptic terminals. 
Biochemical interaction experiments as well as ablation and overexpression experiments in primary 
neuronal cultures uncovered a specific role of synArfGEF in regulation of mismatched GABAergic 
PSD proteins. This function depended on the Sec7 domain and the phenotype of synArfGEF ablation 
and overexpression experiments was recapitulated by overexpression of Arf6 mutants, making a 
strong argument for an involvement of synArfGEF catalytic function in control of misapposed 
GABAergic postsynaptic proteins. The specificity of this regulation is underlined by the finding that 
synArfGEF overexpression did not affect PSD-95 apposition and by binding of synArfGEF to 
gephyrin in co-IP experiments. Furthermore, several observations indicated that synArfGEF function 
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is controlled by neuronal activity. Calmodulin interaction with synArfGEF depended on Ca2+ 
concentrations, synArfGEF aggregation in dendrites was modulated by NMDA application in primary 
neurons, and FISH revealed synArfGEF transcripts in dendrites. Together, these results demonstrate 
that synArfGEF serves a specific function in regulating GABAergic PSD proteins which are 
mismatched to glutamatergic presynaptic structures, which may underlie the fidelity of GABAergic 
synapse formation in vivo. 
Interneuron subtype-selectivity of DG function suggests that a molecular 
code underlies specificity of GABAergic synapse formation 
A key finding from in vivo DG conditional ablation is the selective requirement of DG for basket cells 
of the CCK-containing but not of the PV-containing type. Indeed, innervation from other GABAergic 
interneuron classes seemed unaffected, judging from the unaltered VGAT and GAD immunostainings. 
The finding that glutamatergic pre- and postsynaptic markers were also essentially unchanged by loss 
of DG further confirms the specificity of DG function. These findings have far-reaching implications, 
since the DGC is the first postsynaptic GABAergic complex found to be essential for the function of 
only one subtype of GABAergic interneurons. 
The diversity of presynaptically located transmembrane proteins became evident with the description 
of neurexin alternative splice variants and drove speculations that this diversity might underlie a 
molecular code, which ensures that postsynaptic targets are innervated by appropriate cell types or 
brain regions (Boucard et al., 2005; Krueger et al., 2012). Considering that the total number of splice 
isoforms is 12 for NLs but amounts to several thousand for neurexins, it is clear that other postsynaptic 
proteins have to be involved, possibly in a combinatorial manner together with NLs, to account for the 
specificity of the vast amount of neuronal circuits in the brain (Baudouin and Scheiffele, 2010). In 
order for DG to be part of a molecular code which coordinates the specificity of synapse formation, 
two requirements have to be met, apart from the observed synapse specificity of DG itself. First, 
presynaptic binding partners have to show a selective, cell type-specific distribution. These binding 
partners might be neurexins or other laminin-alpha, neurexin and sex hormone-binding globulin 
(LNS)-domain containing proteins such as agrin or pikachurin. The second requirement is that DG 
exhibits selective interactions with presynaptic binding partners. Studies which have addressed these 
issues allow for an assessment whether the two criteria are met. The hypothesis of interneuron-specific 
expression of neurexin splice variants was recently tested using single cell quantitative PCR (qPCR) 
(Fuccillo et al., 2015). Overall, neurexin1α and neurexin3 levels were found to be much more 
abundant in CCK-positive than in PV-positive cells, suggesting a larger dependence of CCK-positive 
basket cells on neurexin for synapse specification. Among neurexin1 mRNA, only CCK-positive 
basket cells exhibited substantial amounts of neurexin1 transcripts that lack splice inserts 2, 3 and 4. 
This finding is in striking accordance with the biochemical investigation of DG-neurexin interaction, 
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which revealed that LNS domains 2 and 6 in neurexin1 are DG binding partners only in the absence of 
inserts at splice sites (SS) 2 and 4, respectively (Sugita et al., 2001). If neurexin1 is indeed the 
presynaptic DG binding partner in this context, the cell type-specific alternative splice programs of 
basket cells might be sufficient to ensure that DG trans-synaptic signaling is restricted to CCK-
positive cells. Together with the perisomatic distribution of the DGC in pyramidal cells, this 
mechanism might hinder axon terminals from other interneuron classes to form or maintain synapses 
containing the DGC. Alternatively, other interneuron classes might employ an active mechanism to 
avoid interaction of neurexin1 lacking inserts at SS2 and SS4 with DG. Neurexophilin is a neurexin-
interacting protein that binds to neurexin1 at SS2, thereby inhibiting the interaction of neurexin1 with 
DG at SS2 (Missler et al., 1998; Reissner et al., 2014). The expression pattern of neurexophilin is in 
agreement with a limited distribution in a subset of interneurons in the hippocampus and cerebral 
cortex (Petrenko et al., 1996). Furthermore, neurexophilin displays the domain structure and PTMs 
typical of a secreted protein (Petrenko et al., 1996; Missler and Sudhof, 1998). It is therefore 
conceivable that locally secreted neurexophilin acts as an inhibitor of DG-neurexin1 trans-synaptic 
signaling. 
Based on the interneuron subtype-specific distribution of neurexin isoforms, matching DG binding 
preferences, and the interneuronal expression of neurexophilin, it is tempting to posit that this diversity 
underlies subtype-selectivity of DG function. However, in the light of the unaltered CCK-positive 
terminals in DG T190M KI mice, the notion of a combinatorial code arising from these molecules 
remains speculative. Hara et al. (2011) demonstrated that neurexin (and laminin) binding capacity of 
DG T190M is dramatically reduced, both in DG isolated from brain and from muscle. Still, only 
neurexin1α was tested in these assays (Kevin P. Campbell, personal communication). This leaves open 
the possibility that the interactions with neurexin2 and neurexin3, which bind to wildtype DG, are not 
affected by the T190M mutation (Sugita et al., 2001). It is also not clear whether residual binding of 
neurexin1α to DG T190M might be sufficient for DG function at CCK-positive terminals. 
Still, results from T190M KI mice call for the consideration of other molecules as presynaptic 
receptors of DG to mediate its trans-synaptic function. Only few other DG binding partners were 
described to date, including laminin, perlecan, pikachurin and agrin, all of which primarily act as 
secreted proteins in the ECM (Sato et al., 2008; Waite et al., 2012). Although laminin and perlecan 
were found to serve important functions in the nervous system, their distribution and mode of action 
make these ligands unlikely to mediate trans-synaptic signaling (Jucker et al., 1996; Farach-Carson et 
al., 2014; Yao et al., 2014). In contrast, pikachurin is the first DG ligand for which a function in CNS 
synapses was described (Sato et al., 2008; Omori et al., 2012). Both DG and pikachurin are necessary 
for normal development and function of ribbon photoreceptor synapses in the retina. However, in the 
ribbon synapse, DG is localized presynaptically and pikachurin is released into the ECM, where it 
binds to α-DG. It is therefore likely, that in addition, a postsynaptic receptor is required for this 
function. Together with the observation that pikachurin expression in the brain is almost undetectable 
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in the brain, these findings do not suggest a function of pikachurin as a presynaptic receptor in the 
forebrain. 
Several lines of evidence render agrin a better candidate for the role of DG presynaptic receptor. Agrin 
binds to DG and is important for postsynaptic differentiation and maturation at the NMJ (Sugiyama et 
al., 1994; Shi et al., 2012). Furthermore, a transmembrane form of agrin is highly expressed in the 
brain, which might serve functions for which its secreted counterpart might not be suited (Daniels, 
2012). On the basis of experiments using recombinant agrin in primary hippocampal cultures, agrin 
was reported to induce homeostatic upscaling of GABAergic synapses through DG (Pribiag et al., 
2014). Whether these results reflect a physiological plasticity mechanism for synaptic scaling in vivo 
is not clear, especially because the interneuron subtype-specific innervation central to DG trans-
synaptic function is lost in dissociated cultures. Furthermore, a function of DG in homeostatic 
plasticity of postsynaptic GABAergic proteins is in stark contrast with the present finding that 
clustering of GABAergic PSD proteins in DG-ablated mice is almost unaffected. The increased 
synaptic localization of DG upon agrin application is, however, consistent with an interdependence of 
both factors for trans-synaptic signaling. Examination of markers specific for CCK-positive terminals 
in brain tissue deficient in agrin will elucidate the role of agrin in GABAergic synapses on pyramidal 
cells. 
The wealth of DG binding partners, serving different tasks in different tissues, highlights that 
molecules that were not yet described as DG interactors should not be excluded as potential DG 
receptors in CCK-positive basket cell synapses. The Roundabout (Robo) receptor Slit was added to the 
list of DG interacting proteins when mutations in DG glycosyl transferases revealed the involvement 
of DG in aggregating Slit in the spinal cord floor plate (Wright et al., 2012). Mice carrying the same 
mutations also have deficits in axon guidance in the forebrain, as axons of the internal capsule show 
abnormal trajectories (Wright et al., 2015). Because these deficits resemble the phenotype of mice 
lacking Cadherin EGF LAG seven-pass G-type receptor 3 (Celsr3), and because Celsr3 contains two 
LNS domains, Celsr3 might act as a presynaptic DG receptor in this context (Tissir et al., 2005). 
Similarly, Celsr3 is a candidate DG receptor at CCK-positive terminals to mediate trans-synaptic 
signaling. The availability of Celsr3 floxed and CCK-Cre mouse lines allows the conditional ablation 
of Celsr3 in CCK-positive interneurons to test this hypothesis (Zhou et al., 2008; Taniguchi et al., 
2011). 
The integrity of CCK-positive terminals in DG T190M KI mice implies that post-phosphorylation 
glycosylation is not essential for DG function at CCK-positive terminals. On the other hand, these 
mice display muscle weakness and reduced NMJ size (Hara et al., 2011). This illustrates that distinct 
glycosyl modifications on α-DG are required for different functions. Considering the diversity of DG 
glycosyl transferases and the complexity of DG glycosylation, these modifications might themselves 
contribute to synaptic diversity. By cell type-selective expression of glycosyltransferases, 
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glycosylation of DG and other postsynaptic proteins such as NLs might thus generate postsynaptic 
molecular heterogeneity, matching the diversity of presynaptic adhesion molecules. 
DG requirement for functional innervation by CCK-positive basket cells in 
adulthood points towards continuous trans-synaptic signaling 
Ablation of neuronal DG in adult mice led to the unsuspected finding that DG is necessary after initial 
synapse formation for synapse maintenance. Two mechanisms (or a combination of both) may 
underlie the continuous requirement of DG during adulthood. The DGC may mediate continuous 
trans-synaptic, retrograde signaling which is essential for the function of CCK-positive axon terminals. 
Alternatively, the DGC could serve a structural function, ensuring CCK-positive terminals are aligned 
properly with GABAergic PSDs. Because of continuous synapse turnover in adulthood, the latter 
hypothesis may involve a structural role in maintenance of synapses or only in formation of synapses. 
Deficits in formation of new synapses during adulthood thus may be sufficient for loss of functional 
innervation by CCK-positive basket cells, due to an imbalance of synapse formation and elimination. 
The results of several independent experiments point towards a role of the DGC in trans-synaptic 
signaling rather than in structural integrity of CCK-positive basket cell synapses. Although markers 
for CCK-positive terminals, which constitute a substantial part of GABAergic terminals in the 
pyramidal layer of the hippocampus (Nyiri et al., 2001), were almost completely lost in DG cKO mice, 
general markers of GABAergic terminals were not affected. VGAT and GAD showed neither a 
reduction in puncta size not density, which would be expected from the structural loss of CCK-
positive terminals. Furthermore, the idea that PV-positive axons sprout and compensate for the lack of 
CCK-positive terminals does not hold, since PV immunolabeling as well as the fraction of PV puncta 
colocalized with VGAT was unaltered by DG ablation. Mdx mice display a reduction of CB1 and 
VGluT3 immunoreactivity in CA1 pyramidal layer, indicating that dystrophin is part of trans-synaptic 
signaling through DG (Krasowska et al., 2014). Again, PV immunolabeling in CA1 pyramidal layer 
was unaltered in these mice. There is evidence to suggest that PV-positive somata are more abundant 
in the hippocampus of mdx mice (Del Tongo et al., 2009; Krasowska et al., 2014). However, since 
also interneurons other than basket cells express PV and because no changes were seen in PV 
immunolabeling in the pyramidal layer, whether this increase represents a compensatory upregulation 
of PV-positive basket cells is questionable. Furthermore, no major differences were found in density 
of symmetric synapses between mdx and wildtype mice on the ultrastructural level, reinforcing the 
notion that reduction of CCK-positive terminals is not accompanied by a structural loss of synapses 
(Graciotti et al., 2008; Miranda et al., 2009). Finally, no alterations of PV or GAD immunolabeling in 
CA1 pyramidal layer were found in an epilepsy model, despite the loss of CCK-positive terminals 
(Wyeth et al., 2010). 
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If the absence of CCK-positive terminal markers does not imply synapse loss, then the compromised 
function of these synapses represents a conundrum. Electrophysiological recordings from pyramidal 
cells established that inhibitory drive is blunted in DG-ablated cells, and the inefficiency of CCh to 
elevate IPSC frequency suggested that this reduction is due to dysfunction of CCK-positive terminals. 
Under the assumption that loss of CCK-positive terminals is not paralleled by structural synaptic 
changes, trans-synaptic signaling through the DGC must thus be essential for normal synaptic 
transmission at these terminals. All interneuron subtype-specific markers analyzed for CCK-positive 
cells (CCK, CB1, VGluT3) were drastically reduced in hippocampus pyramidal layer of DG cKO 
mice. Also, an increase of immunolabeling of these markers in other areas was not evident, arguing 
that mislocalization of these proteins is not the cause for the absence of immunolabeling in the 
pyramidal layer. Even more surprisingly, the amount of CCK-positive somata in the hippocampus of 
DG cKO mice was reduced to around half the density found in control mice, and the staining intensity 
of immunopositive cells in cKO mice was decreased. Assuming that ablation of DG does not lead to 
synapse or cell loss, these results suggest that DG trans-synaptic signaling is involved in maintaining a 
specific expression profile in CCK-positive cells, aimed to uphold transcription of synaptic proteins 
essential for function of CCK-positive terminals. 
Testing of this hypothesis is hindered by several difficulties. First, it would require to conclusively 
demonstrate that neuronal DG ablation does not lead to morphological changes in axon terminals and 
somata of CCK-positive basket cells. This might be approached in DG cKO mice by ultrastructural 
analysis of inhibitory synapses and ectopic expression of a marker protein in CCK-positive basket 
cells. However, untangling structural from transcriptional changes represents a challenge because the 
expression of marker proteins by promoters specific for CCK-positive cells might be blunted in DG-
ablated mice due to the loss of DG trans-synaptic signaling. Thus, it would be difficult to distinguish 
whether the reduction in a CCK-driven fluorescent protein in DG cKO mice is due to reduced 
transcription or due to cell loss. Therefore, this approach would require the expression of a marker 
protein in CCK-positive basket cells under the control of a constitutive promoter, for instance with the 
help of a CCK-driven Cre recombining a floxed stop cassette. Combined with the concurrent ablation 
of DG in pyramidal cells, this approach might faithfully visualize morphology of (formerly) CCK-
positive basket cells. Secondly, expression profiles of CCK-positive cells would have to be analyzed 
to demonstrate that genes specific for this interneuron class are downregulated. Using the same 
technique of ectopic expression of a marker protein, fluorescence-assisted cell sorting followed by 
qPCR or RNA sequencing could be employed to characterize expression profiles of CCK-positive 
cells. Finally, the mechanism of retrograde signaling from CCK-positive terminals to transcriptional 
regulators in the cell soma would have to be elucidated. For this, the presynaptic binding partner of 
DG and the associated signaling pathway would have to be identified. 
The involvement of GABAergic PSD proteins in synaptic maintenance was only recently addressed by 
ablation of NL2 in the prefrontal cortex of adult mice (Liang et al., 2015). Similar to loss of DG, NL2 
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ablation in adulthood caused a reduction of a presynaptic marker over several weeks. However, the 
decrease of GAD65 puncta density indicates that NL2 is necessary for the maintenance of all 
GABAergic terminals, and does not exhibit the interneuron subtype-specific function found for DG. 
General phenotype of DG cKO mice and potential off-target effects 
The use of the NEX-Cre driver line for ablation of neuronal DG resulted in cKO mice with a 
compromised physical constitution. DG cKO mice were smaller and displayed reduced body and brain 
weight compared to control mice. Furthermore, an increased mortality rate was noted for DG-deficient 
mice. 
The occurrence of this systemic phenotype was unexpected because of the specificity of the NEX 
promoter. NEX expression is restricted to the CNS, and is specific to principal neurons within cerebral 
hemispheres (Bartholoma and Nave, 1994; Schwab et al., 1998). Replacement of the coding region of 
NEX with the Cre recombinase expression cassette did not change the limited expression of this locus 
(Goebbels et al., 2006). Western blot analysis revealed similar DG levels in muscle of DG cKO and 
control mice, providing evidence that muscle DG was indeed not affected by NEX-Cre mediated 
ablation of DG. However, to rule out subtle anatomical changes due to residual NEX expression in 
muscle, histological and immunohistochemical analysis of muscle tissue should be performed. 
Close examination of NEX-Cre expression pattern using mice harboring a floxed β-Galactosidase as a 
reporter line reveals that weak NEX expression is present in brain areas outside the cerebral cortex 
(Goebbels et al., 2006). These areas include small cell populations in the olfactory bulb, amygdala, 
cerebellum and in the brainstem. Since DG expression partly overlaps with these areas, it is 
conceivable that weak Cre expression leads to ablation of DG in these cells. For instance, DG was 
localized to the mitral cell layer in the olfactory bulb, and to the pontine nucleus, where Cre 
expression was detected (Zaccaria et al., 2001; Goebbels et al., 2006). NEX expression was further 
demonstrated in the amygdala, a region where dystrophin and thus presumably also DG is expressed 
(Sekiguchi et al., 2009). The function of the DGC in these brain areas is unknown at the moment, and 
the consequences of the putative ablation of DG therefore remain elusive. However, it is possible that 
the use of the NEX-Cre driver line leads to cognitive and behavioral deficits which are caused by DG 
ablation in brain neurons outside of the cerebral hemispheres. 
NEX expression was further demonstrated in the developing and adult spinal cord (Goebbels et al., 
2006). The essential role of DG in binding Slit, an essential axon guidance protein for midline crossing 
of commissural axons, suggests that this function might be compromised in DG cKO mice. However, 
DG is localized mostly in the floor plate, in contrast to the diffuse distribution of NEX primarily in the 
dorsal horn. Therefore, it seems unlikely that ablation of DG in the spinal cord is the cause of the 
deficits in physical constitution of DG cKO mice. 
In the light of the reduced size of DG cKO mice and of the crucial role of DG for CCK-positive 
interneurons, it is striking that CCK is a regulator of satiety. CCK is released in the small intestine in 
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response to food intake and acts as a satiety signal and to increase the release of digestive enzymes. 
However, in the CNS, CCK acts locally over activation of CCKB receptors, in contrast to CCKA 
receptors which are abundant in the periphery and more relevant for the regulation of food intake 
(Noble et al., 1999). In addition, CCK action in the brain was connected to anxiety and cognitive 
functions, but not directly to the control of satiety. The idea that a compensatory upregulation of CCK 
release and therefore increased satiety signaling accounts for the smaller size of cKO mice therefore 
does not hold. 
After considering potential off-target effects of neuronal DG ablation, the notion that behavioral 
deficits arise from the loss of CCK-positive terminals on pyramidal cells emerges as a plausible 
possibility. As CCK-positive interneurons make up around half of all basket cells, dysfunctional 
neurotransmission from CCK-positive cells would be expected to have a dramatic impact on cognition 
and behavior (Whissell et al., 2015). Indeed, essential functions of CCK-positive interneurons in 
synaptic plasticity and for network activity were described (Bartos and Elgueta, 2012). Whether 
disruption of neurotransmission from CCK-positive terminals causes the reduced body size by social 
rejection in competition with littermates in the home cage or whether the phenotype arises from 
intrinsic causes remains to be determined. To address this question, DG cKO and control mice should 
be separated at birth or at the time of weaning and their development monitored. If the deficits in 
physical constitution persist despite genotypical separation, social rejection could be excluded as the 
sole cause. Still, intrinsic factors might be attributed to dysfunctional neurotransmission from CCK-
positive basket cells or to other, nonspecific deficits, or to a combination thereof. 
NEX-Cre DG cKO mice as a model to study function of CCK-positive 
interneurons 
The specific and complete loss of immunohistochemical markers and the reduced inhibitory drive in 
pyramidal cells of DG cKO mice point towards the dysfunction of CCK-positive basket cells. Further 
physiological and morphological characterization of CCK-positive basket cells in DG cKO mice will 
have to be carried out to confirm the completeness of this loss-of-function. If subsequent studies 
validate this notion, NEX-Cre DG cKO mice represent a powerful model to study the contribution of 
CCK-positive basket cells to brain function. 
Various roles were ascribed to CCK-positive basket cells in cortical neuronal circuits, many of which 
are connected to the interneuron class-defining proteins that are exclusively expressed by this cell 
type. For instance, the presence of VGluT3 in CCK-positive terminals is unique among GABAergic 
interneurons and is thought to serve the corelease of glutamate with GABA (Somogyi et al., 2004; 
Stensrud et al., 2013; Stensrud et al., 2015). The terminal release of CCK is another speciality of 
CCK-positive basket cells, and has far-reaching implications for the activity of neighboring PV-
General discussion 
101 
positive cells (Lee and Soltesz, 2011). The impact of the lost CCK-positive terminals could be tested 
by examining compensatory changes of CCKB receptors on PV-positive basket cells, for instance. 
The presence of CB1 receptors on axon terminals of CCK-positive basket cells is a further defining 
feature. Disinhibition through endocannabinoids by silencing GABA release from CCK-positive 
basket cells, known as DSI, is activity-dependent. During gamma activity, which is promoted by 
exploratory behavior, CCK-positive basket cells fire in a phase-locked manner shortly before the peak 
of the oscillation (Tukker et al., 2007). When pyramidal cells, acting as place cells, increase action 
potential frequency, this might trigger the release of endocannabinoids and locally lead to DSI 
(Leutgeb et al., 2007). The resulting disinhibition from CCK-positive terminals might cause place cells 
to fire in a phase-shifted rhythm, relative to surrounding pyramidal cells. This process, which is likely 
to play an important role in spatial navigation, is predicted to be disrupted in DG cKO mice. 
Behavioral testing as well as correlating pyramidal cell activity to population activity in the 
hippocampus of DG cKO mice might elucidate the dependence of this mechanism on CCK-positive 
interneurons. 
Oscillatory activity patterns correlate with distinct behaviors and interneuron firing patterns, including 
those from CCK-positive basket cells, are aligned with oscillations in vivo (Klausberger et al., 2005; 
Klausberger and Somogyi, 2008). Therefore, there is a large interest in identifying the cell types and 
physiological processes that generate oscillations. The mechanisms underlying generation of theta 
oscillations in different subfields of the hippocampus are still controversial, but there is evidence 
suggesting a crucial role of CCK-positive basket cells. PV-positive basket cells seem to be heavily 
involved in generation of rhythmic activity patterns, especially in CA3 (Gulyas et al., 2010; Amilhon 
et al., 2015). However, theta oscillations induced by the AChR agonist CCh are sensitive to DSI, 
which is mediated by activation of CB1 receptors (Pitler and Alger, 1992). Furthermore, CCh-induced 
neuronal firing in CA1 is strongly attenuated by CB1 agonists, showing the dependence of this 
rhythmic activity on CB1-containing terminals more directly (Wyeth et al., 2010). Along the same 
lines, only optogenetic inhibition of CCK-positive but not of PV-positive basket cell activity resulted 
in the loss of CCh-induced oscillatory activity (Nagode et al., 2014). The finding that, in contrast to 
control mice, sIPSC frequency could not be increased by CCh application in DG cKO mice, confirms 
therefore that CCK-positive terminal function is disrupted in DG cKO mice. Conversely, this finding 
also highlights that NEX-Cre DG cKO mice represent a unique opportunity to study the contribution 
of CCK-positive basket cells to theta oscillations in vivo, without the need for pharmaceutical 
manipulations. Therefore, spectral analysis of surface electroencephalogram or local field potential 
recordings in DG cKO mice might reveal clues about the role of CCK-positive basket cells in 
generation of oscillatory activity patterns. 
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Clinical implications of DG-CCK-positive basket cell interconnection 
Conditional ablation of DG in principal neurons of the forebrain represents an unphysiological 
manipulation, which does not directly correspond to any known disease. However, by unraveling the 
importance of DG for CCK-positive terminals, the results of this experimental approach are likely to 
shed light on the neuronal circuits that are compromised in patients with genetic defects in DGC 
components. 
The partly severe ID exhibited by muscular dystrophy patients without associated brain malformations 
indicates that neuronal DG serves essential functions for normal cognition. DG T190M KI mice are a 
model for dystroglycanopathy patients carrying the DG T192M mutation (Hara et al., 2011). Since 
these patients suffer from severe ID despite lacking gross neuroanatomical alterations, the DG T190M 
KI mice might represent the disease model most closely resembling the situation in DG cKO mice 
(Dincer et al., 2003). The integrity of CCK-positive terminals in KI mice was therefore unexpected. 
However, the presence of immunohistochemical markers does not exclude the possibility that CCK-
positive terminals are dysfunctional in this model. DG binding to an unknown presynaptic molecule, 
important for maintenance of CCK-positive terminals, might be intact in T190M KI mice. Still, it is 
conceivable that, in addition, neurexin binding is necessary for normal neurotransmission from CCK-
positive terminals, leading to cognitive dysfunctions. Electrophysiological characterization of 
pyramidal cells in T190M KI mice, with a focus on inhibitory input received from basket cells, might 
therefore serve as a starting point in the search for the physiological basis of ID in this group of 
patients. 
It is likely that the DG-CCK interconnection is also relevant in the etiology of ID in 
dystrophinopathies. A reduction in CB1 and VGluT3 immunoreactivity was found in mdx mice, 
hinting at a role for dystrophin in trans-synaptic signaling (Krasowska et al., 2014). In this context, it 
will be instructive to examine the integrity of CCK-positive terminals in DG βcyt/βcyt mice, which 
lack the intracellular part of DG (Satz et al., 2010). If deficits in CCK-positive basket cell markers in 
mdx mice and in brain biopsies of DMD patients confirm a role for dystrophin in this signaling 
pathway, brain alterations associated with DMD might have to be reinterpreted in the light of this new 
role. For instance, an increase in choline-containing compounds was reported in DMD patients and in 
mdx mice (Kato et al., 1997; Parames et al., 2014). These differences might represent compensatory 
changes in response to altered function or abundance of CCK-positive basket cells. This hypothesis is 
especially compelling considering the importance of cholinergic activation of CCK-positive 
interneurons for generating theta oscillations (Cea-del Rio et al., 2010). Thus, special emphasis should 
be put on spectral power analyses of population recordings in dystrophinopathy patients and animal 
models. 
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DG and synArfGEF serve independent functions 
Their biochemical interaction, colocalization and lack of knowledge of their functional role in the 
GABAergic PSD was part of the rationale to study the DGC and synArfGEF in parallel (Fukaya et al., 
2011). A role for both proteins in subcellular domain-specific regulation of GABAergic PSDs was 
suggested by the following observations. First, the DGC displays a preferentially perisomatic 
distribution in pyramidal cells. Secondly, in GABAAR α2 subunit KO mice, NL2 clustering is 
compromised only in dendritic but not in somatic regions (Panzanelli et al., 2011). Together with the 
report of a specific requirement of NL2 in CA1 pyramidal layer for GABAergic PSD clustering 
(Poulopoulos et al., 2009), these findings suggested a common role for the DGC, NL2 and possibly 
synArfGEF in regulation of perisomatic GABAergic PSDs. This notion was further strengthened by 
experiments demonstrating that the scaffolding protein S-SCAM can bind to DG, NL2 and synArfGEF 
(Sumita et al., 2007; Fukaya et al., 2011). Finally, synArfGEF expression is induced by the 
transcription factor NPAS4, which regulates GABAergic PSD clustering in a layer-specific manner in 
the hippocampus (Bloodgood et al., 2013). 
Under the premise that synArfGEF builds part of an extended DGC at perisomatic GABAergic 
synapses, synArfGEF clustering was examined in DG cKO mice. The unexpected result that 
synArfGEF clustering in CA1 pyramidal layer was not substantially different in cKO mice, 
demonstrates that the dystrophin-synArfGEF interaction is not necessary for synaptic targeting of 
synArfGEF. The detailed study of synArfGEF colocalization with GABAergic markers revealed that 
gephyrin immunolabeling was most thoroughly overlapping with the synArfGEF staining pattern 
(Sakagami et al., 2013). Biochemical interaction with gephyrin might therefore be essential for 
postsynaptic clustering of synArfGEF. Indeed, in primary hippocampal cultures, gephyrin 
downregulation was paralleled by a drastic reduction of synArfGEF clustering (Um et al., 2016). 
The initial description of synArfGEF-dystrophin colocalization was based on the 
immunocytochemical analysis of low-density dissociated hippocampal cultures (Fukaya et al., 2011). 
In this preparation, where neurons are separated from an astrocyte feeder layer, the neuronal DGC is 
present in large perisomatic clusters (Brunig et al., 2002; Levi et al., 2002). However, in mixed high-
density hippocampal cultures, as used for synArfGEF experiments in this thesis, immunolabeling of 
DGC components was extremely sparse and generally restricted peripheral areas, which were not 
covered by astrocytes completely (unpublished observation). For this reason, the function of 
synArfGEF in regulation of mismatched GABAergic PSDs is likely independent of the DGC. The 
observation that mutation of the dystrophin-interaction motif in synArfGEF did not affect synArfGEF 
distribution further supports this assumption. 
Still, the presence of a WW domain interaction motif in synArfGEF, together with the colocalization 
in low-density cultures, argues that interaction with dystrophin serves a physiological function in the 
GABAergic PSD. Dystrophin interaction might substitute the binding of synArfGEF to S-SCAM in 
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synapses containing the DGC. Whether interaction with dystrophin has an inhibitory or inducing effect 
on synArfGEF catalytic function is unknown. However, it is tempting to speculate that in synapses of 
CCK-positive terminals, there is a necessity to dampen synArfGEF activity, due to the putative 
corelease of glutamate and the subsequent increase in intracellular Ca2+ concentrations, which would 
otherwise lead to excessive synArfGEF activity. 
Selectivity for GABAergic proteins in regulation of PSD apposition by 
synArfGEF 
The results of overexpression and ablation experiments demonstrated a role for synArfGEF in the 
regulation of GABAergic PSD proteins which are mismatched with glutamatergic presynaptic 
terminals. Neither correctly apposed GABAergic PSD proteins nor glutamatergic PSD proteins were 
affected by manipulation of synArfGEF expression levels. The specificity of this regulation provides 
clues about the mechanism of synArfGEF-mediated regulation of PSD proteins. 
Sec7 mutant overexpression did not affect the density of correctly apposed GABAergic PSDs. 
Assuming that overexpression of this mutant resulted in the complete blocking of synArfGEF catalytic 
activity, this finding suggests that under physiological conditions, synArfGEF is catalytically inactive 
in correctly apposed GABAergic PSDs or that catalytic activity does not impact clustering of PSD 
proteins in these synapses. Two scenarios are conceivable to explain the selectivity of synArfGEF 
function to mismatched GABAergic PSDs. A factor exclusively located at correctly matched PSDs 
might inhibit synArfGEF or its effectors. Alternatively, signaling or proteins specific to mismatched 
GABAergic PSDs are necessary for synArfGEF function. Because neuronal activity is crucial for 
transmitter-specific alignment of synaptic structures, any such factor is likely to undergo activity-
dependent modulation (Anderson et al., 2004; Cesa et al., 2008). Glutamate release at mismatched 
GABAergic PSDs might activate extrasynaptic NMDA receptors, presumably leading to high Ca2+ 
concentrations during neuronal activity. Since calmodulin binds to synArfGEF specifically in low Ca2+ 
concentrations, calmodulin represents a likely candidate to take the role of an activity-dependent 
modulator of synArfGEF function. 
Thus, to induce synArfGEF catalytic activity at synaptic sites, two conditions might have to be met. 
First, gephyrin has to be present in the PSD. This conclusion is inferred from the finding that 
synArfGEF catalytic activity does not affect PSD-95 apposition and from the observation that 
gephyrin downregulation interferes with synArfGEF clustering (Um et al., 2016). Whether gephyrin 
serves only to accumulate synArfGEF at GABAergic PSDs or whether gephyrin binding itself is 
necessary for activation of synArfGEF remains unclear. To address this question, a Sec7 mutant 
construct lacking the N-terminal CC domain should be examined for the capacity to increase the 
density of mismatched GABAergic PSDs, similar to the Sec7 mutant construct. Secondly, Ca2+ influx 
due to glutamate release at mismatched gephyrin-containing PSDs might lead to the dissociation of 
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calmodulin and synArfGEF, thereby facilitating synArfGEF catalytic activity. In addition, increases in 
Ca2+ concentration might lead to the activation of other Ca2+-dependent enzymes. 
A model in which both the presence of gephyrin and the Ca2+-dependent unbinding of calmodulin are 
crucial for synArfGEF function is complicated by evidence suggesting that synArfGEF might bind to 
these proteins in a competitive manner. The gephyrin binding site on synArfGEF is in close proximity 
to the IQ motif, which was found to be essential for apocalmodulin binding. Furthermore, deletion of 
the N-terminal CC domain, which has a putative role in synArfGEF dimerization (Myers et al., 2012), 
revealed that synArfGEF binding to gephyrin and to calmodulin might represent different 
conformational states. The ΔN construct exhibited weaker interaction with gephyrin, whereas the 
binding to calmodulin was enhanced by deletion of the N-terminus. The existence of an inactive 
synArfGEF-gephyrin-apocalmodulin complex therefore seems unlikely. Rather, experimental 
evidence points to a dimeric gephyrin-interacting state and a monomeric apocalmodulin-interacting 
state. 
If release of calmodulin from synArfGEF is sufficient to induce synArfGEF catalytic activity, then the 
IQ mutant, which lacks calmodulin binding capacity, would be predicted to act as a constitutively 
active mutant. However, overexpression of the IQ mutant did not lead to a reduction of mismatched 
GABAergic PSDs. Under the assumption that this result is not due to intrinsic properties of the 
neuronal cultures examined or due to technical artifacts (setting a lower limit on the density of 
mismatched synapses, for instance because of technical limitations such as the resolution of confocal 
microscopy), this finding suggests that additional steps are necessary to induce the catalytic function 
of synArfGEF in mismatched GABAergic PSDs. Residues on synArfGEF which are accessible for 
posttranslational modification only if calmodulin is not bound might represent such a switch to 
activate synArfGEF catalytic function after release of calmodulin. Strikingly, S348 was identified as a 
phosphorylation site and because of the proximity to the IQ motif, the dependence of modification of 
this site on calmodulin release is plausible (Trinidad et al., 2006). The kinases catalyzing 
phosphorylation of S348 in synArfGEF were not yet identified and thus pharmacological approaches 
to test the relevance of this PTM are tedious. However, overexpression of S348 point-mutated 
constructs in primary hippocampal neurons will reveal whether modification of this site is essential for 
regulation of mismatched GABAergic PSDs by synArfGEF. 
Molecular mechanisms underlying synArfGEF-mediated GABAergic PSD 
regulation 
The Sec7 mutation is expected to abrogate catalytic activity of synArfGEF, based on experiments 
which systematically tested the effect of mutations on catalytic activity in proteins containing a highly 
homologous Sec7 domain (Beraud-Dufour et al., 1998; Cherfils et al., 1998; Myers et al., 2012). 
However, conflicting results were reported for the specificity of synArfGEF to Arf1 or to Arf6. While 
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human synArfGEF was found to display specificity to Arf1, specific catalytic activity for Arf6 was 
demonstrated for the rat isoform (Hattori et al., 2007; Fukaya et al., 2011). Besides the fact that the rat 
isoform was used for overexpression experiments, there is additional evidence to suggest that the 
regulation of mismatched GABAergic PSDs by synArfGEF is mediated by Arf6. First, overexpression 
of Arf6 mutants recapitulated the increase in density of mismatched GABAergic PSDs found with 
overexpression of the Sec7 mutant. Secondly, IQSEC1 and IQSEC2, the closest synArfGEF 
homologs, exhibit strongest catalytic activity for Arf6 (Someya et al., 2001; Sakagami et al., 2008; 
Moravec et al., 2012). Finally, Arf6 is the only member of Arf GTPases which cycles between a 
plasma membrane-bound and a endosome-bound form (Peters et al., 1995; D'Souza-Schorey and 
Chavrier, 2006). Other Arf members are predominantly located in ER or Golgi compartments. 
Therefore, Arf6 is predestined to act at synapses due to its subcellular localization. 
Neuronal morphology is controlled by Arf6 through two basic, interconnected mechanisms. On one 
hand, Arf6 regulates membrane trafficking by directly activating phospholipase D (PLD) and 
phosphatidylinositol-4-phosphate 5-kinases (PIP5K). This leads to an increase in phosphatidic acid 
(PA) and phosphatidylinositol bisphosphate (PIP2) production. PIP2, in turn, promotes clathrin-
dependent endocytosis by recruiting AP2 as well as clathrin-independent endocytosis (Brown et al., 
2001; Krauss et al., 2003; Paleotti et al., 2005). On the other hand, Arf6 is involved in regulation of 
actin dynamics. The actin cytoskeleton is impacted by Arf6 activity because of the rise in PIP2, which 
regulates actin dynamics, but also due to the ability of Arf6 to activate the GTPase Rac1 
(Radhakrishna et al., 1999; Yin and Janmey, 2003; Santy et al., 2005). Determining whether Arf6 
activity mainly affects membrane trafficking or actin dynamics in a given context is difficult, because 
both processes are interdependent. Not only is PIP2 involved in regulation of actin polymerization, but 
actin plays an important role in endocytosis as well. 
SynArfGEF-mediated Arf6 activation might thus regulate mismatched GABAergic PSDs by 
modulating actin dynamics or by promoting membrane internalization. Since the actin cytoskeleton is 
not necessary for gephyrin clustering in mature neurons, this regulation is unlikely to rely solely on 
modulation of actin dynamics (Allison et al., 2000). Therefore, the involvement of membrane 
internalization, possibly by GABAAR endocytosis, should be examined. This hypothesis could be 
tested by distinct labeling of cell surface and intracellular pools of GABAAR subunits in primary 
neurons overexpressing wildtype or Sec7 mutant synArfGEF (van Rijnsoever et al., 2005). 
Furthermore, viral overexpression or ablation of synArfGEF in primary neuronal cultures in 
combination with surface biotinylation and immunoblotting of transmembrane proteins might reveal 
differences in the fraction of GABAARs located at the cell membrane. This approach also allows to 
screen for other transmembrane proteins which are potentially targeted for internalization by 
synArfGEF. 
If synArfGEF-induced activation of Arf6 leads to endocytosis of transmembrane proteins at 
mismatched GABAergic PSDs, the question how specificity for these proteins is ensured remains. The 
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interaction and colocalization of gephyrin with profilin 2A might serve as a starting point to address 
this question (Mammoto et al., 1998; Giesemann et al., 2003). Profilins bind to proteins regulating 
endocytosis, such as clathrin and dynamin, in the mouse brain, and in addition serve important 
functions in actin polymerization (Witke et al., 1998; Birbach, 2008). The idea that profilin 2A might 
accumulate proteins in the GABAergic PSD which play a role in synArfGEF-mediated endocytosis of 
GABAergic transmembrane proteins is further supported by the finding that neuronal activity 
promotes the synaptic localization of this protein (Murk et al., 2012). 
Putative physiological functions of synArfGEF 
The extensive and specific expression of synArfGEF in the CNS, association with important 
GABAergic PSD proteins and the function of close homologs in glutamate receptor subtype-specific 
regulation of synaptic strength suggest that synArfGEF serves important functions in the brain. The 
mechanisms preventing the formation of mismatched GABAergic PSDs in vivo were not explored to 
date, possibly due to the lack of mutants exhibiting such a phenotype. However, because synaptic 
structures are more densely packed in intact neural tissue than in dissociated neuronal cultures, the 
conclusive demonstration of synaptic misalignment in vivo is substantially more laborious. The fact 
that mismatched GABAergic PSDs were not yet described in intact brain tissue might thus be caused 
be these technical difficulties, which hampered the systematic search for mismatched synapses. 
GABAergic presynaptic structures were observed on glutamatergic postsynaptic structures such as 
spines in vivo, under blockade of neuronal activity (Cesa et al., 2008). Together with the newly 
uncovered role of synArfGEF in regulation of mismatched GABAergic PSDs, these findings urge the 
investigation of potential molecular mechanisms underlying mismatched GABAergic PSDs in the 
brain. To study the putative role of synArfGEF in alignment of GABAergic postsynaptic proteins with 
presynaptic terminals in vivo, synArfGEF KO mouse models will be instrumental. In addition, 
overexpression of synArfGEF mutations during development might be employed to unravel the 
functions of individual domains in this process.  
Transcriptomic analysis of cortical tissue revealed that synArfGEF is one of only two genes which is 
downregulated in schizophrenia, autism and bipolar disorder patients in comparison to control groups 
(Ellis et al., 2016). Even if these changes represent compensatory alterations rather than a common 
etiology of these neuropsychiatric disorders, this striking finding points towards a physiological role of 
synArfGEF in the human brain. Mutations in IQSEC2, for which a function in GluA1-specific 
internalization of AMPA receptors and in LTD was demonstrated, were implicated in X-linked ID 
(Morleo et al., 2008; Shoubridge et al., 2010; Myers et al., 2012; Tran Mau-Them et al., 2014; Brown 
et al., 2016a). These mutations were located to the Sec7 domain and IQ motif, indicating that activity-
dependent removal of AMPA receptors plays a role in the etiology of cognitive impairment in these 
patients. It might therefore be instructive to explore the occurrence of missense mutations in the 
corresponding regions in synArfGEF in patients suffering from neuropsychiatric disorders. 
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Conclusions 
In the search for the molecular determinants of synaptic specificity, the role of a postsynaptic complex 
containing DG and synArfGEF was analyzed. The study of DG function, primarily based on the 
conditional ablation of DG in vivo, revealed that this complex is essential for synaptic specificity 
within the GABAergic neurotransmitter system. Furthermore, a novel role for the DGC in trans-
synaptic signaling was suggested by the requirement for DG in synaptic maintenance. Molecular 
analysis of synArfGEF function in vitro and in cell culture uncovered an unexpected role in regulation 
of mismatched GABAergic PSDs, thus conferring specificity between neurotransmitter systems. The 
regulatory role of synArfGEF did not extend to correctly matched GABAergic PSDs or to 
glutamatergic proteins, highlighting that both pre- and postsynaptic structures restrict synArfGEF 
function. Together, these findings demonstrate that the postsynaptic molecular heterogeneity reflects 
the presynaptic cell type and neurochemical diversity and that GABAergic postsynaptic proteins can 
mediate synaptic specificity. Due to the far-reaching implications for neuronal connectivity, these 
newly identified mechanisms will provide a framework for the understanding and treatment of clinical 
manifestations of synaptic defects. 
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APPENDIX 
Abbreviations 
5-HT3aR  5-hydroxytryptamine 3a receptor 
AAV   adeno-associated virus 
ACSF   artificial cerebrospinal fluid 
AMPA   α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AP2   adaptor protein 2 
Arf   ADP ribosylation factor 
BRAG   brefeldin A-resistant Arf-GEF 
CA   constitutively active 
CA1   cornu ammonis 1 
CaMKII  Ca2+/calmodulin-dependent protein kinase II 
CB1   cannabinoid receptor 1 
CCh   carbachol 
CCK   cholecystokinin 
Celsr3   cadherin EGF LAG seven-pass G-type receptor 3 
CGE   caudal ganglionic eminence 
cKO   conditional knock-out 
CMD   congenital muscular dystrophy 
CNS   central nervous system 
DG   dystroglycan 
DGC   dystrophin-glycoprotein complex 
DMD   Duchenne muscular dystrophy 
DN   dominant negative 
DSI   depolarization-induced suppression of inhibition 
ECM   extracellular matrix 
eGFP   enhanced green fluorescent protein 
ER   endoplasmic reticulum 
ERK1   extracellular signal-regulated kinase 1 
FISH   fluorescence in situ hybridization 
GABA   γ-aminobutyric acid 
GABAAR  GABA type A receptor 
GABARAP  GABAAR-associated protein 
GAD   glutamic acid decarboxylase 
GAP   GTPase activating protein 
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GEF   guanine nucleotide exchange factor 
GFAP   glial fibrillary acidic protein 
GlyR   glycine receptor 
GODZ   Golgi-specific DHHC zinc finger protein 
GSK3β   glycogen synthase kinase 3β 
GTP   guanosine triphosphate 
HEK293  human embryonic kidney 293 
ID   intellectual disability 
IgSF9b   immunoglobulin superfamily member 9b 
IP   immunoprecipitation 
IQSEC   IQ motif and Sec7 domain 
kDa   kilodalton 
KI   knock-in 
KO   knock-out 
LARGE  like-acetylglucosaminyltransferase 
LFP   local field potential 
LNS   laminin-alpha, neurexin and sex hormone-binding globulin 
LTD   long-term depression 
LTP   long-term potentiation 
mAChR  muscarinic acetylcholine receptor 
MDGA   MAM domain-containing GPI anchor protein 
MGE   medial ganglionic eminence 
MOR   μ-opioid receptor 
mRNA   messenger RNA 
nAChR   nicotinic acetylcholine receptor 
NL   neuroligin 
NMDA   N-methyl-D-aspartate 
NMJ   neuromuscular junction 
NPAS4   neuronal PAS domain protein 4 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PIP2   phosphatidylinositol bisphosphate 
PKA   protein kinase A 
PKC   protein kinase C 
PNS   peripheral nervous system 
PRIP1/2  phospholipase C-related catalytically inactive proteins 1 and 2 
PSD   postsynaptic density 
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PSD-95  postsynaptic density protein 95 
PTM   post-translational modification 
PV   parvalbumin 
qPCR   quantitative PCR 
Rac1   Ras-related C3 botulinum toxin substrate 1 
RGC   radial glial cell 
SH3   Src homology 3 
sIPSC   spontaneous inhibitory postsynaptic current 
SLM   Sam68-like mammalian protein 
SS   splice site 
SST   somatostatin 
S-SCAM  synaptic scaffolding molecule 
SUMO   small ubiquitin-like modifier 
VGAT   vesicular GABA transporter 
VGluT   vesicular glutamate transporter 
VIP   vasoactive intestinal polypeptide  
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